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SUMMARY
Virus-specified antigens induced in the membranes of infected 
cells have been implicated as primary targets in the recognition and 
destruction of virus-infected cells by the immune system of mammalian 
hosts*
Antigenic changes induced in the plasma membranes of 
vaccinia-infected HeLa cells 2 h post-infection were detected by immuno­
fluorescence, immune haemadsorption, and to a lesser extent by 
complement-fixation and complement-mediated cytolysis. Cytopathic 
effects (cell rounding) were seen prior to viral M A  replication and 
also when this was blocked. Other changes occurred at the cell surface 
later in infection when turkey erythrocytes and concanavalin A were 
bound by cells. There was no evidence for an overall increase in 
mucopolysaccharide synthesis in the form of sialic acid. Quantitative 
spectrophotometric assays for haemadsorption, immune haemadsorption and 
concanavalin A binding were developed and the effect of varying growth 
or reaction conditions on the expression of vaccinia haemagglutinin at 
the surface of infected cells was investigated. Vaccinia cell surface 
haemagglutinin (VHA), detected by the binding of turkey erythrocytes, 
was synthesised around 10 h post-infection, even under conditions of 
low multiplicity of infection, and was closely coincident with the 
appearance of infectious virus.
Of seven different cell lines tested, haemadsorption was 
greatest in HeLa cells and least in L-929 cells. Other red cell 
species were bound to infected cells to a lesser degree than turkey cells.
Ill
Haemadsorption occurred within the physiological and alkaline pH 
ranges and at temperatures between 20°C and 56°C. Haemadsorption 
was enhanced by pre-treatment of cells with trypsin or by infecting 
the cells in the presence of trypsin. Hyperimmune rabbit anti­
vaccinia y-globulin prevented haemadsorption (titre l/lOO) and also 
specifically displaced turkey red cells adsorbed to infected HeLa 
cells. Glutaraldehyde fixation of infected cells or susceptible red 
blood cells also prevented haemadsorption. An increase in concanavalin 
A binding sites on vaccinia-infected cells was demonstrated, distinct 
from binding sites for turkey red cells.
Plasma membranes were isolated from uninfected, or vaccinia- 
infected HeLa cells from monolayer cultures. The cells were swollen 
in low molarity buffer, gently homogenised and plasma membranes 
purified by differential and sucrose density gradient centrifugation.
The membrane fraction was characterised by phase contrast microscopy, 
polyacrylamide gel electrophoresis, specific uptake of ^H-L-fucose 
into membrane glycoproteins, and by the presence of the marker enzymes, 
potassium-dependent phosphatase and phosphodiesterase. The absence 
of the marker enzymes, NADH diaphorase (oxidase) and (3-glucuronidase, 
which are not plasma-membrane associated, was also noted.
In immunofluorescence tests 2 h post-infection, antiserum 
raised against plasma membranes from 24 h-infected cells displayed 
discrete membrane fluorescence. This antiserum also prevented 
haemadsorption, while antiserum to uninfected HeLa plasma membranes 
and anti-whole HeLa cell antisera also inhibited the red cell binding
IV
by up to 50 per cent, possibly by steric hindrance.
The relationship between vaccinia-induced cell surface 
changes and the extracellular and intracellular forms of poxviruses 
is discussed.
OBJECTS OF THE RESEARCH
Poxviruses occur in both an intracellular and an extra­
cellular form. Antiserum to extracellular virus neutralises both 
intracellular and extracellular forms whereas antiserum to intra­
cellular virus neutralises only intracellular virus. (Extracellular 
is surrounded by a loose outer envelope possibly derived from the 
host cell plasma membrane.)
A "late” viral antigen, haemagglutinin, is present both in 
extracellular virus and isolated plasma membranes and ^  situ at the 
surface of vaccinia-infected cells. The existence of "early" viral 
antigens at the cell surface has also been demohstrated.
The objectives of this work were:-
1. To quantitate antigenic changes at the cell surface during
vaccinia infection of HeLa cells, including the appearance 
of "early" and "late" viral antigens.
2. To examine the interaction of haemagglutinin iu situ with
antiviral sera, employing a quantitative assay.
3. To isolate and investigate the composition of plasma
membranes from vaccinia-infected HeLa cells, and the 
properties of antiserum to these.
4 . To investigate other surface changes in cells following
vaccinia-infection.
VI
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INTRODUCTION
The Poxviridae
Classification, struct-ural features and chemical composition
The family Poxviridae contains the largest and most complex of 
all viruses. The members are responsible for a wide range of diseases 
in man and animals including smallpox, molluscum contagiosum, cowpox, 
monkeypox and mousepox, all of which are characterised by the formation 
of papules, vesicles and pustules in the skin. Most poxviruses are 
closely related antigenically, and characteristically replicate and 
mature in the host cell cytoplasm, whereas most other viruses have 
their replication sites in the nucleus (Penner et al, 1974)*
Genus A (Table l) comprises the most intensively studied 
members, including the type species, vaccinia virus. The virions are 
brick shaped, containing an ovoid biconcave core or nucleoid where 
genetic material, cross-linked double stranded DNA (Holowczak, 1976), 
is located, which may be 122 to 161 x 10^ daltons (Geshelin and Perns, 
1974; Grange, 1974; Esteban, Flores and Holowczak, 1977a). The DNA 
is surrounded by lipids and proteins of viral origin representing the 
core, and is enclosed by a protein coat and a layer of regularly 
arranged coarse fibrils including the two oval-shaped lateral bodies, 
all composed of protein units (joklik, i960). The whole structure 
is bounded by an outer virion double membrane envelope (bales, 196$). 
The type species, vaccinia virus, and also rabbitpox virus, may derive 
a loose membrane from the host cell (Morgan at 1954; Nagington 
and Horne, 1962; Turner and Squires, 1971; Appleyard, Hapel and 
Boulter, 1971)* The fatty acid and phospholipid complexes existing
rd(U
"ëÜo
3
Ia
m
a cQ
P ou -H w bO P (d
S o
llQ
a g
(U QI
fH -P B
I
I
M
I
I
I
&
o'm
01
(D
I
I
I I
I
«
Mo;
iS o
MI
pi
o
XII
X&
8
H
0)HI
01Pk
m è
eg•H
.gÜI
&.SA P •H0) P
II
PP CQ
cS
X
I0103
P4
•HI
•ëM
U
Q•r-3
tHO
I
0 <3
p *H
H >
X0
1
Xo
PMOga
VDb-0\
r4
0)I
O
P
Î30IPi
8u
within the virion in the form of internal membranes (bales and Mosbaoh, 
1968) are distinctly different in composition from the host cell 
membranes, and this may be due to a virus-mediated selection mechanism 
leading to de novo membrane synthesis (stern and bales, 1974)* This 
may not exclude the possibility of host membraneous material being 
present on the virion after extrusion from the host cell.
Biochemically the virions of genera B and C differ insig­
nificantly from genus A, though anatomically they are somewhat more 
oval and narrow, while orf virus has a surface structure of spirally 
arranged tubules (Uagington and Horne, I962). The Avipoxviruses 
characteristically have a high lipid content and a large irregular 
envelope (Todd, Randall and Coniglio, 1958). The virions are similar 
in structure to those of genus A (Morgan and Wyckoff, 1950)*
I
However Muller ^  ^  (1977) analysed several poxviruses with restriction 
endonucleases and showed a high degree of genetic relatedness between 
individual orthopoxviruses but little genetic relatedness between 
these and fowlpoxvirus. The viruses of subgenus E are characterised 
by long growth cycles and the production of tumours in susceptible 
hosts (chappie and Westwood, I963). There are also a number of pox­
viruses which multiply in insects (Bergoin and bales, 1971)* Several 
other poxviruses remain to be classified absolutely though most of 
these have the same basic virion structure. This review will be 
concerned mainly with the members of subgenus A and in particular, 
vaccinia virus.
The vaccinia virion has a bHA content of 3 to 5 per cent 
(Zwartouw, I964; Joklik, I966), 4 to 6 per cent lipid (joklik, I966)
and 90 per cent protein (joklik, I966). The presence of trace amounts 
of high molecular weight RMA has also been demonstrated within the 
core (Roening and Holowczak, 1974» Paoletti, 1977)* Any carbo­
hydrate present can be accounted for by deoxyribose (Zwartouw, I964).
Although the poxvirus genome is theoretically capable of 
coding for approximately 200 proteins (joklik, 1974)» it is extremely 
doubtful whether this capability is realised. Some thirty to forty 
polypeptides have been identified within the vaccinia virion (Sarov 
and Joklik, 1972; Obijeski et al, 1973î MacRae and Szilagyi, 1975î 
Esposito, Obijeski and Nakano, 1977a), though more may be present 
(stern and Dales, 1976) since current techniques cannot detect poly­
peptides comprising ^  0.1 per cent of the virion,equivalent to 100 
protein molecules per particle (joklik, 1974)*
Poxvirions themselves possess various enzyme activities 
mainly located within the core. In addition, poxvirus replication 
may induce the formation of non virion-associated enzyme activities.
The enzymes associated with poxviruses are listed in Table 2.
The growth cycle
Some doubt exists as to the nature of attachment and entry of 
vaccinia virus into the host cell. Electron microscopical studies by 
Dales and co-workers, reviewed in Dales (1973), implicated viropexis 
as the prime mode of entry, but later work by Armstrong, Metz and Young 
(1973) and Chang and Metz (1976) suggested that entry was achieved by 
an initial fusion between the host cell plasma membrane and the 
envelope of invading virus particles. Following fusion and pene-
Table 2 Enzyme activities of poxviruses
A Virion-associated
(i) DMA-dependent RHA polymerase I Kates and McAuslan, 1967b
(ii) Nucleotide triphosphate 
phosphohydrolases I & II
Gold and Dales, I968; 
Paoletti and Moss, 1972b
(iii) Deoxyribonucleases (exo- and 
endo~)
Pogo and Dales, I969,
1971
(iv) Polyadenylate (a ) polymerase Moss, Rosenblum and 
Paoletti, 1973; Moss, 
Rosenblum and Gershowitz, 
1975» Brown, Dorson and 
Bollum, 1973; Brake1 and 
Kates, 1974
(v) Protein kinase Paoletti and Moss, 1972a; 
Kleiman and Moss, 1973
(vi) RNA-me thylase Wei and Moss, 1974
(vii) Polynucleotide 5'“tri­
phosphatase
Tutas and Paoletti, 1977
(viii) mRNA guanylyl transferase Martin, Paoletti and Moss,
1975
(ix) raRNA (guanine ?') methyl- 
transferase
Martin, Paoletti and Moss,
1975
(%) doRNA (nucleoside 2*) 
me thyltrans ferase
Martin, Paoletti and Moss,
1975
(xi) DNA "nicking-closing” enzyme Bauer _et 1977
B Virus-induced
(i) Thymidine kinase McAuslan, I963
(ii) DNA-dependent DNA- 
polymerase
Jungwirth and Joklik, I965
(iii) Deoxyribonucleases Jungwirth and Joklik, I965
(iv) dAT-primed poly All-synthetase Pitkanen at 1968
(v) Polynucleotide ligase Sambrook and Shatkin, I969
(vi) Ornithine decarboxylase Hodgson and Williamson, 1975
(vii) DNA-dependent RNA polymerase Nevins and Joklik, 1977
tration, the outer viral coat is probably deposited and dispersed over 
the cell surface after degradation by existing host cell enzymes 
(Chang and Metz, 1976). This leaves the protein-bound MA-containing 
core exposed but amenable to transcription. Viral DNA may alter on 
uncoating from double to single-stranded or "nicked", and cross-links 
may be removed (Pogo and O'Shea, 1978)*
Synthesis of "early" mRNA in poxvirus infected cells occurs 
in the absence of prior viral DNA replication (Oda and Joklik, 1967? 
Kates and McAuslan, 1967a) and approximately I4 per cent of the viral 
genome is transcribed at this stage (Kates and Deeson, 1970)• It has 
been reported that virus-specified polypeptides could be detected at 
twenty minutes post infection (p.i.), including one which regulates 
"early" raRNA synthesis (Metz and Esteban, 1972| Esteban and Metz, 
1973)' Two classes of "early" proteins exist; "early-early" proteins 
are translated from mRNA transcribed from the viral core before stage 
II uncoating, while "early-late" proteins originate from mRNA 
transcribed from "naked" parental DNA (McAuslan, I969). On the 
removal of the core coat, which seems to be under virus control 
(Subak-Sharpe and Pringle, 1975), the viral DNA is rendered susceptible 
to exogenous DNases (stage II uncoating).
Host cell functions are promptly reduced to a low level by 
the invading virus (Moss, I968), and disintegration of cellular DNA 
begins within 90 minutes of infection (Parkhurst, Peterson and 
Heidelberger, 1973)* Viral DNA replication begins 1.5 to 2.0 hours 
p.i. at selected sites or "factories" in the host cell cytoplasm# 
(Cairns, i960), and is complete by 6 hours p.i, coincident with the
appearance of infectious virus (joklik and Becker, I964). Viral DNA 
replication is apparently discontinuous, involving single-stranded 
DNA intermediates (Esteban and Holowczak, 1977) and replicating DNA 
contains loops of double-stranded DNA at the ends of the molecule, 
progressively increasing in size during replication (Esteban, Flores 
and Holowczak, 1977B)' Although evidence has been presented for some 
degree of nuclear viral DNA synthesis during vaccinia infection (La 
Colla and Weissbach, 1975), enucleate cells support some viral DNA 
synthesis but produce greatly decreased quantities of infectious virus 
(Prescott, Kates and Kirkpatrick, 1971; Pennington and Follett, 1974)» 
It may be that there is a requirement for nuclear processing or 
maturation of viral DNA.
Many enzymes, both virion-associated or induced by virus 
infection, have been identified in poxvirus-infected cells and may have 
a direct involvement in viral DNA, mRNA and protein synthesis (Table 2). 
Alternatively their function may be degradative or modificational.
As viral DNA is replicated, viral mRNA synthesis switches 
from "early-late" to "late-early" transcription, despite the continued 
synthesis of some "early" mRNA. The consequent translation of these 
mRNA species is concerned principally with the synthesis of virus 
structural proteins. The use of polyacrylamide gel electrophoresis 
(p a g e ) has been instrumental in elucidating both the number and the 
temporal appearance of virus-specified polypeptides.
Twenty polypeptides have been detected by 20 min p.i. (Esteban 
and Metz, 1975) while Pennington (1974) divided a total of 80 detectable
polypeptides into pre- ($0 polypeptides) and post- (50 polypeptides) 
replicative classes. Glycosylation of a small portion of these poly­
peptides is apparent; Moss, Rosenblum and Garon (1971) detected 
several "early" virus-induced glycoproteins, while a virion glyco­
protein is also present (Moss, Rosenblum and Garon, 1975)î the 
identification of three virus-specified glycopolypeptides in the 
vaccinia haemagglutinin (yHA) complex is also significant (ichihashi,
1977).
The process of maturation from naked replicated DNA to fully 
mature progeny virus particles has been followed by electron microscopy 
(Morgan et 1954) and by combined PAGE and electron microscopy 
(Sarov and Joklik, 1975)* The morphogenesis of vaccinia virus has 
recently been described in detail by Morgan (1976a,b) although an 
alternative maturation sequence has also been proposed (stern, Pogo and 
Dales, 1977).
Poxvirus Antigens and Polypeptides
Poxvirus infection of susceptible host cells results in the 
production of new viral proteins which can be identified biochemically 
and immunologically (Wilcox and Cohen, I969). A proportion of these 
proteins is incorporated into mature virions, either as structural 
or enzymic components; some proteins may be induced for purely control 
purposes and are only present in infected cells, while other proteins 
may be combinations of the above classes and have dual functions.
Early serological identification
Early work, reviewed by Smadel and Hoagland (1942), identified
two groups of antigens, nucleoprotein antigen (np) (Craigie and 
Wishart, 1934) labile-stable antigen (LS) (Shedlovsky and Smadel, 
1942). The NP antigen, an alkaline extract of purified virus, 
comprised 50 per cent of the virus mass and all of the D M  (Smadel, 
Rivers and Hoagland, 1942), Woodroofe and Penner (1962) demonstrated 
that the "antigen" was comprised of at least two distinctly different 
antigens, while Zwartouw, Westwood and Harris (I965) demonstrated 
several precipitin lines on reaction with convalescent anti-vaccinia 
serum.
Craigie and Wishart (I936) extracted acid-precipitable 
material (with two serological specificities) from vaccinia virus- 
infected cells, one of these was heat labile (L) and the other heat 
stable ( s ) .  Antiserum to each of these individual components 
precipitated both antigenic fractions and thus the LS complex was 
believed to carry both determinants.
The emergence of more powerful immunological and biochemical 
techniques has revealed that the LS and HP antigens are complex mixtures 
of viral components (Westwood et ad, 1965î Cohen and Wilcox, 1966,
1968), and consequently little further work has been carried out in the 
last decade into their nature. Any benefit to be derived from 
continued study of HP antigen is now in doubt.
Viral antigens and polypeptides in infected cells
The rapid cessation of host cell protein synthesis effected by 
vaccinia soon after infection (Moss, I968) and its reduction to a very 
low background level, has allowed analysis of viral proteins in infected
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cell extracts to be undertalcen with little or no interference from the 
host cell. Immunodiffusion and immunoelectrophoresis, detecting only 
the soluble antigens of poxvirus-infected cells, have revealed the 
presence of only 7 to 20 components (reviewed by Wilcox and Cohen,
1969), significantly less than the 200 proteins for which poxviruses 
are potentially capable of coding (joklik, 1974). Appleyard and 
Westwood (1964a) and Salzman and Sebring (I967) observed virus-specific 
precipitin lines as early as 1.5 hours p.i, while up to twenty lines 
could be shown by the end of the virus multiplication cycle.
The virion antigens and polypeptides
The early work referred to (page 8 ), was performed using crude 
preparations of virus, grossly contaminated by host material and 
soluble virus products. Definitive analysis of the proteins of the 
vaccinia virion could only be undertaken with purified virus (joklik, 
1962a,b). Marquardt,. Holm and Lycke (I965) reported that eight of
nine soluble antigens detectable by gel diffusion were virus structural 
proteins, while Westwood ^  ^  (1965) found only seven antigens from a 
detectable total of seventeen, which could be identified in degraded 
virus particles. Zwartouw ^  al (I965), using alkaline extracts of 
purified virus which solubilised about 20 per cent of the nitrogen 
present, found eight precipitin lines. However, Joklik (1966) argued 
that much improved solubilisation could be obtained using sodium dodecyl 
sulphate (SDS), facilitating detection of more viral antigens.
Recent examples of immunological analysis of the vaccinia 
virion have been concerned with serological comparisons between members 
of the Poxviridae (Baxby, 1975î Esposito, Obijeski and Nakano, 1977h).
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The search for a protective antigen and the existence of intracellular 
and extracellular forms of poxvirus
The identification of the "protective antigen(s)" of poxviruses 
would eliminate the need for a "live" vaccine with associated side 
effects. In the case of the poxviruses, the main aim has been the 
production of an efficient inactivating procedure, and this has yielded 
an array of perplexing results (Turner, Squires and Murray, 1970).
The soluble virus antigens have also been studied for 
protective qualities (Appleyard, I96I), but the most effective antibody 
response results from infection with live vaccinia virus (Appleyard, 
Zwartouw and Westwood, I964). However, in rabbits, inactivated 
vaccinia can elicit neutralising antibody. This is the case for virus 
inactivated by formalin (Parker and Rivers, 1936; Amies, I96I; 
Ramanarao, I962), alcohol (McClean, 1945), ultra-violet radiation 
(collier, McClean and Vallett, 1955î Kaplan, I962), gamma radiation 
(Kaplan, I96O) and heat (Madeley, I968). In most cases, rabbits 
developed some resistance to challenge with vaccinia virus. Virus 
multiplication is therefore not essential for the production of 
neutralising antibody but resistance achieved through an active 
infection provides the best protection.
It was previously assumed that the degree of protection 
conferred by a particular inactivated vaccine could be correlated with 
the level of neutralising antibody induced by it in the animal model 
and consequently the efficacy of vaccines was assessed in these terms. 
The findings of Parker and Rivers (1936), Reunders (I964), Kaplan, 
McClean and Vallett (1962), Ramanarao (I962) and Boulter, Zwartouw and
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Titmuss (1964), showed no correlation with this concept. Despite 
finding high levels of neutralising antibody to inactivated virus on 
subsequent intrademal (l D ) challenge, the degree of protection was 
low. Boulter (1969) acknowledged the important role played by the 
cell-mediated immune system and, in spite of the apparent lack of 
protection even when neutralising antibody levels were high, postulated 
that the humoral immune system was equally important. Based on the 
evidence that the passive transfer of serum from rabbits recovered 
from rabbitpox could prevent death from that disease (Boulter,
Westwood and Maber, I96I), and that virus preparations giving rise to 
high neutralising titres but low protection had been inactivated 
before injection. Boulter suggested that there was a fundamental 
antigenic difference between live naturally infectious virus, and 
virus inactivated by heat, W ,  formalin, etc., which, in turn, gave 
rise to different antibodies. Thus antibodies to inactivated virus 
might not react with live virus and despite high antibody titres to 
inactivated virus, little protection would be offered against live 
virus.
During poxvirus replication, only 10 per cent of virus was 
released naturally (Smith and Sharp, I96O) and distant spread of 
infection might be a function of naturally released virus, which would 
be considerably more important in interactions with the host immune 
system than cell-associated virus. Electron microscopy of poxvirus 
particles revealed the occasional presence of an extra outer envelope 
(Morgan ^  1954; Wagington and Horne, I962). Appleyard et al
(1971) presented evidence that naturally released or extracellular
13
virus (ECV) differed basically from cell-associated or intracellular 
virus (icy) by the acquisition of an outer envelope. However, 
despite neutralisation results similar to Appleyard et ^  for each 
type of virus. Turner and Squires (I97I) could find no evidence for 
the existence of an outer envelope.
The importance of intracellular and extracellular poxviruses 
and their antisera in immunity, have been reviewed by Boulter et ^
(1971) and Boulter and Appleyard (1973) and the lack of protection 
afforded by inactivated vaccines can now be assessed in terms of these 
observations. The source of virus used for preparation of inactivated 
vaccines was almost invariably ICY; after inactivation and immunisation, 
the antisera showed high neutralising titres against the test virus 
(again, ICY) but failed to protect against subsequent I D challenge 
with live virus containing ECY and ICY. The properties of ECY and 
ICY are summarised in Table 3*
Ideally, therefore, the vaccine which should offer maximum 
protection would contain inactivated ECV, However, inactivation of 
ECY may result in the destruction or loss of some important antigens, 
since the antiserum raised was incapable of neutralising either ECY or 
ICY (Turner and Squires, 1971). ECY may be susceptible to envelope 
damage since a constant proportion seems to be neutralisable by 
antiserum to inactivated virus (Appleyard et al, 1971; Baxby, 1972),
In addition, ECY, for reasons unknown, seems to be very poorly antigenic 
(Turner and Squires, 1971; Boulter and Appleyard, 1973), although 
antiserum did protect against ID challenge (Turner and Squires, 1971),
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The very low yield of ECV, its instability and poor antigen­
icity makes the large scale production of vaccine impracticable.
Equally impracticable, is the isolation of protective antigen(s) from 
ECV. However, by 24 hours p.i., rabbitpox-infected HeLa cells acquire 
a surface antigen which reacts with antiserum to live virus but not 
anti serum to inactivated ICY (Appleyard ^  al, 1971) suggesting that 
ECY derives its coat from the plasma membrane of the infected cell.
The surface membrane of infected cells might therefore be the possible 
location of a protective antigen although the apparent absence of host 
components on ECY has still to be explained (Appleyard and Hapel, 
unpub.; Turner and Eunkel, unpub. cited by Boulter and Appleyard, 1973).
Appleyard at ^  (I964) described a "serum-blocking" antigen in 
extracts of rabbitpox or vaccinia-infected tissues which reacted with 
neutralising antibody and induced its formation, on immunisation (Apple­
yard and Westwood, 1964a). In addition, in the case of vaccinia, 
protection against I D challenge was almost as good as that produced 
by vaccination with live virus but less effective protection was found 
with rabbitpox virus soluble antigen preparations. More recent 
studies have identified a virion component which elicited neutralising 
antibody to ICY and corresponded to a virion structural surface tubule 
polypeptide of molecular weight 58,000 (Stern and Dales, 1976).
Cell-mediated Immunity to Poxviruses
Any discussion of immunity to poxviruses must include a brief 
reference to the interactions of virus-infected cells and free virus 
with cells of the immune system. Recent experiments by Blanden and
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co-workers (reviews, Blanden, 1974? Doherty, Blanden and Zinkernagel, 
1976) have demonstrated the important role of circulating T lympho­
cytes in destroying virus-infected cells hy monitoring cell surface 
alterations occurring as a result of infection. These are discussed 
later•
Preparations of poxvirus-infected material have been known to 
confer immunological protection since the time of Jenner (1798) and 
more recent reports have confirmed this protection, in the form of 
delayed type hypersensitivity as a T cell-mediated response to poxvirus 
infection in vivo (Lawrence and Valentine, 1970) and in vitro 
(Koszinowski, Kruse and Thomssen, 1975). Using ectromelia virus 
infection of mice as a model system, the initial response seems to 
involve the recognition of viral antigen by T cells (Blanden, 1974). 
This provides an inflammatory response by polymorphonuclear leucocytes 
and macrophages. Macrophages are the dominant cells in recovery from 
infection by ingestion and destruction of virus.
Poxvirus and poxvirus antigens are capable of specifically 
transforming lymphocytes from immune donors (Rosenberg, Parber and 
Notkins, 1972; Hutt, 1975h). Poxviruses have also been shown to 
replicate within non-immune polymorphonuclear leucocytes in vitro 
(Benda, Cinate and Plaisner, 1975) and numerous reports have appeared 
of replication within non-immune but not immune macrophages (Tompkins, 
Zarling and Rawls, 1970b; Avila, Schultz and Tompkins, 1972; Greer, 
Delfs and McElree, 1974).
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Modifications of the host cell surface induced 
during poxvirus infection
Specific alterations of host cell surface architecture and 
chemistry by the insertion or removal of viral proteins, virus- 
induced lipid exchange and modification or replacement of existing 
host components by virus-specified proteins, have been recognised 
during the infection cycles of a number of viruses (Rifkin and 
Quigley, 1974). Virus induced cell surface changes either by 
antigenic modifications (Table 4) by an altered pattern of binding 
of the lectin, concanavalin A (con A) (Klehk, Becht and Rott, 1974), 
have been shown to occur during infection by many viruses.
Early antigenic alterations in the poxvirus-infected cell membrane
In terms of the host immune response, early poxvirus-induced 
cell surface antigens (VIGSA) may be important in eliciting antibodies 
involved in control of, or prevention of widespread infection. In 
concert with complement, early destruction of virus-infected cells by 
anti-VICSA may be possible. Later in infection, these antibodies may 
also be of some importance in allowing entry of neutralising anti­
virion antibody to infected cells.
Eagraeus and Espmark (I96I) first demonstrated the presence 
of viral antigens on the surface of vaccinia-infected cells by immune 
(mixed) haemadsorption. Similar areas of vaccinia-specific antigen 
on the cell periphery were observed by Morgan, Rifkind and Rose (1962) 
by electron microscopy using ferritin-labelled antibody. In these 
early studies, the exact nature of the antigen(s) under study was not
18
Table 4-
productive virus infection
Genus Virus Technique Reference
ALPRAVIRUS Venezuelan Equine 
encephalomyelitis
Immunofluore scence Hahon, I97O
chikungunya Immunofluore scence Mantani and 
Igarashi, 1971
ARENAVIRUS Lymphocytic
choriomeningitis
Immunofluorescence Rutter and 
Gshwender, 1973
PLAVIVIRUS Dengue Immunoperoxidase 
Immune cytolysis
Catanzaro et al,
1974
IWPLUENZA-
VIRUS
Influenza type A Immunofluorescence Hahon and 
Eckert, 1972
PARAMYXO­
VIRUS
Mumps Electron micro­
scopical techniques
Mannweiler and 
Rutter, 1973
LYSSAVIRUS Rabies Immune cytolysis Wiktor, Kuwert 
and Koprowski,
1968
POLYOMA-
VIRUS
Polyoma Immunofluorescence Irlin, 1967
HERPES­
VIRUS
I & II
II
Immune cytolysis 
Immunofluorescence
Brier et al,
1971
Ito and Barron,
1972a
Varicella-zoster Immunofluorescence I to- and Barron,
1973
Epstein-Barr Immunofluorescence Pearson et al,
1970
Marek's disease Immunofluorescence Chen and 
Purchase, 1970
Gytome galovirus Immunofluorescence The and 
Langenhausen,
1972
ORTHO­
POXVIRUS
Vaccinia Immunof luor e scence Ueda et al, 1969
Cowpox Immune haemad­
sorption
Miyamoto and 
Kato, 1968
Ectromelia Immunofluore scence Gardner, Bowern 
and Blanden,
1974a
LEPORI-
POXVIRUS
Fibroma Immune haemad­
sorption
Miyamoto and 
Kato, 1968
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clarified. Later studies (Miyamoto and Kato, I968; Ueda et al,
1969) identified early poxvirus antigen(s) located on the cell surface 
which appeared before viral DNA replication or when this was blocked. 
Miyamoto and Kato (I968) identified VICSA on two cell lines infected 
with either Shope fibroma or covjpox virus using immune haemadsorption. 
In the same test, antiserum to cowpox virus reacted with cells 
infected with other cowpox strains, two vaccinia strains, ectromelia 
and variola viruses while a weaker reaction was found with cells 
infected with Shope fibroma virus. Fluorescent antibody studies 
confirmed the above results and the authors also established that the 
immune haemadsorption reaction was not attributable to viral haemagg­
lutinin since no binding of susceptible chicken erythrocytes occurred 
if cytosine arabinoside (ara-C) was present during infection,
Ueda et ad (I969), using antiserum raised to purified vaccinia 
virus, demonstrated VIGSA by immunofluorescence on the membrane of 
unfixed vaccinia-infected HeLa cells. The antigen was detectable 
within two hours p.i. and did not require viral DNA synthesis for its 
expression. At this stage cytoplasmic viral antigens were absent.
By use of a mutant which failed to replicate in HeLa cells, but which 
did produce early VIGSA, protein synthesis was shovm to be required for 
expression, Miyamoto and Kato (197I) confirmed this requirement for 
protein synthesis and suggested that VIGSA mRNA was synthesised 
within one hour p.i.
Ueda at al (1972) exploited the non-replicating dermovaccinia 
mutant to produce a concentrated preparation of early virus soluble 
antigens, including VIGSA. Antiserum raised in rabbits to this
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preparation or to whole mutant-infected rabbit kidney cells reacted 
specifically with VTCSA on HeLa cells by immunofluorescence but not 
with cytoplasmic viral antigens, had a low neutralising titre and was 
capable of fixing complement. It was also shown that antiserum to 
UV-inactivated virus did not react with surface antigen but only 
cytoplasmic viral antigen. The antiserum prepared by Ueda ^  ^  was 
further tested by Ito and Barron (1972b), who confirmed the lack of 
vaccinia neutralising activity, noted the lack of haemagglutination- 
inhibiting (HAI) antibodies and found an immune haemadsorption titre
of 1/300,000.
Tanaka and Hatano (1973) made a comparative study of VIGSA 
production in a variety of cell lines infected with cowpox virus and 
noted that some lines were more efficient VIGSA producers, as 
indicated by fluorescent antibody testing, when viral DNA synthesis 
was suppressed. Addition of trypsin (0.5 M-S ml ^) during the virus 
adsorption period resulted in a significant increase in VIGSA 
formation although the appearance of cytoplasmic viral antigen was 
not enhanced. Pretreatment of cells or virus with trypsin led to a 
similar enhancement. The authors suggested that some cell lines 
possessed inefficient stage I virus-unceating systems and trypsin 
pretreatment of virus or cells facilitated this. This would then 
enable transcription and translation of early mRNA directed by the 
virus polymerase, leading to the expression of early functions. 
Further studies on the expression of cowpox VIGSA in VERO cells 
carrying a strain of Sendai virus, indicated that VIGSA was enhanced, 
possibly because of increased proteolytic enzyme activity in the 
carrier cells (Tanaka, Morita and Hatano, 1976; Tanaka, Ogura and 
Hatano, I977).
21
Tompkins ^  ai (1970a) used immunofluorescence to detect a 
cell surface antigen produced during infection of EK cells "by fibroma 
virus, which did not cross-react with anti-vaccinia serum. However, 
the kinetics of appearance of this VTCSA differed from that found 
with other non-oncogenic poxviruses in that ara-C was inhibitory and 
the antigen did not appear prior to viral DNA replication. The 
reaction of immune antiviral serum with fibroma tumours in vitro was 
found to be weaker than with virus-infected tissue culture cells 
(Tompkins and Schultz, 1972). This concurred with in vivo findings, 
where tumours failed to regress in the presence of high levels of 
cytotoxic antibodies. Earlier studies (Tompkins ^  al, 1970h) 
indicated the probable involvement of the cellular immune system in 
response to fibroma virus-induced antigens appearing at the tumour 
cell surface.
Interactions of the cell-mediated immune system with poxvirus- 
induced cell surface antigen
Ueda and Tagaya (1973) first suggested an involvement of the 
cellular immune system relating to the appearance of early poxvirus 
VIGSA. A concentrated early soluble antigen preparation was capable 
of inducing skin resistance to vaccinia, while neutralising activity 
against both EGV and ICV was absent; immunisation of rabbits with 
the early soluble antigen preparation in the absence of adjuvant 
enhanced ID virus multiplication inducing gross skin lesions. The 
occurrence of early poxvirus antigens on the cell surface has 
acquired further importance following the elucidation of the role of 
cytotoxic thymus-derived (T) lymphocytes in immune surveillance of
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virus-infected cells both in vitro and in vivo (Doherty-et al, 1976). 
Yirus-inraiune cytotoxic T cells inhibited growth of vaccinia virus 
in target cells in vitro by destroying them before virus assembly 
(Zinkernagel and Althage, 1977)-
The mouse-derived L-929 cell system has been intensively 
studied with regard to the appearance of virus-specific antigens at 
the infected cell surface, the modification of the H-2 transplantation 
antigens on these cells as a result of virus infection and in vivo 
appearance of specific cytotoxic "killer" T cells directed specifically 
against target cell surface viral antigens.
Viruses producing VIGSA and giving rise to cytotoxic "killer"
T cells include lymphocytic choriomeningitis virus (LCM) (Doherty, 
Zinkernagel and Ramshaw, 1974), ectromelia virus (Gardner, Bowern 
and Blanden, 1974h), parainfluenza (Sendai) virus (Ertl and Koszinowski, 
1976a; Doherty and Zinkernagel, 1976), SV40 (Trinchieri and Knowles, 
quoted in Doherty et 1976), measles (Labowskie et al, 1974), 
coxsackie B3 (¥ong, Woodruff and Woodruff, 1977) and vaccinia 
(Koszinowski and Ertl, 1975&; Zinkernagel, 1976). The original 
finding that immune T cells in mice became sensitised to altered 
"self" antigens following infection with LGM virus (Zinkernagel and 
Doherty, 1974a,b) was followed by similar observations with the pox­
viruses, ectromelia (Gardner, Bowern and Blanden, 1975) and vaccinia 
(Koszinowski and Ertl, 1975a). The "killer" T cells so induced 
lysed specifically only syngeneic target cells compatible at either 
the H-2K or H-2D genetic locus and infected with the same virus, as 
measured by the release of ^^Gr (Blanden et 1975? Koszinowski 
and Ertl, 1975a,b).
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Ectromelia-immuüie spleen cells were shown to specifically 
lyse target virus-infected B929 cells in the absence of complement 
by 4 hours p.i. (Gardner ^  1974a). The effector cells were
identified as T cells and no blocking of cytotoxicity by immune or 
hyperimmune antiviral serum pretreatment of target cells was evident. 
Ada et ai (1976) demonstrated that such virus directed cell surface 
changes occurred in the absence of viral DNA synthesis. Protein 
synthesis was required for the development of susceptibility to T 
cell-mediated cytolysis, and this occurred within one hour p.i.
Jackson, Ada and Tha Hla (1976) compared the PAGE polypeptide profiles 
of purified plasma membranes from target uninfected and 2 to 5 hour 
infected cells; no major demonstrable difference in plasma membrane 
protein composition was found at this stage. It was suggested that 
only minor antigenic changes, not readily detectable as new poly­
peptides, occurred on the target cell surface, which were however 
sufficient to render the cells susceptible to T cell-mediated cytolysis-
Koszinowski and colleagues have carried out similar studies 
yielding similar conclusions with immune T cells from vaccinia virus- 
infected mice (Koszinowski and Ertl, 1975o,b,c, 1976; Koszinowski 
and Thomssen, 1975)» Virus-specific antigens were found by surface 
immunofluorescence on infected L929 cells by 2 hours p.i.,
Koszinowski and Ertl (1975%) further reported that H-2 allo- 
antisera, with no cross reactivity against vaccinia virus could 
inhibit the lysis of vaccinia-infected target cells. Blocking was 
achieved only when an antiserum directed against H-2 antigens of the 
target cells was added. This suggested that the target antigen might
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be either a specifically altered H-2 antigen different from virus 
cell surface antigens, or a combination of non-specifically altered 
"self" and virus cell surface antigens. A close relationship 
between H-2 and VIGSA was implied by the finding that vaccinia- 
infected cells had a reduced capacity to absorb H-2 antiserum while 
virus specific immunofluorescence was reduced on preincubation of 
the infected cells with the same antiserum. Proof that the "altered 
self" hypothesis was correct in the case of vaccinia was obtained by 
Koszinowski and Ertl (l975h,c) by quantifying possible H-2 alterations 
by immunofluorescence and enzymatic reduction of H-2 antigens which 
reduced cell-mediated cytotoxicity without affecting anti-vaccinia 
antibody-mediated cytolysis. Virus-specified cell surface antigens 
could be removed by enzyme treatment (Ertl and Koszinowski, 1976b) 
but resynthesis of these antigens was demonstrable within four hours ; 
host H-2 antigens were not, however, resynthesised, presumably because 
of the general brealcdown of host metabolism.
Koszinowski and Ertl (I976) suggested an important role for 
early vaccinia-coded cell surface antigens in both the generation of 
cytolytic T cells in vivo and as the target antigens involved in T 
cell immune cytolysis. Early VIGSA production was common to cells 
infected with each virus strain tested, although the Elstree (Lister) 
strain was an inefficient producer (see also Ito and Barron, 1972b). 
Antibody to purified virions however did not react with VIGSA, 
suggesting the existence of distinct non-virion antigens at the 
vaccinia-infected cell surface.
Demonstration of poxvirus VIGSA by radioimmunoassay
The effect of antibody and complement on vaccinia virus-
25
infected cells in vitro has been examined by Brier _et ^  (1971)
who proposed that several factors influenced cell destruction, notably
the density of viral antigens on the cell surface, the nature of the
antiviral antibodies and the presence of anti-immunoglobulins,
51However, a substantial increase in Cr release was only found by 10 h 
p.i. suggesting that either VIGSA did not appear until this time or 
that they were not of a sufficiently high density to be assayed 
earlier.
Hayashi, Rosenthal and Notkins (1972) measured the binding of
125^Iodine labelled rabbit anti-vaccinia y-globulin to vaccinia-infected 
cells. By one hour p.i., three to four times more antibody had 
bound to infected than uninfected monolayers and binding increased 
precipitously from 5 h. The early binding of antibody may have been 
a result of the high m.o.i, (multiplicity of infection) employed 
rather than early viral antigens, resulting in some deposition of 
virion material on the cell surface but later than 2 hours p.i. 
new antigens were actively synthesised.
125The binding of ^Iodine-labelled rabbit anti-vaccinia y- 
globulin was also investigated by Harry and Medzon (1974)• Binding 
to infected monolayers was found to decrease from 0 to 50 minutes 
while from 45 minutes p.i. to 12 hours p.i., binding increased. The 
presence of "early" VIGSA was suggested by the fact that no DNA 
synthesis was required for its appearance, although RNA and protein 
synthesis were essential. The "early" virus induced cell surface 
antigen was not blocked by antiserum to host cell components.
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Poxvirus-induced changes in cell saarface structirce and composition
A series of papers by Bandlow and others indicated that cells 
infected with vaccinia virus were more efficient than uninfected cells 
in eliciting an antibody response to host cell antigens, when 
injected into guinea-pigs, i.e. the virus had an adjuvant effect 
(Bandlow, Kieling and Thomssen, 1971)• This effect was present prior 
to virus maturation and was attributable to viral antigens on the cell 
surface (Bandlow, Fischer and Thomssen, 1972). The adjuvancy seemed 
to be located in an isolated plasma membrane fraction from vaccinia- 
infected cells (Bandlow, Koszinowski and Thomssen, 1973)- Increases 
in antibody levels against host cell antigens were apparent and an 
increase in cell-mediated immunity was also noted (Bandlow and 
Koszinowski, 1974)* Live virus was not required and the appearance 
of "adjuvancy" seemed to be an "early" event. The adjuvancy was 
attributed to an intimate association of viral and host antigens.
Bandlow ^  ^  (1973) noted that in addition to displaying 
early viral antigens on the infected cell surface, the cells became 
agglutinable by con A (2 h p.i.). Early changes in the virus-infected 
cell surface, resulting in increased con A agglutinability, occur 
generally on virus infection (Tevethia et al, 1972; Becht, Rott and 
Klenk, 1972; Salzberg and Raskas, 1972; Ludwig, Becht and Rott, 1974) 
as well as on viral transformation (Inbar and Sachs, I969).
Zarling and Tevethia (1971) observed the same effect during 
vaccinia-infection of rabbit kidney cells as early as 2 hours p.i.. 
Heat-inactivated or neutralised virus failed to induce agglutinability 
and the possibility of a virion component being responsible was
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excluded, since viral protein synthesis hut not IMA synthesis was 
required. The authors suggested the component responsible for 
agglutination might be a viral glycoprotein. Since trypsin could 
induce agglutinability of normal cells by exposing con A binding 
sites (Burger, I969), the insertion of a viral glycoprotein at the 
cell surface might cause rearrangement of host components leading to 
the same situation.
Bubel and Blackman (1975) assayed con A-binding sites using 
mouse erythrocytes reacted with con A-treated vaccinia-infected HEp-2 
cells. Red cell binding increased from 5 hours p.i. and the binding 
sites were distinct from the VBA binding sites. Binding sites for 
con A were identical to those induced in Newcastle disease virus- 
infected cells. Bubel and Lambert (1967) suggested that increases 
in auto-agglutinability of cells during vaccinia infection were 
attributable to the deposition of acidic mucopolysaccharides on the 
cell surface. Sialic acid synthesis was related temporally to virus 
appearance and accumulated particularly on the cell surface.
However Bubel and Blaclonan (1975) failed to remove surface sialic 
acid by neuraminidase treatment. The increase in sialic acid 
synthesis on vaccinia infection of HEp-2 cells was concluded to result 
in increased intracellular deposition of sialic acid.
An increase in cell size after vaccinia infection leading to 
a decrease in buoyant density was demonstrated by Ball and Medzon 
(1975)* This shift was equated with virus-induced cell surface 
changes and was present by 2 hours p.i. Further studies (Ball and 
Medzon, 1976) established that the density shift was due to the
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synthesis of an "early-early" virus-coded protein and did not require 
viral W A  synthesis.
Cytopathic effects of poxviruses
Invasion of susceptible cells by poxviruses leads to a 
readily recognisable early rounding (Bro\m, Mayyasi and Officer, 1959)' 
A relationship between the cytopathic effect (c.p.e.) and viral 
protein synthesis was indicated by Appleyard, Westwood and Zwartouw 
(1962). Viral antigens could be found by 90 minutes p.i. at a stage 
when cell rounding had begun. Non-replicating virus induced rounding 
and also the synthesis of some viral antigens, but the toxicity could 
not be attributed to inoculum virus. Inhibitors of viral protein 
and RNA synthesis protected infected cells from c.p.e. (Bablanian, 
1968), When these inhibitors were removed viral c.p.e. began almost 
immediately suggesting that a viral protein(s) was responsible for 
early rounding, Bablanian (1975) reported that early c.p.e. was 
related to the m.o.i., was actually faster when this was low and 
seemed to require a background of host protein synthesis. He 
suggested that virus inhibition of host protein synthesis was not 
mediated by a virion component, but was associated with synthesis of 
viral RNA.
Late c.p.e., represented by the fusion of rounded cells into 
polykaryocytes (Appleyard et I962) follows virus replication.
This may be associated with the accumulation of cell surface material 
discussed earlier (Bubel and Lambert, I967). Fusion may be exogenous 
(Mbuy and Bubel, 1976) or endogenous (Kaku and Kamahora, I964;
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Ichihashi and Bales, 1971). Late vaccinia c.p.e. may also be 
associated with an increase in activity of host lysosomal enzymes as 
a response to infection (Allison and Sandelin, I963) although this 
has been questioned (Wolff and Bubel, I964).
The toxicity of viral proteins acting intracellularly has 
been shown by Stephen et ^  (1974)» HeLa cells were killed by 
inducing the uptake of a virus-free soluble antigen fraction from 
vaccinia-infected HeLa cells. The cytotoxic factor was tentatively 
identified as a virus-coded protein of molecular weight ^0-100,000 
daltons (Wolstenholme et al, 1977)*
Poxvirus haemagglutinin
Introduction. Nagler (1942) found evidence for the existence of
a by-product of vaccinia virus infection of chorioallantoic membranes 
(cam) which specifically agglutinated approximately 50 per cent of ^  
op adult fowl(erythrocytes^ This was in contrast to the large range of 
red blood cells found by Hirst (194I) 1° be agglutinable by influenza 
virus.
Burnet and Stone (I946) demonstrated that vaccinia haemagg­
lutinin (VEA) was separable from infectious virus particles by 
absorption with susceptible fowl red blood cells. Initial attempts 
to elute VHA from the agglutinated red cells were unsuccessful, but 
treatment with anti-vaccinia hyperimmune serum did remove VHA, and 
the inclusion of antiviral serum in VHA titrations inhibited 
agglutination.
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Haemagglutinin was serologically specific, inactivated at
2 ■
pH 5*0 or by moderate heat, inhibited by Ga ions, precipitated by 
50 per cent saturated ammonium sulphate, oxygen-labile and was 
inactivated by Cl, perfringens a-toxin and cobra venom (Burnet,
1946 Burnet and Stone, 1946; Stone, 1946a.). There have been no 
other reports of oxygen lability, and other workers have emphasised 
the heat stability of VHA (Chu, 1948a; GGKvin. and Haukenes, 1976; 
Tagaya _et 1977).
Purification and properties. Chu (1948a,b), in an extensive study 
of the chemical and immunological properties of crude VHA, reported 
a particle size of 65 nm, a tissue-dependent density of I .09 to 
1.11 gm 1*"^ , and stability between pH 5.92 and 10,79* Virus-specific 
HA could be recovered by boiling VHA/anti-VHA complexes eluted from 
agglutinated red cells, Chu concluded that VEîA was a virus-host 
complex unrelated to the neutralising antigen(s) of the virus particle.
Later workers attempted to improve the purity of the VHA 
used for chemical and immunological analysis. More than one virus 
specified HA was found by Gillen, Burr and Nagler (I950); McCrea and 
O’Loughlin (1959) and Youngner and Rubenstein (1959). The latter 
authors subsequently found evidence for a "soluble" HA in uninfected 
CAMs (Youngner and Rubenstein, I962). Lipid analyses of both 
uninfected and vaccinia-infected CAMs showed that infected membranes 
contained less phospholipid than uninfected controls while the semi­
purified non-viral "soluble" HA had a high triglyceride content with 
phosphatidyl choline as the major phospholipid (Gausch and Youngner,
31
1963). It was suggested that VHA was an abnormal lipoprotein of 
virus-host origin, formed under conditions of increased cell lipid 
and protein (Gausch and Youngner, I965). Anthony et ^  (1970) 
found three distinct virus-specified HAs in variola virus-infected 
CAMs; a low density, heat-labile HA, a higher density, heat- 
labile HA (possibly an aggregate of the above), and a heat-stable 
intra-virion HA released by reducing agents.
Gurvin and Haukenes (1973) separated VHA from infectious 
virus particles at a density of 1.08 to 1,18 gm 1 Material from
a second-stage flotation failed to exhibit bands on PAGE or to 
precipitate with antiviral serum on immunodiffusion. Neff, Ackermann 
and Preston (1965) found significant variation in the buoyant density 
of VHA from various tissue cultures and the original buoyant density 
was retained following recentrifugation. The authors emphasised the 
heterogeneity of VHA and its susceptibility to aggregation at 4°C in 
concentrated preparations; the drop in titre was restored by 
sonication. Gurvin and Haukenes (1976) noted that VHA was inactivated 
by trypsin treatment, in contrast to the trypsin-resistant HA of 
Youngner and Rubenstein (I962). No evidence was found for the 
presence of carbohydrate, and, contrary to previous findings (Burnet 
and Stone, 1946), the HA activity was resistant to lipase and phospho- 
lipase treatment; VHA was heat stable (56^0 for 24 hours) and stable 
between pH 5*0 and 9*0 at 57°0. Gwvin and Haukenes reported a 
sedimentation coefficient of 5OS for VHA.
The separation of VHA into components and subsequent 
"reconstitution" was described by Smith, Pratt and Baxby (1973).
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After the removal of debris from disrupted cowpox or vaccinia virus- 
infected cells, VHA was deposited by high speed centrifugation, 
extracted with organic solvents and subjected to column chromatography. 
Some fractions showed high non-specific HA activity, but did not 
react with anti-HA, while other fractions blocked anti-HA but did not 
haemagglutinate. Recombination of fractions restored the compat­
ibility of antibody-blocking and HA activities. The antibody-blocking 
fractions had a high protein content and no lipid, while the HA rich 
fractions had a high lipid content. No reconstitution was possible 
if the corresponding HA fractions from an HA-negative strain of 
rabbitpox virus were employed or if the corresponding "antibody-blocking” 
fractions were mixed with HA-positive fractions. This established a 
specific haemagglutinating and antigenic combination of lipid and 
protein components only from HA-positive strains. A recent study by 
Ichihashi (1977) however implied that combination between the poxvirus 
specific HA protein component and any phospholipid restored HA 
activity. It was suggested that the insertion of VHA-specific protein 
into liposomes might be essential for the enhancement of heat stability 
and the acquisition of antigenicity.
The range of red blood cells agglutinated by VHA. Early studies by 
Nagler and colleagues (Nagler, 1942, 1944; Clark and Nagler, 1945) 
established that extracts of vaccinia virus-infected tissue specifically 
agglutinated red cells from 50 per cent of adult chickens. Embryonic 
chick red cells were not agglutinated but by six months approximately 
50 per cent of these chickens had red cells susceptible to agglutination.
Of a wide range of other red cells tested (Table 5) the only 
non-fowl species regularly giving agglutination with VHA was the mouse.
Table 5 The agglutinability of red blood cells by poxvirus
haemagglutinin
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Species Result Reference
chicken 3
chick embryo - 2
turkey + 5
pigeon + 1 , 2
cat 4- 4
horse — 3, 4
human - (+) 1,(4)
sheep - 1, 3, 4
rabbit " (+) 1,(4)
mouse + 1, 2, 4
rat - (+) 1,(4)
pig + 4
cow — 2, 4
1. Burnet and Stone, 1946
2. McCarthy and Helbert, I96O
3. Nagler, 1942
4. Clark and Nagler, 1945
5. Batt, 1964
S ê i
4- erythrocytes agglutinated
- weak or doubtful reaction
- erythrocytes not agglutinated
re.-suit(■ )
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Batt (1964) and Joseph (1974) showed that turkey erythrocytes were 
uniformly agglutinable by VHA; from a total of 214 birds tested 
by Batt, only one failed to react.
Gilmour and Allison (1969) reported that agglutinability by 
fowl erythrocytes was genetically determined by the blood group 
factor Vh, unlinked to groups C, L, and N and probably A and B.
This was a dominantly inherited trait, while failure to agglutinate 
was a recessive autosomal trait. The alleles determining the K 
system of red blood cell iso-antigens were found to control the 
susceptibility to agglutination (Brown, Briles and Brown, 1975)*
Haemadsorption to poxvirus ^-infected cells. Tissue culture cells 
infected with influenza virus were shown to adsorb guinea-pig red- 
blood cells (Vogel and Shelokov, 1957)» a reaction specifically 
inhibited by antiserum to the infecting virus. Other viruses, 
including vaccinia, were shown to cause similar adsorption of various 
red blood cell types to the surface of infected cells (Shelokov,
Vogel and Chi, 1958)* The reaction, termed "haemadsorption," 
could also be demonstrated with virus-infected tissue sections 
(0*Connell £t I964). Briessen and Greenham (1959) attempting to 
correlate haemadsorption (HAD) with a property of VHA, found that 
some fowl cells were HAD positive, while appearing to be negative in 
the HA test. They therefore postulated an independent factor 
responsible for HAD. Fujio (1962) and Bekking and van Billen (1968) 
however found complete correlation between HAD and HA. In an 
extensive study of VHA, Blackman and Bubel (1972) correlated the 
temporal appearance of VHA and HAD at about 9 b p.i.* Calcium ions.
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which inhibit poxvirus HA (Burnet and Stone, 1946; Williamson, I966), 
inhibited HAD also, as did sucrose, while the binding of red cells 
was abolished by trypsin. Plasma membrane ghosts from vaccinia- 
infected cells also adsorbed sensitive red cells, suggesting an 
intimate association of VHA with the outer cell membrane.
Bubel and Blackman (1975) reported that the appearance of 
progeny virus preceded HAD by 90 min. The binding site for VHA- 
susceptible fowl red cells was different from that for con A.
Ichihashi, Matsumoto and Bales (l97l) and Ichihashi and Bales 
(1971), comparing HA^ and HA vaccinia strains, noted that ferritin- 
labelled antibody bound to the plasma membrane of HA*** but not HA”- 
infected cells and suggested that VHA became inserted into the plasma 
membrane. HA^ virus, unlike the negative mutant, migrated "naked" 
to the cell surface and probably associated with the modified plasma 
membrane just prior to release. VHA was detected in infected cells by 
10 h.p.i., rising to a maximum at 18 h, . Cells became HAD*** by I5 h p.i, 
and on examination by electron microscopy, the bound red cells were in 
intimate contact with the cell membrane. Cytoplasmic fluorescence 
of viral antigen was evident by 7 b p.i. and cell surface fluorescence 
by 10 h p.i, . Saburi et ^  (1977) demonstrated by scanning electron 
microscopy that vaccinia-induced HAD of susceptible red cells occurred 
either by direct, close binding to the tissue culture cells, by binding 
through microvilli of infected cells or by binding of projections of 
the red cells.
Electrophoretic analysis of plasma membranes from vaccinia-
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infected HeLa cells by Weintraub and Dales (1974) showed the following 
results. Pre-existing host plasma membrane proteins and glyco­
proteins were not modified. A major plasma membrane glycoprotein, 
synthesised after infection by an HA strain, was iderAifired as a 
component of VHA, This was absent from the plasma membranes of cells 
infected with HA virus although a polypeptide portion of the glyco­
protein was synthesised but lacked carbohydrate. The glycoprotein 
was synthesised and inserted late in infection ( ~ 10 h p.i.) and this 
could be prevented by inhibitors of viral DNA replication but not 
rifampicin. The carbohydrate moiety included fucose and glucosamine 
residues, and thus was distinct from the simpler virion glycoprotein 
(llolowcaak, 1970; Garon and Moss, 1971; Sarov and Joklik, 1972). 
Evidence was found for a possible virus-specified VHA precursor in 
the plasma membrane. Immunological studies suggested that the 
insertion of new surface components caused surface antigenic rearrange­
ment. VHA was distributed evenly on the cell surface without capping 
(c.f. Ichihashi and Dales, 1971)*
These findings were extended by Ichihashi (1977) who identified 
a VHA-specific glycoprotein complex associated with a microsorae 
fraction from cells infected with an HA*^  strain of vaccinia. The 
complex comprised three glycopolypeptides of molecular weights, 150,000,
34,000 and 12,000 daltons. The first, a polymeric form of the second, 
was equivalent to the major plasma membrane virus-specified glyco­
protein of Weintraub and Dales (1974)* Synthesis of a host cell 
membrane protein (24,000 daltons) continued until 6 h p.i. when virus- 
specific glycosylation of this molecule began. Polymerisation of the 
VHA-glycosylated host protein was proposed to occur almost immediately 
within the membrane.
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The association of VHA with the virus particle. The question of the 
existence of a specific HA associated with vaccinia virions has until 
recently been unresolved because of the difficulties in obtaining 
highly pure virus free from residual contaminating VHA and in 
demonstrating it to be so. Burnet and Stone (1946) first showed that 
reduction of the HA^g titre by absorption with susceptible red cells 
did not reduce the virus titre, and similarly high speed centrifugation 
of virus did not reduce the HA titre significantly. Thus virus and HA 
seemed to be separable entities apparently confirmed by other evidence 
(ichihashi and Dales, 1971? Blackman and Bubel, 1972). Using highly 
purified virus, Joklik (1962a,b) and Zwartouw, Westwood and Appleyard 
(1962) showed that on centrifugation on sucrose density gradients, 
virions and VHA were readily separable and the virions had no 
demonstrable HA activity. Westwood jet al (I965) found that antiserum 
raised to gradient purified virus could not inhibit haemagglutination.
However Anthony £t al (1970) using variola virus, purified by 
sucrose density gradient centrifugation and disrupted with SDS, urea 
and 2-mercaptoethanol, isolated a heat-stable HA free of host antigens. 
Marquardt (1971) also demonstrated that purified vaccinia virus 
contained a virus-specified HA, only found when particles were disrupted 
by pepsin treatment. Immunisation with this material elicited an 
antibody response to VHA.
Studies by Boulter and Appleyard (1973) on the existence of 
extracellular and intracellular forms of poxviruses, suggested that 
the extra envelope derived by EGV might contain cell surface components 
and in particular VHA. Preliminary observations (Boulter and Thornton,
58
unpublished) indicated that EGV did indeed have HA activity. Further 
observations (Payne and Norrby, 1976) showed that EGV from HA"^  strains 
adsorbed to susceptible red blood cells, whereas EGV (HA ), IGV (HA*^ ) 
and IGV (HA~) viruses did not. The removal of EGV (HA***) virus by 
adsorption led to a concomitant drop in the HA^q titre and infectious 
virus titre of the residue. Adsorption could be inhibited by antibody 
to ha"** virus. These observations suggested the presence of VHA in 
the envelope of EGV which may partially explain conflicting reports on 
the existence of virion HAs.
Kinetics of VHA appearance
"Gytoplasmic" VHA has been detected approximately 10 h p.i., 
just after the appearance of mature virus (Baxby and Rondle, I968; 
Blackman and Bubel, 1972; Weintraub and Dales, 1974)* As a late 
cytopathic effect after cell rounding, vaccinia-infected cells may fuse 
to form giant multinucleate cells or polykaryocytes (Appleyard et al, 
1962; Kaku and Kamahora, I964). The latter authors demonstrated 
that fusion**" strains of vaccinia were VHA and vice versa. Inhibitors 
of viral DM, E M  and protein synthesis prevented fusion although 
mitomycin did not. Ichihashi and Dales (l97l) confirmed the 
independence of fusion and HA capacities, and suggested that the fusion- 
inducing component was carried by mature virus to the cell surface 
from within host cells. Acquisition of VHA at the cell surface may 
be linked to inhibition of fusion possibly by surface modification, 
and cell fusion is by implication a recessive characteristic.
Weintraub and Dales (1974) found a similar polypeptide 
composition of plasma membranes from cells infected with fusion"** HA
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and fusion HA**" strains. However in the case of the fusion^  ^HA**" 
strain, only one polypeptide, component had a carbohydrate residue.
This implied that the conversion from fusion to fusion^  ^was 
associated with the acquisition of a carbohydrate residue(s) on the 
putative VHA glycoprotein. Later, Weintraub, Stern and Dales (1977) 
showed that addition of 2-deoxy-D-glucose or glucosamine inhibited 
glycosylation of virus-specified proteins. The blocking of ^H-fucose 
incorporation was correlated with inhibition of glycosylation, HA 
activity and virus infectivity but there was no effect on capacity 
for cell fusion.
Stern and Dales (1976) isolated surface tubules from purified 
vaccinia particles which were comprised of homogeneous polypeptide of 
molecular weight 38,000 daltons. This polypeptide which carried both 
neutralising and cell fusing capacities corresponded to polypeptide 4c 
of Sarov and Joklik (1972).
Inhibitors of poxvirus HA
The effects of metabolic inhibitors on the production of VHA 
are summarised in Table 6 and confirm the concept of VHA as a late 
antigen appearing after virus replication. Rifampicin acts at a late 
stage in maturation (Follett and Pennington, 1975) arresting the 
further development of virus, but at a stage after VHA has been 
synthesised. The role of bromodeoxyuridine (BUdR) is less clear.
High doses of BUdR had little effect on VHA synthesis although yields 
of infectious virus were insignificant with minimal doses of the drug 
(Baxby and Rondle, I968; Aasen and Haulcenes, 1972). As with rifampicin, 
immature viral membranes accumulate in the cytoplasm when BUdR
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is present (Easterbrook and Davern, I965) and synthesis of several 
virus soluble antigens occurs (Appleyard and Westwood, 1964b). 
Discrepancies regarding the effects of mitomycin C on VHA synthesis, 
can possibly be attributed to varying test conditions. Inhibitors, 
either of VHA synthesis or of the red blood cell-VHA interaction, 
have been detected in a number of tissues. Burnet and Stone (1946) 
described the non-specific agglutination of VHA-susoeptible red blood 
cells by tissue extracts and Stone (1946b) demonstrated the affinity 
of lipid dispersions for the same red cells. Agents such as calcium 
ions and phospholipases are regarded as inactivators rather than 
inhibitors of VHA (Stone, 1946a).
Nagler (1942) reported that calf lymph with a high virus 
content contained little VHA. Virus of similar titre, grown on CAMs 
with rich in VHA,and Chu (1948b) reported a VHA-inhibitor in calf 
lymph. Some vaccinia strains were shown to produce VHA in rabbit 
but not calf dermis (Stone and Burnet, 1946) and Rondle (1969), who 
fractionated extracts of calf dermis by gel filtration, recovered VHA 
blocking activity in only one fraction. The inhibitor was thought to 
be a single protein and was not an inmmnoglobulin.
Collier (1949) demonstrated a VHA inhibitor from crude extracts 
of human lung while Szathmary (I96O) found inhibitors of VHA in various 
human body fluids and tissue extracts. These were thermostable and 
inactivated by trypsin/kaolin.
In the above cases, it is likely that inhibition of VHA 
occurred by biophysical means rather than by suppression of HA synthesis. 
However studies by Cassel and colleagues have established that HA"*"
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strains of vaccinia lose the capacity to produce VHA on prolonged 
passage in Ehrlich ascites tumour cells; subsequent passage in 
embryonated eggs and immunisation of rabbits showed that the virus 
had lost the capacity to synthesise VHA (Cassel, 1957; Cassel and 
Eater, 1958) but not to replicate (Cassel, Garrett and Blair, 1962).
It was suggested that this resulted from exposure to an inhibitor in 
the ascitic plasma which was a non-dialysable, acid-labile, thermo- 
labile protein, with an estimated molecular weight of 209,000 (Lau 
and Cassel, 1972).
Antibody to poxvirus HA and its role in vivo. Nagler (1942) noted 
that haemagglutination could be inhibited by antiviral serum.
Antibody to VHA has been used to quantitate VHA by the HAI test (e.g. 
Joseph, 1974) and HAD of susceptible red cells can also be inhibited 
by antiviral hyperimmune serum (Driessen and Greenham, 1959)- The 
neutralising and HAI specificities of anti-vaccinia serum were 
separated by Oda (1963a) who absorbed out neutralising antibodies 
without affecting the HAI titre. In addition, antiserum to purified 
virus did not inhibit haemagglutination (Westwood et I965) and 
VHA" strains did not elicit HAI antibodies (ichihashi and Dales, 1971) 
The role of HAI antibodies in protection has been discussed by Lybing 
and Hedstrom (1975)• Their results suggested that the levels of 
anti-VHA antibodies correlated with the degree of skin immunity 
elicited by immunisation either with inactivated or live virus 
preparations. Turner ^  si (I970)» however, reported that HAI 
antibody was a poor indicator of immunity afforded by inactivated 
vaccines, as was complement fixing antibody. McCarthy, Downie and
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Bradley (1958) reported that poxvirus complement fixing and HAI 
antibodies were not always detectable or even increased after 
secondary stimulation and Madeley (1968) found that only large doses 
of inactivated vaccine could induce HAI antibody; indeed, a lack of 
HAI antibodies raised to an inactivated poxvirus preparation, could 
be taken as evidence of complete inactivation. Although the role of 
HAI antibody in immunity is unclear, the facts that the antibody is 
present in high titre, and that HA is present in large quantities on 
the surface of poxvirus-infected cells, imply that a dynamic antigen- 
antibody interaction exists where the infected cell membrane and the 
immune system are in contact. The elucidation of the importance of 
early poxvirus VTGSA in stimulation of the host cell-mediated immune 
system (Koszinowski and Ertl, 1976) emphasises the importance of 
these non-virion induced antigens: VHA stimulation of the host immune
system may also be possible, and the resultant immune defences in the 
form of antibody or lymphocyte may play some part in hindering the 
spread of infectious virus or the destruction of host cells.
The demonstration of the existence of a "naked" intracellular 
form and an "enveloped" extracellular* form of poxvirus (Appleyard et al, 
I97I; Turner and Squires, 1971) allowed speculation both on the 
possible origin of this outer coat, and on the apparently differing 
susceptibilities of each virus type to neutralisation and the differing 
properties of antisera to each. EGV differs antigenically from IGV 
and appears to be important in virus spread. Antibody to EGV 
neutralises EGV and IGV while anti-IGV is only effective against IGV 
(Boulter and Appleyard, 1975)* Payne and Horrby (I976) demonstrated 
that one of the "new" antigens acquired by EGV was VHA. This finding
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emphasised the possible importance of VHA in poxvirus infection and 
suggested that EGV derived cell surface VHA as part of its envelope.
A study of poxvirus-induced cell surface antigens (including 
VHA) might provide some information on the interactions of infected 
cells with the immune system. Also, changes at the cell surface 
during poxvirus infection can be detected in terms of con A 
agglutination (Zarling and Tevethia, 1971) and infected cells may 
also bind con A to a greater extent (Bubel and Blackman, 1975).
The purpose of this thesis is to examine changes in the 
surface membrane of vaccinia-infected cells with particular regard 
to antigenic changes of potential importance in stimulating an 
effective anti-viral response by the host.
MATERIALS AND METHODS
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A. CHEMICALS
L-l-^H-Fucose and Wa ^^^I (carrier-free) were purchased 
from the Radiochemical Centre, Amersham.
The following chemicals were obtained from Sigma Chemical 
Co, Ltd. -
Goncanavalin A, N-acetyl neuraminic acid, sodium metaperiodate, 
p-nitrophenyl phosphate (di-tris salt)j calcium bis p-nitrophenyl 
phosphate, phendphthalein |3-glucuronide, ^-nicotinamide adenine 
dinucleotide (reduced, disodium salt), human serum albumin (fraction V), 
cytochrome c (grade II ex horse heart), lysozyme, actinomycin D, 
hydroxyurea, cytosine arabinoside, rifampicin.
Trypsin (2x crystallised), soy bean trypsin inhibitor, 
cycloheximide (actidione), histidine monohydrochloride and chior amine T 
were obtained from Koch-Light Ltd.
Unless otherwise stated, all other chemicals were supplied 
by British Drug Houses Ltd., and were of "Analar" grade.
B. IMJNOLOGIGAL REAGENTS
Rabbit anti-sheep red cell serum (haemolysin), goat anti­
rabbit precipitating serum and complement (freeze-dried ex-guinea pig) 
were obtained from Wellcome Laboratories. Sheep anti-rabbit immuno­
globulin (fluorescein isothiocyanate-conjugated) was purchased from 
Gibco-Biocult Ltd. Complete Freund*s adjuvant was obtained from 
Difco Ltd.
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C. TISSUE CULTURE REAGENTS
Unless otherwise stated, cells were cultured in Eagle's 
Minimal Essential Medium with Earle's salts (M.E.M,) ("Autopow", Plow 
Labs Ltd.). New-born calf serum (mycoplasma free) (Plow) was added 
to 10 per cent and L-glutamine (Plow) to 2 mM. Crystamycin (Glaxo 
Labs Ltd.) and/or kanamycin sulphate ("Kannasyn", Winthrop Labs.) 
were routinely included at concentrations of 50 units ral""^  and 100 qg 
ml"*^  respectively.
The pH of the medium was adjusted by the addition of $.0 ml
per SOD
of 7*5 per cent sodium bicarbonate^ Serum was omitted during 
maintenance or virus infection (serum-free medium or SPM) .
Trypsin, obtained from Gibco-Biocult Ltd. as a 2.5 per cent 
solution in salts, was diluted l/lO in PBS for detachment of monolayer 
cells.
B. CELL LINES
2 2Cells were cultured routinely in 75 om and 120 cm glass 
tissue culture flasks with screw caps, and occasionally in Winchester 
bottles. All glassware was immersed for at least 24 hours in chioros 
(i.e.I.), followed by a further 24 hours in 0.5% Divolab (Uiversey Ltd.). 
Finally the glassware was thoroughly washed with tap water before rinsing 
with either deionised or distilled water, drying and sterilising.
In most experiments, cells were cultured in 3.5 cm vented 
plastic petri dishes (Flow Labs Ltd.) which were incubated in plastic 
sandwich boxes, under an atmosphere of 5 per cent carbon dioxide in air.
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BSG-l cells were obtained from Hr, T.H, Pennington,
Department of Virology, University of Glasgow and were grown in Eagle's 
MEM containing 10 per cent foetal bovine serum (Flow).
BHK-21 (GI3), HEp-2, HeLa, HK-I3, human embryonic lung (HEL), 
L-I32 and L-929 cell lines were obtained from Gibco-Biocult Ltd.
BHK-21 (CI3) cells were cultured in Eagle's MEM (Glasgow modification) 
with Earle's Salts (Gibco-Biocult) supplemented with 10 per cent 
tryptose phosphate broth (Gibco-Biocult). HEL cells were grown in 
Eagle's MEM containing 10 per cent foetal bovine serum. RK-I3 cells 
were grown in Parker's medium 199 (Gibco-Biocult),
Other cell lines were cultivated in Eagle's MEM containing 
10 per cent new-born calf serum.
E. VIRUS
The strain of vaccinia virus described by Westwood et ^  (I966),
"Liverpool" strain, derived from the Lister Institute Strain, was used
as a crude extract of infected rabbit dermal pulp. This was originally
obtained from Dr. E.A. Boulter, Microbiological Research Establishment,
Porton Down, Wiltshire. Some stock virus was passaged in HeLa cells
7and stored as a crude suspension of titre 1 to 10 x 10 plaque forming 
units (p.f.u.) ml"^.
P. RED BLOOD GELLS
Turkey red cells were obtained by courtesy of British United 
Turkeys Ltd., Fenton Barns, Dirleton, East Lothian. Red cells were 
collected from the jugular vein of freshly slaughtered turkeys and 
pooled in 3*8 per cent sterile trisodium citrate.
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Other red blood cells were obtained from the following sources:-
human
horse
African Green monkey 
sheep
dog, cat and chicken 
mouse, rat and rabbit 
cod
self (group "0")
defibrinated (Gibco-Biocult Ltd.)
Plow Labs Ltd.
Dr. D.E.S. Stewart-Tull, Department of 
Microbiology, University of Glasgow 
Veterinary Hospital, University of 
Glasgow (from Mr. D.D. Whitelaw)
Animal House, Department of Microbiology, 
University of Glasgow 
Dr. T.H, Birkbeck, Department of 
Microbiology, University of Glasgow.
G. GENERAL METHODS
(i) Infection of cells and production of stock virus
The original stock virus was passaged in HeLa cells by
7
infecting 3 day old confluent monolayers of 2 x 10 cells at an m.o.i* 
of one p.f.u. per cell using a suspension of virus in SîTM. After an 
adsorption period of approximately 1 hour at 37*^ 0, the overlay was 
discarded and replaced with SPM. Following incubation for 48 to 72 
hours the overlay was removed and retained if necessary for separation 
of extracellular virus (see below). The monolayers were then scraped 
off using a sterile 1.5 inch silicone covered bar ( E s c o  Rubber Co.)
7
and magnet, and the cells suspended to a volume of 1.0 ml per 2 x 10 
cells in SFM or Dulbecco's phosphate buffered saline "A" (PBS). The 
concentrated suspensions were sonicated on ice at 20 Kc/s for 5 one
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minute cycles with one minute intervals for cooling using an M.S.E.
100 watt Ultrasonic Disintegrator. Gross debris was removed by 
brief centrifugation (1000 g) and the supernatant distributed in 
aliquots of 0.5 ml or 1.0 ml for storage at -70°G. This served as 
general virus stock and as a crude intracellular virus preparation.
On thawing, all stock virus was sonicated before use.
For the preparation of crude extracellular virus, overlay 
medium was briefly centrifuged to remove cell debris and the super­
natant used freshly.
For experimental infection of cells, an adsorption period 
of one hour at 57^0 was generally employed and the virus was added in
1.0 ml volumes per petri dish. After this period the overlay was 
discarded, the monolayers washed with medium and 2.0 ml of SFM added.
An m.o.i, of between 0.1 and 1.0 p.f.u. per cell was used.
(ii) Plaque assay of vaccinia virus
Vaccinia virus was assayed by a modification of the method of 
Appleyard and Westwood (1964b). Prewarmed 5*5 om plastic petri 
dishes were seeded with 1.0 x 10^ HeLa cells suspended in MEM 
containing 10 per cent calf serum and supplemented with 0.75 per cent 
carboxymethyl cellulose to obtain a uniform monolayer (Ross, Cameron 
and Wildy, 1972), The plates were incubated stacked in sealed 
sandwich boxes under an atmosphere of 5 per cent CO^/air at 37°C for 
a period of 1-2 days or until the monolayers were completely confluent. 
Dilutions of test virus suspension were made in SFM, and the range 
of dilutions included the probable readable virus titre end point.
50
usually lO"^ to Monolayers were overlaid with 1,0 ml of each
dilution (duplicate plates) and the plates reincubated at 37^0 for 24 
hours. On day 3, after discarding the overlay, the cell sheets were 
washed with a stream of SFM and overlaid with medium containing 3 
cent calf serum and 0,3 per cent rabbit anti-vaccinia hyperimmune y- 
globulin concentrate to inhibit secondary spread of virus from primary 
foci.
The plates were reincubated at 37°C and plaques were allowed
to develop over a 48 hour period. On day 5» the medium was discarded
and 1,5 ml of a solution of Loeffler's methylene blue added per plate.
Plates were left at room temperature for at least 30 minutes, excess
stain poured off and the monolayers repeatedly washed with a stream of
saline until no free dye eluted. Plaques were counted in the range
10-100. From this, the infectious virus titre of the original test
-1
virus suspension was calculated in terms of p.f.u. ml
(iii) Production of virus soluble antigen fractions
Soluble antigens were prepared from heavily infected cell 
monolayer cultures in flasks harvested 48-72 hours p,i. Cell sheets 
were treated by sonication as described above. However, after an 
initial brief centrifugation to remove gross debris, other debris and 
virus was pelleted by high speed centrifugation at 50,000 g for 30 
minutes (MSE Superspeed 65) using 10 ml polypropylene tubes, and a 
10 X 10 ml titanium angle rotor. The supernatant was retained as the 
soluble antigen fraction and occasionally was concentrated by dialysis 
(Visking tubing) against polyethylene glycol 40OO for 4 hours at 4^0.
51
Corresponding soluble antigen fractions were prepared from uninfected 
cell cultures as controls. Fractions were stored at -20^C.
(iv) Production of antisera and preparation of y-globulin concentrates
(a) Rabbit anti-vaccinia hyperimmune serum. A crude extract of
rabbit dermal pulp was mixed 1;1 with complete Freund*s adjuvant (C F A ). 
One ml of this emulsion was injected intramuscularly (l M ) per rabbit 
weighing approximately 2 kg and a test bleed taken 21 days later.
10 weeks after the primary injection, 0,5 ml of virus suspension, 
without adjuvant, was administered intravenously (l V ) to each rabbit, 
followed by two similar injections at 2 day intervals. A test bleed 
was taken 6 days after the final injection.
After a total of 5 months, the rabbits were given an additional 
three "booster" injections as above, and bled out 5 days after the last 
injection,
(b) Rabbit antiserum to whole HeLa cells. HeLa cells (4 x 10^)
grown in monolayer culture were disrupted by ultrasonication and 
emulsified in C F A (1:1). Two New Zealand White rabbits, approximately 
2 kg in weight, were injected I M with 0,5 ml emulsion. This 
procedure was repeated 14 days later. Booster I V injections were 
given at 8 and 16 weeks (0,25 ml per rabbit, without adjuvant) and the 
animals bled out 5 days after the final injection,
(o) Rabbit antiserum to plasma membranes from uninfected HeLa cells.
Two 2 kg Lac Dutch rabbits were used; 200 (ig of membrane protein from 
a purified HeLa cell plasma membrane preparation in 1,25 ml was
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emulsified with an equal volume of C P A. This mixture (0,5 ml 
containing 48 pg protein) was injected I M into each rabbit. Eight 
weeks later, the rabbits were again injected I M with 40 fig protein 
from the above preparation. Five days later, 50 pg of a purified 
plasma membrane preparation in 10 mM Tris-HCl buffer pH 7,0 was 
injected I V without adjuvant. Test bleeds were made seven days 
later. Booster I Y injections of 50 pg aliquots of plasma membrane 
protein were administered 6 and 8 weeks later. Rabbits were bled out 
by cardiac puncture five days after the final injection.
(d) Rabbit antiserum to plasma membranes from vaccinia-infected HeLa 
cells. Two 2 kg New Zealand White rabbits were used; 0,6 ml
of a preparation of purified plasma membranes from vaccinia-infected 
HeLa cells was emulsified in an equal volume of C P A and 0,5 ml 
aliquots of the emulsion, containing approximately 40 pg of protein, 
were injected I M, Four weeks later the rabbits were given a second
similar injection. After a further 12 days an I V booster injection
of 50 pg of "infected" plasma membrane protein was given and a further 
injection four weeks later. Test bleeds were taken seven days after 
booster injections had been administered and after further "boosters".
The animals were bled out by cardiac puncture five days after the last 
injection,
(e) Sheep antiserum to rabbit-y-globulin. This was obtained as a 
Y-globulin concentrate from Dr. Stewart-Tull, Department of Microbiology, 
University of Glasgow (Stewart-Tull and Rowe, 1975)*
All sera and concentrates were stored at -20^0 until required.
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(f) Preparation of y-globulin concentrates. These were prepared
by the method of Smith ejb ^  (1962).
(v) Immunodiffusion
This was carried out on microscope slides according to the 
method of Growle (1958)*
The slides were incubated at room temperature for 56 to 60 hours 
to allow precipitin lines to develop, after which the template was 
removed.
The slides were soalced overnight in PBS, stained for ten 
minutes in 2 per cent acetic acid/saturated nigrosin solution and 
destained with 2 per cent acetic acid/l per cent glycerol and dried 
at 37°c.
The diffusion patterns were photographed using the slide as 
a negative, by projection onto photographic paper (Kodak Ltd.).
(vi) Complement-fixing titres of antisera
This was performed according to the micro-method described 
by Grist, Ross and Bell (1974)* The antigen source was the super­
natant from an extract of rabbit dermal pulp infected with vaccinia 
virus.
The complement-fixing titre was defined as the highest dilution 
of antiserum giving a reading of"4" or"3” haemolysis on a scale from
0 to 4.
54
(vii) Neutralising titres of antisera
Intracellular virus stock was prepared as described in 
"Methods" section A(i) and low titre stocks (10^ p.f.u. ml were 
stored at -70^0. A sample from each batch was titrated for virus 
and for neutralisation tests stock virus was diluted to contain 
approximately 200 p.f.u. ml 1 ml volumes of the 200 p.f.u. ml"^
virus stock were mixed with equal volumes of serial 10 fold dilutions 
of test antiserum and incubated at 37°C for 30 minutes. For each 
dilution of antiserum, duplicate 0.9 ml volumes were overlaid on HeLa 
cell monolayers in a 25 section plastic tissue culture tray (Flow Labs 
Ltd.). Appropriate controls were included and plaques were counted 
after 3 days. The neutralising titre was defined as the highest 
dilution of antiserum in the initial serum-virus mixture which caused 
a 50 per cent reduction in plaque formation (ND^^),
(viii) Quantitative spectrophotometric assay of the degree of red 
cell binding to monolayer cell cultures
An estimation of red cell binding by quantitative measurements 
of haemoglobin was used in the assay for haemadsorption (HAD) and 
adapted for the con-A-coated red cell binding assay.
Monolayers with bound red cells were washed three times with 
PBS to remove non-specifically adherent erythrocytes. After drying,
2.0 ml of 0,005 per cent saponin solution in PBS was added to each 
plate to lyse the red cells. The entire cell sheet was scraped off 
into the saponin solution and transferred to a 4” x &" test tube*
The optical density was measured against distilled water at wavelengths
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of 410 and 280 nm using silica (l cm) semi-micro cells and a Pye
Unicam SP500 spectrophotometer. The ^  gave an assessment of
the haemoglobin content of the suspension but because of the gross
cytopathic effects induced by vaccinia late in infection, parts of
the cell sheet became detached resulting in less overall red cell
binding; thus the simple measurement of E^^q ^  was not adequate and
Enon was measured to allow corrections to be made for the detached 280 nm
cell sheet.
It may be assumed that the measured E^^^ (^410R^ the sum of 
the E^^Q ^  of lysed turkey erythrocytes and HeLa cells and
®410H respectively). Similarly, the measured E^qq (Eggg^) Is the sum 
of the E^qq ^  of lysed turkey erythrocytes (Eggq^) and HeLa cells 
(E28oh)* For the quantitative haemadsorption test the degree of 
binding of turkey erythrocytes to HeLa cells (E^^^QgyEgg^g) is required 
and it can be shown that
^410T _ &10R ~ ^280R
1
^280H ®280R “ y ®410R
where x = E ^   ^ y = E ^
^280H ^280T
Lysed HeLa cells and lysed erythrocytes consistently gave E^^q/E^q^ 
ratios of 0,250 and I.92 respectively. The derivation of the 
above equation is shown in Appendix 2,
(ix) Preservation of turkey red blood cells by freezing in liquid 
nitrogen
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The citrated suspension of red cells was made 15 per cent (v/v) 
with respect to glycerol by addition of an equal volume of $0 per cent 
glycerol in PBS. The suspension was then transferred to a glass 
separating funnel and blood was dropped ( ^ 50 drops min""^ ) from a 
height of 20 cm into liquid nitrogen contained in a polystyrene ice 
bucket. Frozen globules of blood were transferred to metal pipette 
canisters with drilled outlet holes and these were stored under liquid 
nitrogen. Cells remained usable for at least four months under these 
conditions. The frozen globules were found to reconstitute optimally 
when thawed quickly with stirring, in an equal volume of I5 per cent 
glycerol in warm PBS. After centrifugation, the pelleted red cells 
were washed once with 5 per cent glycerol in PBS and at least twice in 
PBS before resuspending to the desired concentration. Cells re­
constituted from the frozen state could be stored for up to 4 days at 4°C
(x) Sodium dodecyl sulphate polyacrylamide gel electrophoresis
The method of Davis (1964), as modified by McNiven, Owen and 
Arbuthnott (1972) was used for disc gel electrophoresis, while slab-gel 
electrophoresis was conducted by the method of Wardlaw, Parton and 
Hooker (I976).
(xi) Protein estimation
This was carried out as described by Lowry et ^  (195I)•
(xii) Estimation of sucrose content of density gradient fractions
The sucrose content, in terms of percentage weight by volume 
was measured using an Abbe refractometer.
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H. DETECTION OF VIRUS-INDUCED CELL SURFACE ANTIGENS
(i) Immunof luor e s cenoe
The appearance of VICSA was monitored by a double layer 
fluorescent antibody technique using unfixed cells. Test monolayers 
in 3*5 cm plastic petri dishes were washed three times with PBS and 
0,5 ml of test antiserum added and plates were incubated for 30 minutes 
at 4°0. After washing three times with PBS, 0,5 ml volumes of a 1/5 
dilution of fluorescein isothiocyanate (FITC)-conjugated sheep anti­
rabbit immunoglobulin were added to each plate and allowed to react for 
30 minutes at 4^0. Monolayers were then washed five times with PBS 
to remove excess conjugate and examined by phase contrast and by U V 
light for specific fluorescence (Leitz Orthoplan; E. Leitz, London) 
using fluorescein filters (bG 12, 2 x FITC Filters) and a Fluorescence 
Vertical Illuminator (Ploem, I967). Sample fields (phase contrast 
and ultraviolet) were photographed using an automatic exposure device 
and black and white Kodak film (FP4, ASA125, DIN22) developed in Kodak 
Microdol-X and fixed in Ilford Hypara.
(ii) Immune haemadsorption
This was based on the method described by Miyamoto and Kato
(1968).
(a) Preparation of complete indicator cells. Doubling dilutions 
(0.1 ml) of rabbit anti-sheep red cell haemolysin, inactivated at 56°C 
for 30 minutes, were made in PBS in a Cooke Microtiter plastic disposable 
tray and 0,1 ml volumes of a 4 per cent washed sheep red cell
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suspension were added per well. The tray was shaken, incubated at 
57^0 for 60 minutes and read after 2 hours further incubation at room 
temperature. The dilution of antiserum which just failed to 
agglutinate was noted. The antiserum was diluted accordingly and 
equal volumes of dilute antiserum and 4 per cent red cell suspension 
were mixed and incubated at 37^0 for 3^ minutes with occasional agitation. 
The sensitised red cells were centrifuged and washed twice in PBS 
before resuspending to 2 per cent.
Goat anti-rabbit precipitating serum (inactivated and absorbed 
1:1 with packed sheep red cells) was titrated in doubling dilutions as 
described above, against the 2 per cent sensitised sheep erythrocytes. 
Control dilutions were also titrated against unsensitised red cells.
The highest dilution just failing to give maximum agglutination was 
recorded. The goat anti-rabbit serum was diluted appropriately and 
mixed with 2 per cent sensitised sheep cells in equal volumes, and the 
suspension incubated at 37^C for 30 minutes, after which the cells - 
"complete indicator cells" - were pelleted and washed twice in PBS 
before suspension to 0,5 per cent in PBS for storage at 4°0.
(b) Assay of complete indicator cells. Rabbit anti-HeLa cell 
serum (inactivated) was diluted 1/20 in PBS and absorbed with packed 
sheep red cells (l:l) for 30 minutes at 37°C. Monolayer cultures of 
uninfected HeLa cells in 3*5 cm plastic petri dishes were washed with 
PBS, overlaid with O .5 ml of the absorbed antiserum and incubated at 
37°C for 30 minutes. Monolayers were washed three times with PBS, 
treated with 0,5 ml of complete indicator cells (CIC) or a 0.5 per 
cent suspension of sensitised sheep red cells for 5O minutes at 37^0.
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Control plates were also prepared using inactivated absorbed normal 
rabbit serum. After washing off excess red cells, monolayers were 
examined for specific binding of CIC or sensitised red cells, either 
by microscopy or by the quantitative haemadsorption method.
Batches of CIO showing positive adsorption, in the absence of 
absorption of sensitised red cells, were used in testing for immune 
haemadsorption.
(c) Assay for virus-induced cell surface antigens by immune
haemadsorption. The assay was conducted as above except that 
rabbit anti-HeLa cell serum was replaced by rabbit anti-vaccinia y- 
globulin concentrate (antiVACyG) diluted l/lO to 1/20, and absorbed 
with sheep red cells. Other inactivated antisera were also tested. 
The bound red cells were lysed and the degree of binding assessed 
spectrophotometrically. However, since, in these experiments, 
minimal loss of cells from test monolayers occurred, only the 410 nm
of the lysate was recorded.
(iii) Complement fixation
The assay was designed to test for the presence of VICSA by 
measuring any depletion in the amount of added complement when 
antiVACyG was incubated with virus-infected cell monolayers. Fixation 
of complement would thus indicate the presence of cell surface viral 
antigens.
By carrying out a "chessboard" titration of complement and 
rabbit anti-sheep red cell haemolytic serum against 4 per cent washed
60
sheep red cells in veronal-buffered saline (VBS) (0#25 ml volumes), 
the optimal sensitising dose of haemolytic serum, i.e. that giving 
complete lysis with the highest dilution of complement, and the 
highest dilution of complement giving 50 per cent lysis (HD^q) were 
determined. Appropriate controls were included. In the subsequent 
test 4 units of complement were used per test plate.
Monolayers in 5*5 cni plastic petri dishes were tested at 
various times after infection. The cell sheet was washed with VBS 
and treated for 20 minutes at 57°C with 0.5 ml per plate of a l/lO 
dilution in VBS of either normal rabbit y-globulin (NyO) or rabbit 
antiVACyG concentrates. The monolayers were then washed three times 
with VBS and 4 ED^Q units of complement, in a volume of 0.5 ml, added. 
Incubation was at 37^0 for 20 minutes, after which .all the complement
overlay was carefully removed and the plates discarded. The complement 
fractions were re titrated (using VBS as diluent and perspex \<JEO trays), 
against washed 4 per cent sheep red cells which had been treated with 
the optimal sensitizing dose of haemolytic serum. The results were 
read after 40 minutes at 37°C.
(iv) Complement-mediated cytolysis
The method employed was based on the "dye exclusion" assay of 
Saijo (1973) and was carried out using two approaches.
Test monolayers in 3*3 om plastic petri dishes were washed 
with the buffer described by Saijo - termed here "Saijo" buffer.
Gelatin was omitted from the buffer. Concentrates of rabbit NyG and
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antiVACyG were diluted in "Saijo" buffer to contain 1-2 mg protein ml ^ 
and 0*75 ml volumes were overlaid on test plates which were incubated 
for 30 minutes at 37°C before washing three times with buffer.
Reconstituted freeze-dried guinea-pig complement was diluted 
1/20 in "Saijo" buffer and 0.75 ml per plate was added. The plates 
were incubated at 37°C for 30 minutes and transferred to a -20°C 
freezer to bring the temperature quickly to ~ 0°C to inhibit further 
complement activity. Ice-cold 1 per cent trypan blue in buffer 
(0.2 ml per plate) was added to each plate and mixed with the complement 
overlay. The plates were incubated for a further 7 minutes, washed 
four times with "Saijo" buffer, excess moisture dried off and the cell 
layer solubilised by the addition of 2.0 ml of IM NaOH. After 
vortexing, the of the solubilised cells was determined (Pye
Unicam SP500 Spectrophotometer, silica semi-micro cells).
An alternative method was devised which proved more sensitive. 
Instead of pretreatment of test monolayers with normal or antiviral yG, 
this was added simultaneously with complement. Otherwise the assay 
was as described above.
(v) ^^^lodine-labelled antibody binding
Two volumes of hyperimmune sheep anti-rabbit serum were mixed 
with one volume of saturated ammonium sulphate solution and the 
resulting precipitate dissolved in saline and dialysed against PBS.
The final protein concentration was I5 mg ml" . lodination of the 
y-globulin concentrate was carried out by a modification of the method 
of McConahey and Dixon (I966). One mCi (10 |jil) of carrier-free Na ^^^I
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and 200 [il of chloramine-T solution (l mg ml were added dropwise
to 100 mg of y-globulin concentrate in a volume of <2.0 ml. After
5 minutes the reaction was terminated by addition of 200 fil of sodium
metabisulphite (l mg ml ) and 200 pi of potassium iodide (5 mg ml" ).
The reaction mixture was applied to a column of Sephadex G-25 to
125separate unreacted Na I and iodinated y-globulin. Fractions
125containing coincident peaks of and protein were pooled and stored
at 4°C.
Binding assay. Monolayers of HeLa cells on 3.5 cm plates were
washed with PBS before treatment with dilutions of rabbit NyG or
antiVACyG (0.75 ml) for 30 minutes at 37^C. The plates were washed
125three times with PBS and incubated with O .5 ml volumes of "^I-labelled
sheep anti-rabbit globulin (^^^I-SAEyG) at varying concentrations.
After 30 minutes at 37°0, the monolayers were rinsed six times with
PBS and cells brought into suspension by treatment with 0.25 per cent
trypsin in PBS. The trypsinates were transferred to glass
125scintillation vials and •"^I was determined using a Nuclear Enterprises 
Liquid Scintillation Counter (model 83I2).
I. ASSAYS OF VACCINIA HAEMAGGLUTININ
(i) Assay for haemadsorption of susceptible red blood cells to
virus-infected cells
This assay measured the binding of turkey red cells to the 
infected cell surface by VHA. Infected cell monolayers in 3*5 cm 
plastic petri dishes were washed with SFM and a 5 per cent suspension 
of turkey red cells in PBS added (0.75 ml per plate). The plates
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were incubated stationary at 37°C for 30 minutes to allow settling 
and binding, washed with PBS and the bound red cells assayed as 
described previously,
(ii) Assays for free haemagglutinin and haemagglutination inhibition
"Soluble" haemagglutinin in infected cell extracts was assayed 
in plastic disposable Cooke Microtiter trays. Serial 0,1 ml doubling 
dilutions of test suspension were made in PBS containing 1 per cent 
normal rabbit serum as an inhibitor of non-specific agglutination 
(Burnet and Stone, 1946); 0,1 ml per well of 1 per cent turkey red
cells in 1 per cent normal rabbit serum/PBS was added. The plates 
were agitated briefly and incubated at 37^0 for 60 minutes with 
occasional agitation. After further incubation for 60 minutes at room 
temperature the plates were read. Complete red cell shielding was 
scored as 5+» partial as 4+» granular agglutination as 3+» moderate 
granular agglutination as 2+, slight agglutination as 1+ and no 
agglutination as 0, The 50 per cent end point was taken as the last
well giving 3+ haemagglutination and the inverse of this dilution was
designated the BA^^ titre.
In the HAI assay, 0,1 ml doubling dilutions of test serum were
made in 1 per cent normal rabbit serum/PBS in a Microtiter plate, A
standard suspension of VHA (an extract of virus-infected cells) was 
diluted to contain 4 HA^q units per 0.1 ml and 0.1 ml added per well. 
Plates were incubated at 37°0 for 3O minutes, 0.1 ml of 1 per cent 
turkey red cells in 1 per cent normal rabbit serum/PBS was added per 
well and the plates incubated and read as in the HA test. The
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reciprocal of the highest dilution of antiserum reducing haemagglut­
ination to 3+ was defined as the HAI^q titre.
(iii) Purification of vaccinia haemagglutinin
This was carried out by the method of Gurvin and Haukenes
(1975)» O.IM glycine*NaOH buffer pH 8.6 was used for all solutions.
From 48 h-infected cells the overlay was discarded and the cell sheet
scraped into glycine-NaOH buffer using a silicone covered bar and
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magnet to a final volume of 2.5 ml per 2 x 10 cells. The infected 
cell suspension was frozen and thawed twice and sonicated at 20 Kc/s 
in an MSE 100 watt Ultrasonic Disintegrator at 0°G for 120 s. After 
centrifugation (lOOO g for 10 min) the supernatant was made up to 10 
per cent w/w with sucrose. The 10 per cent sucrose supernatants were 
overlaid on to 40 per cent w/w sucrose in a 25 ml polycarbonate 
centrifuge tube using a volume-volume ratio of 7:3* Gradients were 
centrifuged at 90,000 g for 12 h, using a 3 x 25 ml aluminium swing- 
out rotor in the MSE Superspeed 65. Gradient tubes were pierced from 
the bottom (MSE Tube Piercer) and fractions of 50 drops ('^  1.0 ml) 
collected and tested for sucrose concentration, HA activity and protein 
content. Fractions containing the bulk of HA activity were pooled, 
adjusted to 50 per cent w/w with respect to sucrose, transferred to a 
12 ml polycarbonate centrifuge tube and overlaid with 40 per cent w/w 
sucrose (volume ratio 3:4). This gradient was centrifuged at 100,000 g 
for 18 h as described above and fractions of 10-20 drops were collected 
and assayed as before.
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J. DETECTION OF VIRUS INDUCED CELL SURFACE CHANGES
(i) Concanavalin A agglutination of vaccinia-infected cells
This was based on the method of Earling and Tevethia (1971).
Human embryonic lung (HEL) cells were infected with vaccinia and 
tested at predetermined periods after a one hour adsorption period.
Cells were detached from duplicate petri dish cultures by treatment 
with 0.02 per cent ethylenediaminetetra-acetic acid (EDTA) in PBS, 
washed twice in PBS and resuspended in normal saline (l.O ml per plate 
culture). From this suspension, duplicate 0.1 ml volumes were mixed 
with 0.1 ml saline, while a further two 0.1 ml volumes of suspension 
were mixed with 0,1 ml volumes of con A (lOOO pg ml" in saline).
After 15 minutes incubation at room temperature, the droplets were 
examined by inverted microscope for agglutination.
(ii) Binding of concanavalin A by vaccinia-infected cells
The assay was based on a method described by Furmanski,
Phillips and Lubin (1972) in which Concanavalin A binding sites on cells 
were measured indirectly by coating human "0" red blood cells with con A 
and reacting the treated cells with vaccinia-infected or uninfected 
HeLa cell monolayers.
Human "0" red cells were washed three times in PBS and 1,5-2.0 
ml of packed erythrocytes were resuspended in 10 ml of a 200 pg ml"^ 
solution of con A in PBS. The optimum concentration of con A for 
coating was determined by assay (see "Results" p 112 ). The 
suspension was incubated with occasional agitation at 57°C for 60 minutes
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and the coated cells washed thrice in PBS before resuspension to 
2 per cent in PBS. Test HeLa cell monolayers in 3*5 cm plastic petri 
dishes were washed with PBS and overlaid with 1.0 ml of the conA/red 
cell suspension. Plates were incubated at room temperature for 20 
minutes, excess unbound red cells washed off with PBS and the amount of 
bound red cells estimated by the quantitative haemadsorption test.
(iii) Assay of total sialic acid in vaccinia infected cell extracts
Sialic acid was estimated using the method of Warren (1959)
(see Appendix 5)*
K. HELA CELL PLASMA MEMBRANES : PREPARATION, PURIFICATION AND
CHARACTERISATION
(i) Method of preparation and purification
This was based principally on the methods described by 
Atkinson (1973) and Johnson, Stokke and Prydz (1974)» Normally 2 to
7
8 X 10 cells were processed in one batch from monolayer cultures grown 
2in 120 cm glass flasks. Uninfected cells were harvested at 3 to 6 
days after seeding or after reaching confluence. Virus-infected 
cells were harvested at 24 hours p.i.
After decanting the overlay medium, the monolayers were washed 
with PBS; 10 ml of 0.02 per cent EDTA in PBS was added, and cells 
incubated at 37^0 for 20 minutes. The detached cells were collected 
by centrifugation and washed once in PBS, twice in cold 10 mM Tris-HGl 
buffer (pH 7*0) and once in cold 10 mM Tris-HCl pH 8,0. The cells 
were finally allowed to swell in 5 ml of 10 i#l Tris-HCl pH 8,0 for 10 
min at 0°C.
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The swollen cell suspension was transferred to a pre-cooled 
5 ml glass homogenisation vessel (jencons Uniform, body type PTG 2). 
Efficient breakage was achieved with a plunger giving a clearance of 
0,05 mm. A series of Teflon "bell-shaped" plunger heads were 
prepared by the Mechanical Engineering Department, Research Annexe, 
University of Glasgow. Two full strokes were found to be sufficient 
for breakage of 95 per cent of cells as monitored by phase contrast 
microscopy. Cold 2 mM calcium acetate in 10 mM Tris-HCl pH 7.0 
(5 ml) was slowly added to stabilise the free nuclei which became 
refractile with the nucleoli visible. The ghosts appeared at this 
stage as limp, transparent "leaves" (Plate l).
The suspension was transferred to a conical centrifuge tube 
and centrifuged at 680 g for 90 s to deposit nuclei and unbroken cells.
If required for enzyme assay, the pelleted nuclei were resuspended in
2,0 ml 2 mM calcium acetate/lO mM Tris-HCl pH 7.0. The 680 g super­
natant, containing substantial numbers of ghosts in diluted cytoplasm, 
was subjected to sucrose density gradient centrifugation. Supernatant 
(3.5 ml) was layered on top of a discontinuous sucrose gradient 
comprised of 1,5 ml 45 per cent w/v sucrose/lO mM TrislHCl pH 7.0 in 
the bottom layer, and 4.O ml of 30 per cent w/v sucrose in the same 
buffer, in the top layer. Gradients were formed in 12 ml poly­
carbonate tubes (MSE) and were centrifuged at 10,000 g for 20 min at 4°0, 
in a 3 X 25 ml aluminium swing out rotor with adaptors and an MSE 
Superspeed 65 centrifuge. Two distinct bands formed; one, at the 30 
per cent w/v sucrose/sample interface, was composed, as judged by 
microscopy, of cytoplasmic organelles and very small membraneous
68
Plate 1 HeLa cell plasma membrane "ghosts"
Plasma membranes, prepared as shovm in Figure 11 , were 
photographed under phase contrast at a magnification 
of X400. Plate magnification 2.8X.
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structures; the second, at the 30 per cent/45 per cent w/v sucrose 
interface, was composed of large, intact ghosts. An ill-defined 
zone between the interfaces may have represented fragmented plasma 
membrane material.
The two bands were extracted from the top of the gradient with 
a syringe and 2" needle. The first, designated "top" band, was 
retained for enzyme assay. The second band was diluted 1:3 in 10 mM 
Tris-HCl pH 7.0, applied to another 30 per cent/45 per cent sucrose 
gradient and recentrifuged as described. The band formed from this 
centrifugation, at the 30 per cent/45 per cent interface, was extracted, 
diluted 1:8 in buffer and centrifuged again at 10,000 g for 5 min.
The membranes were recovered in the pellet and resuspended in buffer 
(1.0 to 2.0 ml) for assay and examination by microscopy.
(ii) Enzyme assays
(a) Assay of potassium-dependent phosphatase activity of cell
fractions. The enzyme activity was measured by the method of 
Robinson (1975) and monitored the release of nitrophenol from p- 
nitrophenyl phosphate (Tris salt).
The reaction mixture contained:-
Final concentration
1*0 ml 60 mM Histidine monohydrochloride-
Tris buffer, pH 7.8 30 mM
0.5 ml 12 mM MgClg 3 i#
0,3 ml 20 mM p-nitrophenyl phosphate (Tris salt) 5 mM
0.2 ml test suspension.
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A parallel reaction mixture was also prepared with a 
solution of 12 mM MgClg 40 mM KOI replacing 12 mM MgCl^. The p- 
nitrophenyl phosphate was added last to initiate the reaction, and 
the assay tubes incubated in duplicate for JO min in a 57°0 water 
bath. The reaction was stopped by the addition of 2,0 ml of 2M NaOH
and the extinctions read at 410 nm against distilled water in a Pye
Unicam SPJOO spectrophotometer. Headings were compared in the 
presence or absence of K"*" ions.
(b) Assay of phosphodiesterase activity in cell fractions. Phospho­
diesterase was measured by the method of Ostrowski and Tsugita (1961). 
The reaction mixture contained;-
0.5 ml O.IM Tris-HCl buffer pH 8.9 
6-;4 0.02M MgSO^
0  ' k m l  0  02.SWI Coicnum bi^ s, p -n v tro p V ie n a l
0.1 ml of test suspension.
Duplicate assay tubes were incubated at 37°0 for JO minutes 
and the reaction terminated by addition of 1.0 ml O.IM NaOH. Tubes 
were centrifuged at 1000 g for IJ minutes and the ^  read against
distilled water as blank reference (Pye Unicam SPJOO Spectrophotometer, 
semi-micro silica cuvettes, 1 cm path length).
(c) Assay of NADH diaphorase activity in cell fractions. The 
method of Wallach and Eamach (1966) was employed.
The assay mixture consisted of;-
0.4 ml of 0.02M Tris-HCl buffer pH 7-4
0.2 ml of O.OOJJM potassium ferricyanide
0,4 ml of a freshly prepared solution of NADH,
100 pg ml"^ in 0.02M Tris-HCl buffer pH 7•4*
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This was transferred to a 1 cm silica semi-microcuvette 
and the reaction started by addition of 0.1 ml of test suspension 
activated at J7°0 for 2 minutes. The oxidation of NADH was followed 
using a Pye Unicam SPJOO spectrophotometer by measuring the decrease 
in ^  when read against distilled water in the reference cell.
The reaction rate, linear over 2 to J minutes, was measured at this 
stage in all fractions and average rates compared graphically.
(d) Assay of ^-glucuronidase activity in cell fractions. This was 
performed by the method of Allison and Sandelin (I963).
The assay mixture consisted of:-
0,5 ml of O.IM sodium acetate buffer
0.1 ml of O.OIM phenolphthalein [3-glucuronide
0.1 ml of test suspension.
The mixtures were incubated in duplicate in a J7°0 water bath for JO 
min and the reaction stopped by addition of 2.0 ml O.4M glycine-NaOH 
buffer pH 10,7 which provided the alkaline conditions for development 
of the pink colour of free phenolphthalein. The suspensions were 
centrifuged at 1200 g for I5 min in a bench centrifuge and the Er,r 
of the supernatants read against distilled water.
(iii) Measurement of specific uptake of ^H-L-fucose by plasma 
membranes
The method described by Atkinson (1973) was followed,
71.0 X 10' exponentially growing cells were overlaid with SFM 
containing 80 pCi ^H-L-fucose and incubated for 24 hours at 37°C.
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The overlay was removed and stored, and the monolayer washed thoroughly
with PBS. The total "wash" volume was also stored. Cells were
then processed as described above to produce a purified plasma membrane 
fraction. Fractions were assayed for the uptake of H-B-fucose by 
two methods;
(a) Direct assays 200 pi volumes were pipetted into glass 
scintillation vials and 4*0 ml of scintillant fluid (NE260 Micellar 
Scintillator, Nuclear Enterprises Ltd.) added. Protein estimations 
were carried out on these fractions,
(b) Assay of acid precipitable radioactive material. 100 pi volumes
2were pipetted onto 2.0 cm pieces of filter paper (Whatman No, l).
These were air dried and immersed for 60 minutes in 10 per cent ice- 
cold trichloroacetic acid (TGA), 20 minutes in 5 per cent cold TGA and
finally in cold 95 per cent ethanol for 20 minutes. The filter papers
were placed in glass scintillation vials and 8,0 ml of scintillant 
fluid added. The radioactivity was counted using a Nuclear Enterprises 
Liquid Scintillation Counter (model 8312).
RESULTS
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A. DETEGTIQI^ OF VIRÏÏS-II7DUCED CELL SURFACE CHANGES : MTIGENIG 0HABGE8
Previous work employing immunofluorescence and immune 
haemadsorption had indicated the presence of specific "early" VICSA 
on the poxvirus-infected cell surface (Miyamoto and Kato, 1^68, 1971? 
Ueda ^  1969) and other VICSA which increased in quantity during
infection (Brier _et 1971? Hayashi ejt 1972). In the present 
work, attempts were made to demonstrate VICSA using a range of 
techniques.
(i) Immunofluorescence
Vaccinia-infected HeLa cell monolayers were tested at 2 and 
24 h p.i. for the presence of VICSA using specific rabbit antiVACyC- 
followed by EITG-labelled sheep anti-rabbit yC. Cells infected in the 
presence of ara-C (25 [ig ml were similarly tested for VICSA.
In a preliminary experiment to test the specificity of 
staining, monolayers of uninfected HeLa cells treated with anti-HeLa 
cell serum followed by FITC-labelled conjugate showed strong surface 
fluorescence (Plate 2). Control plates treated with PBS or normal 
serum prior to addition of conjugate showed no fluorescence indicating 
the specificity of the staining. Virus-infected cells tested with 
anti-VACyG at 2 h p.i. displayed whole cell fluorescence (Plate $b) 
which by 24 h p.i, had only moderately increased (Plate 3d). Cells 
infected in the presence of ara-C showed similar fluorescence by 24 h 
p.i, when tested with anti-VACyG (Plate 3f)* Virus-infected cells 
treated with either PBS or normal serum followed by PITC-sheep anti­
rabbit yG showed no fluorescence.
TU
Plate 2 Immunofluorescence of uninfected HeLa cells
Confluent monolayers of unfixed HeLa cells were incubated with 
rabbit anti-HeLa antiserum, washed and further incubated with PITC- 
labelled sheep anti-rabbit globulin. After washing in PBS, the 
cells were examined for fluorescent staining and the same field 
photographed under ÜV light and phase contrast.
Magnification: UOOX, Plate magnification 2.8X.
Plate 2a:- phase contrast
Plate 2b:- W

T5
Plate 3 Immunofluorescence of vaccinia-infected EeLa cells
Confluent monolayers of infected HeLa cells were incubated with 
rabbit anti-HeLa antiserum. After washing in PBS, the monolayers 
were treated with FITC-labelled sheep anti-rabbit globulin and 
again washed in PBS. The cells were examined for fluorescent 
staining under UV light and by phase contrast.
Magnification; UOOX, Plate magnification 1.8X.
Plate 3a: 
" 3b 
" 3c 
" 3d 
" 3e 
" 3f
2 h p.i.; no ara-C; phase contrast
ti ti II II p Y
24 h " " " phase contrast
It II II II xjY
" " + ara-C; phase contrast
II It II B Y
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(ii) Iimnime haemadsorption
In the present work VICSA was readily detected by immune 
haemadsorption and a quantitative assay was developed based on the 
quantitative haemadsorption (qPAB) test ("Methods" page 54 )• The 
specificity of the reaction was tested by exposing monolayers of 
HeLa cells to PBS, rabbit NyG, rabbit anti-HeLa serum or rabbit anti- 
VACyG before addition of complete indicator cells (CIC). HeLa cells 
and adherent erythrocytes were lysed and the degree of red cell 
binding determined spectrophotometrically in terms of released haemo­
globin in the lysate.
Infected monolayers were assayed at 2 h p.i. and 24 h p.i, 
using the same antisera. The results (Table 7) are corrected for a 
slight general increase in the binding of each CIC batch between the 
sampling times. Highly specific binding by anti-HeLa serum 
(inactivated) demonstrated the suitability of the test system. The 
test antibody, antiVACyG, was bound preferentially to virus-infected 
cells by 2 h p.i. and binding increased by 24 h p.i. Buffer and HyG 
effected no binding to uninfected or vaccinia-infected cells.
(iii) Complement fixation
This experiment was designed to establish whether the 
reaction between antiviral antibodies and VICSA in situ resulted in 
detectable fixation of complement.
The results (Table 8) showed a small but consistent 
depletion of complement at 2, 5 and 24 h p.i. when antiVACyG but not
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Table 7 Detection of vaccinia-specific antigens on the surface 
of infected HeLa cells assayed by immune haemadsorption
Monolayers were tested at 2 and 24 h p.i. by the addition of PBS or 
one of the listed sera followed by CIC and the degree of red cell 
binding estimated quantitatively, by measuring haemoglobin in the 
cell lysate ^ ) .
1^ cmAverage E _ of lysate (corrected)
Serum treatment Uninfected cells Vaccinia :infected cells
2 h . 24 h 2 h 24 h
none (PBS) 0.165 0.175 0,175 0.188
HyG 0.172 0.184 0.161 0.182
anti-HeLa serum 1.050 1.070 n.t. n.t.
anti-VAC yG 0.165 0.184 0.285 0.600
n.t. = not tested
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Table 8 Fixation of complement by vaccinia-induced cell surface 
antigens in the presence of antiviral y-globulins 
titration of residual complement
Following incubation with antibody, test monolayers were 
washed and allowed to react with guinea pig complement. The overlay 
was later removed and residual complement determined by titration 
against sensitised sheep red cells. The titre was defined as the 
highest dilution of complement giving 50 per cent haemolysis. The 
working solution of complement contained 4 units and the
results are expressed in terms of the measured number of units
remaining in the overlay from each test plate.
units per assay remaining after
Cells serum treatment 2 h 5 h 24 h
uninfected normal yG 4.0 4.0 4.0
uninfected antivaccinia yG 4.0 4.0 4.0
infected normal yG 4.0 4.0 4.0
infected antivaccinia yG 2.7 2.7 1.8-2.7
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NyG reacted with vaccinia-infected monolayers. An increase in 
complement fixation was not detectable throughout the sampling time 
and the small difference observed made routine quantitative assay 
impracticable.
(iv) Complement mediated cytolysis
The appearance of VICSA was monitored by the complement- 
mediated destruction of the infected cell surface after interaction 
with antiviral antibody, thus allowing access of the dye, trypan blue, 
to the cell cytoplasm.
Initial experiments indicated that cytolysis was more 
pronounced when complement and antibody were added simultaneously 
rather than sequentially. In terms of dye uptake, cytolysis was 26 
per cent greater but control monolayers and HyG treated monolayers 
showed no non-specific increase in uptalce of dye under these conditions.
By 2 h p.i. vaccinia-infected cells took up dye in the 
absence of specific antibody (Fig 1). Bye uptake was slightly greater 
at 2 and 5 k p.i, with anti-VACyG than with NyG and by 24 h p.i. the 
difference in dye uptake had increased approximately fourfold from the 
corresponding figures at 5 h p.i., possibly reflecting an increase 
in the number of viral antigens expressed at the cell surface. Non­
specific dye uptake also increased up to 24 h p.i. perhaps as a 
result of progressive virus-mediated cell death.
(v) ^Iodine labelled antibody binding
Despite manipulating the conditions of preparation of
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Figure 1 Detection of virus-induced cell surface antigens by
complement-mediated cytolysis
Vaccinia-infected HeLa cells were examined at various times 
after infection, to quantitate VICSA, measured by the uptake of 
trypan blue after the interaction of antiviral antibody, VICSA 
and complement.
Key:-
vaccinia-infected cells + NyG
0-0 vaccinia-infected cells + antiVACyG 
A—A uninfected cells + NyG
A—A uninfected cells + antiVACyG
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at no stage was preferential 'binding of antibody to
vaccinia-infected cells detectable. In early experiments, the lacto-
peroxidase method of iodination was employed (Gow and V/ardlaw, 1975)•
In common with the findings of Pages, Louvard and La%dunski (1975)
128however, a lack of ^iodine incorporation into the SARyG- was apparent
using this method. The chloramine-T method of McConahey and Dixon
(1966) yielded an improved incorporation of label. However the 
128"^I-GAHyG failed to show improved or specific binding to test mono­
layers. To establish whether iodination had a detrimental effect on
the antigen binding sites on the immunoglobulin, the specificity of 
128I-GAHyG was tested by passive haemagglutination of tanned sheep red 
cells coated with normal rabbit y-globulin. The results indicated 
that the iodinated antibody was still specific although the activity 
had been reduced by 75 per cent. This preparation incorporated $6 per 
cent of the ^^^I originally added. A second preparation of ^^^I-SARyG 
similarly failed to react in the antibody binding assay but was viable 
by the passive haemagglutination test (titre I/I600) and had a specific 
activity of 1.53 % 10^ counts mg"^ protein.
Using an antigen-antibody system consisting of human serum 
albumin and rabbit anti-human serum albumin in optimum proportions, 
^^^I-SARyG was found to bind to the complex. Prom 0.1 ml of ^^^I-SARyG 
(second preparation) a maximum of 4 ^ lO'^  c.p.m, was bound to the 
antigen-antibody complex indicating that 2.5 per cent of the ^^^I-SARyG 
protein was specific anti-rabbit yG antibody.
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H. POXVIRUS HA3MAG0LÏÏTIIIIM
(i) Kinetics of appearance of cell surface VHA
To correlate the time of appearance of cell surface VHA 
with virus replication, test plates were assayed at various times 
after infection for a) infectious virus titre (intracellular)
h) haemadsorption 
c) haemagglutinin.
The infectious virus titre rose exponentially after 10 h 
p.i. at the completion of one virus infection cycle (Figure 2)* The 
HAD titre rose in parallel with the infectious virus titre hut with a 
lag of 2 h and was still increasing by 48 b p.i. The failure of the 
HA assay to detect low VHA levels reflects the different sensitivity 
from the HAD assay. Very low levels of VHA activity ( < $0 per cent 
agglutination) were detected by 10 h p.i. but did not reach a 
significant level until 6 hours later.
The appearance of VHA at the cell surface was therefore 
characteristically that of a late viral antigen, possibly, considering 
the almost parallel rise, governed by the appearance of mature virus.
(ii) The effect of multiplicity of infection on cell surface 
VHA formation
Over the range tested (Figure 3) there was a small but 
measurable amount of red cell binding with m.o.i. as low as 0.01, 
which increased sharply as the m.o.i, was increased to 1. When an 
m.o.i, of 5 was employed, the consequent destruction of the cell
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Vaccinia haemagglutinin ; kinetics of appearance of 
cell surface VHA and intracellular virus
Vaccinia-infected HeLa cells were examined at various times 
after infection, for the presence of VHA by HA titration of cell 
extracts, for VHA at the cell surface by HAD, and for the 
infectious virus content by plaque assay.
Key;-
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monolayer by 24 h p.i# made accurate quantitation of HAD difficult.
An m.o.i. less than or equal to 1 was therefore used in subsequent 
experiments•
(iii) The effect of metabolic inhibitors on the expression of cell 
surface VHA
The effect of various metabolic inhibitors on HAD to 
vaccinia-infected cell monolayers was examined. After the initial 
virus adsorption period of 1 h, the adsorption medium was replaced 
with SFM containing inhibitor. At 24 h p.i. plates were assayed 
for HAD (Table 9) and intracellular virus titre was assessed.
All antiviral agents tested markedly inhibited infectious 
virus formation by at least 90 per cent an.d HAD was impaired by all 
inhibitors. Cytosine arabinoside which is an inhibitor of viral 
D M  synthesis, reduced HAD to background levels while hydroxyurea 
also reduced HAD considerably, possibly inhibiting at a post­
replication stage during virus maturation (Pil et af, 1974)•
Actinomycin D is thought to interfere with viral RHA
synthesis but a specific antiviral target has not been conclusively
identified (Metg and Esteban, 1972). In these experiments, at
concentrations greater than 0.5 qg ml"^, the drug was cytotoxic. At 
-"10.5 pg ml and higher concentrations, viral replication was not 
completely inhibited, which may account for the relatively higher HAD. 
Rifampicin, an inhibitor of vaccinia virus maturation (Subak-Sharpe, 
Timbury and Williams, 1969; Pollett and Pennington, 1975) also 
reduced HAD, but uninfected cells also appeared to non-specifically
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Figure 3 The effect of multiplicity of infection on cell
surface VHA formation
Monolayer cultures of HeLa cells were infected with vaccinia 
virus at an m.o.i. of between 1 and lo"^ p.f.u./cell and after 
24 h, monolayers were assayed in triplicate for HAD. The 100 
per cent level in this experiment was taken as the average reading 
when an m.o.i. of 1 was employed.
Hey:-
haemadsorption to vaccinia-infected cells
compared to HAD to cells infected at a 
m.o.i. of 1 p.f.u. cell ^ as 100 per cent.
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haemadsorb slightly after rifampicin treatment. The lack of VHA 
production in the presence of inhibitors of viral IMA synthesis 
indicated that the appearance of VHA was a ’’late” function possibly 
related to virus maturation,
(iv) The effect of pH on haemadsorption to vaccinia-infected cells
The influence of pH on the binding of red blood cells to 
vaccinia-infected monolayers was investigated.
The results (Table lO) indicated little pH dependence for 
red cell binding within the range tested. Only at the extremes of 
the range was binding significantly depressed. Haemadsorption was 
optimal within the range pH 7*1 to pH 7*6 affirming the use of Dulbecco*s 
HBS (pH 7*4) as suspending buffer in routine HAD assays. In the case 
of uninfected cells, no enhancement or reduction of binding was 
evident over the pH range tested.
(v) The effect of incubation temperature on haemadsorption of 
turkey red blood cells to vaccinia-infected cells
Over the temperature range tested (Figure 4) binding was 
maximal at 57°0 and minimal at 7°0 and below. At 58^0 binding was 
still firm implying a heat stable interaction. Some non-specific 
adherence of erythrocytes to uninfected cells was also evident at this 
temperature•
(vi) The range of erythrocytes susceptible to haemadsorption to 
vaccinia-infected cells
Erythrocytes from eleven species were tested by quantitative
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Table 10 The effect of pH on the haemadsorption of turkey red 
blood cells to vaccinia-infected cells
A series of phosphate-buffered saline solutions (0*85 per 
cent NaCl) was prepared to produce a range of pH values from 5«75 
to 7*90 and two glycine-HaOH buffers were prepared for the more 
alkaline pH range. Vaccinia-infected HeLa cell monolayers (24 h 
p.i.) were washed and 5 per cent suspensions of turkey erythrocytes 
in buffers of varying pH added to cultures in triplicate.
Buffer pH Haemadsorption (%)^
5.75 64, 67, 61
6.05 87, 68, 80
6.45 85, 90, 85
7.10 92, 74, 117
7.40 100
7.60 78, 104., 114
7.90 74, 85, 90
8.30^ 74, 69, 70
8 .70^ 64, 65, 65
1. Compared to pH 7*4*
2. Glycine/HaOH.
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Figure 4 The effect of incubation temperature on haemadsorption 
of turkey red blood cells to vaccinia-infected cells ^
Washed 24 h virus-infected monolayers were pre-incubated at 
the test temperatures for 10 min, a pre-incubated turkey red cell 
suspension (5 per cent in PBS) was added and allowed to react for 
30 min at the required temperature.
Key:-
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haemadsorption; all were suspended in PBS to 5 per cent and the 
assay carried out in the same way. In the case of cod erythrocytes, 
the incubation temperature was 22°C, since appreciable haemolysis 
occurred at 57*^ 0.
In order to calculate percentage HAD, the values of 
4^10 / ®280 determined for each red cell species by lysis in
saponin/PBS, and these values substituted in the QBAI) equation 
(Appendix 2). Apart from turkey erythrocytes significant HAD 
occurred (Table 11) with three red blood cell types - rabbit, African 
green monkey and mouse. Two other red cell types, cod and rat, 
adsorbed slightly and all other species were negative. That the HAD 
was virus-induced in all cases was shown by the lack of binding to 
uninfected cells.
(vii) Haemadsorption of turkey red blood cells to various cell 
lines infected with vaccinia virus
Seven tissue culture cell lines were infected with rabbit 
dermis passaged vaccinia (l p.f,u,/cell) and examined 24 hours later 
for HAD and intracellular virus titre. HeLa cells, despite 
producing the lowest yield of progeny virus, yielded the highest HAD 
percentage (Table 12), Virus growth was three times as efficient in 
BHK 2I-GI3 cells, but 40 per cent less efficient in terms of HAD. In 
EEp-2 cells little HAD occurred although viral growth was unimpaired, 
and this was apparent to a greater extent in the mouse epithelial 
cell line L-929» where HAD was virtually absent although the yields 
of infectious virus were similar to those obtained with HeLa cells.
The results illustrate the varying susceptibility of cells to both
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Table 11 The range of erythrocytes susceptible to haemadsorption 
to vaccinia-infected cells
Erythrocyte species
Haemadsorption (%)'
Infected cells Uninfected cells
Turkey 100 5, 5, 4
African Green Monkey 52, 77, 66 5, 2, 5
Rabbit 48, 57, 46 4, 4, 5
Mouse 54, 41, 54 5, 5, 4
Rat 17, 16, 15 2, 2, 2
Cod 15, 18, 25 6, 8, 6
Human 'O' 7, 8, 10 5, 7, 6
Horse 6, 5, 7 8, 8, 6
Sheep 8, 10, 9 7, 9, 7
Cat 5, 8, 8 5, 4, 6
Dog 8, 5, 6 5, 2, 2
Chicken 4, 4, 5 5, 2, 2
* The results of three separate experiments are shown and are 
compared to turkey erythrocytes (100 per cent).
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propagation of infections virus and production of YHA, and also the 
lack of correlation between VHA synthesis (measured hy HAD) and virus 
growth yields.
To determine whether an inhibitor of HAD was present in 
L-929 cells, soluble antigen preparations were made from uninfected 
HeLa and L-929 cells, Turkey red cells were suspended to 5 per cent 
in the extracts before reaction with 24 h vaccinia-infected HeLa cell 
cultures and the results compared with those obtained using erythro­
cytes suspended in PHS. Ho inhibition of red cell binding was found 
in either HeLa or L-929 soluble extracts. In addition, the intra­
cellular HA^q titre of virus-infected L-929 cell extracts was 
considerably reduced compared to infected HeLa cell extracts.
(viii) The effect of trypsin on haemadsorption to vaccinia-infected
cells
(a) Treatment of cell monolayers prior to assay
Twenty four hours after infection of HeLa cell monolayers 
the overlay medium was replaced, after washing, with 1 ml of dilutions 
of trypsin in SPM. After 60 min at plates were washed and
monola,yers tested for PIAD. Residual trypsin activity was blocked by 
the addition of soy-bean inhibitor at a concentration equivalent to 
the original trypsin. Preliminary experiments indicated that trypsin 
enhanced red cell binding; cells were therefore infected at a lower 
multiplicity than normal, such that enhancement could be more easily 
detected against a low background HAD level.
9k
Trypsin at 0.1 to 10 pg ml ^ enhanced red cell binding to
infected cells (Table IJa). Despite some destruction of the
-1
infected cell monolayer by trypsin at 10 pg ml , the remaining cells 
were capable of binding almost three times more erythrocytes than 
when trypsin was absent. Below 10 pg ml trypsin did not remove 
cells from the monolayer but still increased HAD above normal levels.
Dninfected cells were minimally affected by trypsin at
1.0 pg ml ^ and red cell binding was only slightly elevated. However 
~1at 10 pg ml , and in the absence of gross cytotoxic effects, trypsin 
rendered uninfected cells almost twice as susceptible to HAD, possibly 
by gross cell surface protein and lipid rearrangements.
(b) Inclusion of trypsin in overlay medium during virus infection
The cells were infected at low ra.o.i. to facilitate measure­
ment of trypsin-enhanced HAD against a low background of red cell 
binding. After virus adsorption, cell monolayers were washed and an 
overlay medium containing various concentrations of trypsin applied. 
After 24 hours the trypsin overlay was removed and residual activity 
abolished by the addition of soy bean inhibitor at an equivalent 
concentration before assaying for HAD,
At all concentrations of trypsin tested, HAD to infected 
cells was enhanced (Table l^b). Trypsin concentrations of 62*5 and 
125 pg ml ^ removed cells from the monolayer but the degree of red 
cell binding to the remainder, was similar to that found with lower 
trypsin concentrations. With uninfected cells, HAD increased from 
the base level of 2 to 8 per cent to approximately $0 per cent in the
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Table 13 The effect of trypsin on haemadsorption of turkey red
blood cells to vaccinia-infected cells
(a) Treatment of cell monolayers prior to assay
Trypsin concentration 
(pg ml"^)
Haemadsorption (%)#
Infected cells Uninfected cells
0 100 7, 5, 9
0.1 150, 151, 182 14, 9, 11
0.5 173, 194, 183 n.t.
1.0 141, 143, 142 16, 9, 13
10.0 359, 382, 324 158, 195, 216
(b) Inclusion of trypsin in overlay medium during virus infection
Trypsin concentration Haemadsorption (%)*
(pg ml""^ ) Infected cells Uninfected cells
0 100 7, 5, 6
7.8 189, 233, 201 n.t.
15.6 188, 220, 202 n.t.
31.2 148, 223, 185 n.t.
62.5 170, 274, 259 n.t.
125.0 247, 252, 237 39, 28, 29
n.t. ” not tested
m = compared to infected cells in the absence of trypsin
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presence of 125 pg ml*"^  trypsin, although some cell removal from 
the monolayer was apparent at this concentration.
(ix) The effect of glutaraldehyde on the VHA-turkey red hlood 
cell interaction
To obtain information on the chemical nature of the binding 
sites on both vaccinia-infected HeLa cells and turkey erythrocytes, 
these cells were individually treated with glutaraldehyde, a bi­
functional aldehyde known to cross-link proteins on the cell surface 
(Avraraeas and Ternynck, I969).
Glutaraldehyde treatment of HeLa cell monolayers for either 
1 or 20 min with 0.25 per cent glutaraldehyde in PBS at 25°C adversely 
affected the integrity of the monolayer making quantitative HAD 
measurements impossible. Microscopical examination showed that 
glutaraldehyde considerably reduced I-ÎAD, particularly on prolonged 
fixation.
The capacity of turkey red cells fixed with 0.25 per cent 
glutaraldehyde in PBS to bind to vaccinia-infected tissue culture 
cells was impaired and binding was reduced to base level as assessed 
both by QBAB assay and by microscopy,
(x) The effect of antiviral antibody on haemadsorption of turkey 
red blood cells to vaccinia-infected cells
To investigate the specificity of the erythrocyte/infected 
cell interaction, the capacity of rabbit antiVACyG to block HAD was 
investigated, Normal rabbit y-globulin (HyG) of similar protein 
concentration in PBS was employed in control assays.
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(a) The inhibition of haemadsorption to vaccinia-infected cells 
by specific antiviral antibody
Taking the haemadsorption-inhibition (HADI^q) assay end 
point as that dilution of serum which reduced BAD to 50 per cent of 
the control (PBS) level, the antiVACyG had an HADI^q titre of l/lOO 
(Figure 5), and abolished red cell binding completely at a dilution of 
1/20. Vdien NyG concentrate replaced antiVACyG, no inhibition of HAD 
occurred at dilutions of I/5 or greater.
The haemagglutination-inhibition (HAI^q) titre of the 
antiVACyG concentrate was also tested, the highest dilution of serum 
giving 50 per cent inhibition of agglutination, was 1/16,000.
(b) Blocking of the haemadsorption-inhibition assay by a vaccinia 
soluble antigen preparation
Antigen dilutions as high as I/IO24 exhibited some anti-HAD 
activity (Table I4). The blocking titre of the soluble antigen 
preparation, i.e. that which reduced HAD by 50 per cent, was I/8  - I/4,
(c) The resumption of haemadsorption to vaccinia-infected cells 
after blocking by antiviral antibody
In preceding experiments, antibody to vaccinia efficiently 
blocked HAD to infected cells. Two further experiments were carried 
out to determine whether, on removal of antibody, the haemadsorbing 
antigen reappeared at the cell surface.
In the first experiment, monolayers were infected employing
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Figure 5 The effect of antiviral antibody on haemadsorption of 
turkey red blood cells to vaccinia-infected cells #
Serial dilutions of antiVACyG were applied in 0.75 ml volumes 
to washed, 24 h virus-infected monolayers and after incubation 
(50 rain, 57^C), the cell sheet was washed lightly with PBS before 
testing for HAD.
Hey:'
# + antiVACyG
o + ïïyG
compared to HAD to vaccinia-infected 
cells treated with NyG.
100#-
90#-
80#-
70#-
< 60#-
40#-
3CF
20#-
10#-
 ^ ' « G  Dt LN
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Table 14 Blocking of the haemadsorption-inhibition assay by a
vaccinia soluble antigen preparation
A soluble antigen preparation from vaccinia-infected HeLa 
cells was serially diluted in PBS and mixed with equal volumes of 
1/15 anti-VAGyG. After incubation at 37^0 for 3O min to allow 
antigen/antibody interactions, the mixtures were tested for their 
ability to reduce HAD; the dilution of antiserum employed (I/30  
final dilution) was, from the previous experiment, sufficient to 
block HAD.
Dilution of 
cell extract
Anti VAGyG dilution Haemadsorption
(NyG) 100
1/2 1/15 60, 56, 52
1/4 1/15 55, 69, 72
1/16 1/15 45, 45, 51
1/32 1/15 32, 31, 37
1/64 1/15 31, 33, 36
1/256 1/15 13, 16, 20
1/1024 1/15 10, 15, 12
PBS 1/15 4, 3, 4
uninfected cells - 4, 6, 4
^Compared to infected cells incubated with normal rabbit y-globulin
100
the normal virus adsorption period. After washing, the cell mono­
layers were overlaid with 1,0 ml per plate of calf serum-free medium 
(GSPM) containing rabbit antiVAGyG or rabbit NyG (1.5 per cent v/v). 
After a further 24 h at 37^G overlays were replaced, with CFpM. At 
various times thereafter the plates were tested for HAD (Table 15&). 
After removal of anti-viral yG red cell binding increased slowly, and 
in the 24 hours after removal of the overlay, increased by the same 
amount as the control (HyG treated) cells. Plaque titration of 
infectious virus 24 h after removal of antiserum (48 h p.i.) yielded 
only 40 per cent of the virus found in untreated plates (48 h p.i,), 
whereas in the case of plates overlaid with antiserum throughout the 
48 h period the infectious virus titre was only 8 per cent of the 
control.
The second experiment was designed to measure the rate of 
reappearance of VHA at the cell surface of 24 h vaccinia-infected 
cells after brief treatment with antiviral serum. The temporal 
reappearance of VHA was first measured, Haemadsorption increased 
slowly as soon as antiVACyG was removed (Table 15b) and rose to 50 
per cent of the control level by 4*5 h* At this stage VHA was just 
detectable intracellularly but at a level well below control.
To determine whether protein synthesis was necessary for 
reappearance of VHA, cycloheximide was incorporated in the overlay 
medium after removal of antiVACyG, In this case by 5 h after antibody 
treatment, HAD increased from background to approximately 75 per cent 
of the control level when no inhibitor was present (Table 15c).
During the 5 hour period, HAD to control (HyG) infected cells increased
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by approximately 25 per cent but in cells treated with antiVACyG, 
the level increased from background to 75 per cent of the control 
level. Cycloheximide totally suppressed the increase in HAD to 
control cells and markedly reduced the increase in HAD to antiVACyG 
treated cells.
(d) The effect of antiviral antibody on turkey red blood cells 
haemadsorbed to vaccinia-infected cells
Anti-vaccinia serum has been shown to remove VHA from 
haemagglutinated red blood cells (Burnet and Stone, 1946) and the 
"regenerated" cells could be re-agglutinated by VHA preparations. An 
experiment was designed to ascertain whether this effect could also 
be produced on red blood cells bound to vaccinia-infected cells by 
the addition of antiviral serum after HAD had taken place.
The progressive elution of adsorbed red cells by specific 
antiserum is shown in Figure 6. Elution was apparent soon after the 
addition of antibody and after 45 minutes incubation, red cell binding 
was reduced by 60 per cent although HyG caused no elution of bound 
erythrocytes. Passive elution of bound red cells was not apparent,
(xi) The purification of vaccinia haemagglutinin
An attempt was made to purify VHA from vaccinia-infected 
HeLa cells by the 2 stage density gradient centrifugation method of 
Gurvin and Haukenes (1975)* Uninfected cells and cells infected in 
the presence of an inhibitor of viral DNA synthesis were subjected to 
the same purification procedure. The results of the purification
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Figure 6 The effect of antiviral antibody on turkey red blood 
cells haemadsorbed to vaccinia-infected cells
Virus-infected cultures were tested for HAD at 24 h p.i, by 
the addition of a 5 per cent suspension of turkey red cells. After 
50 min incubation at the excess red cells were removed by
washing. The cells were then overlaid with either HyG or anti-VACyG 
at a dilution of l/lO in PBS (0.75 ml per plate). At various times 
after, the plates were washed with PBS to remove unattached red cells 
and the bound red cells estimated by QJIAD.
Key:-
# vaccinia-infected cells + antiVACyG
O  uninfected cells + antiVACyG
▲ vaccinia-infected cells + HyG
A uninfected cells h- ByG
^  compared to HAD to vaccinia-infected
cells treated with NyG.
100
90-
< 60
: 50
40
30
20
20to 40 5030
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procedm?e are shovm in Fignre 7 and Table 16
The material extracted from vaccinia-infected untreated 
cells had an HA titre of I/IO24 but uninfected and ara-C-treated 
infected cells were both devoid of HA activity; virus replication 
was inhibited by 99*8 per cent in ara-C-treated cells. The 
distribution of protein over the gradients was similar in all three 
cases and the peak of HA activity from extracts of infected cells 
was recovered in three major fractions ranging in density from 1.09  
to 1,14 gm l”^ (Figure 7a). The average activity in terms of HA^q 
units per |j.g protein was lower than in the original material (Table 
16). The YRA peak did not coincide with any major protein peak.
The three major fractions from each of the gradients were 
individually pooled and subjected to Stage 2 purification. The 
protein distributions in this case showed a marked difference between 
the "infected” preparation and the remaining two preparations, both 
of which displayed similar distributions (Figure 7b, 7c). In the 
latter cases the bulk of the protein was concentrated towards the 
bottom of the gradients although the top fractions were also rich in 
protein. The protein from the "infected" preparation steadily 
increased in quantity towards the top of the gradient and the protein 
peak coincided with the one pealc of HA activity found in the density 
gradient in the top fraction. In terms of specific activity this 
represented a 10-fold purification of VHA from Stage 1 to Stage 2 
(Table I6). This semi-purified material was subjected to SH8- 
polyacrylamide gel electrophoresis. The complex banding pattern 
produced (Plate 4) suggested that this semi-purified material 
represented a heterogeneous mixture of cellular and viral polypeptides.
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Figure 7 The purification of vaccinia haemagglutinin
comparison of sucrose density gradient fractions from 
uninfected HeLa cells and cells infected in the 
presence or absence of cytosine arahinoside
Extracts of i) 24 h-vaccinia-infected cells (Figure 7a)
ii) 24 h-vaccinia-infected cells in the presence 
of ara-C (Figure 7b) 
iii) uninfected cells (Figure 7c) 
were subjected to a two-stage sucrose density gradient purification 
procedure to purify VHA (Gurvin and Haukenes, 197$).After centrifugation 
of a "soluble" cell extract on density gradients in stage (l), the 
peak VHA fractions in a) were pooled, as were the corresponding 
fractions in b) and c), and re-centrifuged on a second, but different 
gradient. From this stage (2) centrifugation peak fractions of VHA 
activity could be demonstrated in a). For each fraction sucrose and 
protein concentrations were also measured.
Key:- 0— 0 protein (pg ml
o__o haemagglutinin
A— A sucrose (per cent w/v)
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Sodj-um dodecyl siilphate polyacrylamide p:el electrophoresis 
of "purified" vaccinia haemagglutinin
YÏÏA purified by sucrose density gradient fractionation 
of extracts of vaccinia-infected HeLa cells was subjected to SDS-HAGE 
according to the method of McHiven _et ^  (1972). The resulting 
polypeptide pattern (left on plate) was compared to that obtained 
with human serum albumin (right on plate).
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G. INTERACTIONS BETV/EEM CQMGAMAVALIN A AND VACCIMA-IMFECTEiD CELLS
A variety of plant lectins capable of binding to specific 
sugars have been described (reviewed by Lis and Sharon, 1975)• In 
particular, con A, which binds to a-D-glucopyranose, a-L-manno- 
pyranose, a-L-fructofuranose and their glycosides (Poretz and 
Goldstein, 1970), has been used to monitor changes in the distribution 
of sugars on the surface of mammaJian cells (Nicholson, 1974)» In 
the following experiments con A was used to detect surface changes in 
vaccinia-infected cells.
(i) Goncanavalin A agglutination of vaccinia-infected human 
embryonic lung cells
Zarling and Tevethia (l97l) and Pandlow et al (1975) 
reported that vaccinia-infected cells became agglutinable by con A 
as early as two hours p.i.*
Here, the method used by Zarling and Tevethia was modified, 
and cell agglutination was assessed not by macroscopic patterns in 
plastic trays but by direct microscopical examination of the cells. 
Preliminary experiments demonstrated the susceptibility of the HeLa 
cell line itself to agglutination in the presence of con A at 1 mg ml” ,^ 
A primary cell line, human embryonic lung cells was therefore selected. 
The results (Table I7) showed that preferential agglutination by 
con A of virus-infected cells could be demonstrated within 5 to 5 h 
of infection. In saline, although no agglutination was initially 
apparent, some auto-agglutinaiion occurred with infected cells, but 
not with uninfected cells.
Ill
Table 17 Goncanavalin A agglutination of suspensions of 
vaccinia-infected human embryonic lung cells
Time (h p.i.) Degree of agglutination*
Autoagglutination Agglutination by Gon A
3.5
6.5
10
14
18
24
* Results of four assays; degree of agglutination was assessed 
visually, 0 = no agglutination
1 = 2-3 cells clumped
2 = 6-20 cells clumped
3 =  ^ 20 cells clumped
Uninfected cells tested at all times showed no aut o agglutinât ion 
or agglutination by con A.
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Clumps of autoagglutinated cells consisted of two to tliree 
cells early in infection and later increased to six or more. However 
it did not resemble the massive conglomerates of  ^ 100 cells produced 
in the presence of con A. Autoagglutinability was evident as early 
as 3*5 b p.i. and increased moderately thereafter. It may be related 
to the increased amount of cell surface mucopolysaccharide reported to 
be present during "vaccinia infection (Bubel and Lambert, 1 % 7 ) or the 
virus induced "fusion from without" observed by Mbuy and Bubel (1976).
(ii) Goncanavalin A binding to vaccinia-infected cells
(a) Determination of optimum concanavalin A concentration for 
coating human red blood cells
Since uninfected HeLa cells were agglutinated by con A and 
presumably therefore also bound con A in significant amounts, it was 
of interest to determine whether vaccinia-infected cells might 
preferentially bind more con A during infection. In initial 
experiments the protocol of Bubel and Blaclonan was followed using 
human rather than mouse erythrocytes since the latter react with both 
con A and VHA. However, the high degree of red cell binding did not 
allow precise quantitation, especially of differences in binding 
between infected and uninfected cells due to red cell binding by excess 
con A.
An alternative approach, similar to that used by Furmanski 
et al (1972) and Branny, Sainerova and Sovova (1976) was used, whereby 
instead of sequential treatment of the test cell monolayer with con A 
and human erythrocytes, the erythrocytes were pre-ooated with con A
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prior to reaction with the test cells. The hinding of con A to 
erythrocytes apparently leaves other binding sites exposed on the 
con A molecule which can further react with receptor sites on the 
snrface of the test cells (Leon and Young, 1970)• This method, 
where excess lectin was removed prior to test, provided a more 
sensitive assay for con A binding sites. The optimum concentration 
of con A to be used for red cell coating was first determined.
The comparative binding of con A-red cells to both infected
and uninfected cells is shown in Figure 8. At concentrations of less
than 50 |ig ml  ^the amount of con A bound to erythrocytes was
insufficient to detect differential binding to virus-infected cells.
Only at levels of 100 |j.g of con A and above did con A-red cells show
selective binding properties. A level of 200 (ig ml  ^was the minimum
concentration of con A for coating erythrocytes to allow enhanced
adhesion to virus-infected test cells to be easily and consistently
distinguished from background binding to uninfected test cells. Con A
-1-red cells prepared with 1000 jig ml con A showed greater binding to 
infected cells but the increased inter-red cell binding and agglutin­
ation interfered with the monolayer binding test.
In all further experiments to determine con A binding, human 
red cells were treated with the lectin at 200 |ig ml~^.
(b) The effect of vaccinia infection on concanavalin A binding 
to HeLa cells
Con A-red cells prepared as described above were allowed to 
react with monolayers of infected or uninfected HeLa cells at various
Figure 8 Determination of the optimum concanavalin A concen­
tration for coating human red blood cells
Aliquots of 0.5 ml packed human *0’ red blood cells were 
mixed with 2,5 ml volumes of Con A solutions (O - 1000 [_ig ml  ^
in PBS) and incubated for 60 min at 57^0. Coated red cells 
(con A-red cells) were washed three times in PBS and stored at 
4°C as a 2 per cent solution in PBS prior to use. Vaccinia- 
infected cell monolayers (24 b p.i.) were treated with con A-red 
cells and the degree of binding assessed spectrophotometrically 
as in the QHAD test. The results were calculated using the 
average nm^®280 nm oon A-red cells talcen from the
measured values for red cells treated with each concentration 
of con A.
Key:-
vaccinia-infected cells
0 —0  uninfected cells
concanavalin A is expressed in 
|ig ml
compared to binding at a coating 
concentration of 1000 pg ml
100h
90F
80F
5 70F
60F
50F
40F
30F
20F
10F
L O G  CONC ANAVALIN  A 
10
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times after vaccinia infection to determine the degree of con A 
binding.
In both uninfected and vaccinia-infected HeLa cells a 
fluctuating pattern of con A-red cell binding emerged during the test 
period, particularly evident from 0 to I4 h (Figure 9)» From I4 h on, 
binding to both was more consistent as was a reproducible, significant 
difference in binding between uninfected and vaccinia-infected cells. 
Fluctuations in con A-red cell binding to infected cells differed from 
uninfected cells, the most marked difference being a sharp reduction 
by one hour p.i. followed by a recovery. Consistent binding differ­
ences between uninfected and vaccinia-infected cells became clear by 
14 h p.i. This was not related to the appearance of cell surface "VHA; 
human "0" red cells were not haemadsorbed to vaccinia-infected cells 
and the adsorption of con A-red cells was not inhibited by anti-vaccinia 
serum.
(c) The effect of metabolic inhibitors on concanavalin A binding
to uninfected and vaccinia-infected HeLa cells
This experiment was carried out employing the same conditions 
used to investigate the effects of inhibitors on HAH.
Treatment of cells with each of the inhibitors had a profound 
effect on the red cell binding (Table 18). In all cases the binding 
to virus infected monolayers was greater than to monolayers infected in 
the absence of inhibitor, and increased four-fold in the presence of 
cyclohexiraide. The inhibition of cellular metabolism apparently led to
Il6
Figure 9 The effect of vaccinia infection on concanavalin A
binding to HeLa cells
Uninfected and vaccinia-infected HeLa cell monolayers 
were tested at various times after infection for the ability to 
bind con A-coated human ’O' erythrocytes by incubation at 
washing and removal of "free" red cells, and determination of 
binding by spectrophotometry after lysis.’of the erythrocytes.
Key;
vaccinia-infected cells
0—0  uninfected cells
compared to binding to vaccinia-infected 
cells at 24 h p.i.
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an increase in the n-umher of oon A binding sites at the cell surface, 
since enhanced binding was also demonstrable when nninfected cells 
were incubated with medium containing inhibitor. The presence of 
inhibitors did not affect the binding of untreated human erythrocytes.
The greatest increase in con A-red cell binding occurred with cyclo- 
heximide and actinoraycin D, potent inhibitors of protein synthesis and 
KNA synthesis respectively. Cytosine arabinoside and rifampicin 
inhibit predominantly viral rather than cellular functions which may 
partly explain the lesser effect of these inhibitors on con A binding 
to uninfected cells. They did however enhance binding to virus- 
infected cells but to a lesser degree than the other inhibitors tested. 
Progeny virus yield was inhibited to the levels previously found 
(page 85 ).
(d) Differentiation between the binding sites on vaccinia-infected 
cells for turkey erythrocytes and concanavalin A-coated 
human erythrocytes
Human red cells were not spontaneously haemadsorbed to vaccinia- 
infected HeLa cells, but if pre-coated with con A they did adhere to 
virus-infected cells, suggesting that the second haemadsorption 
reaction was not mediated by VHA but was attributable to receptor sites 
on the cell surface with an affinity for con A. As shown above, these 
receptors are present also on uninfected HeLa cells.
In this experiment the relationship between the two red cell 
binding specificities was investigated, to determine whether prior 
binding of one red cell type interfered with subsequent binding of the 
other erythrocyte. The results are presented in Table 19.
119
I
p
SH
0
Ü
fd
0
P0
.g
Ü
Ï
g
0
0
.■g
0
tiD
I.a
rS
P
g
I
g
•H
•H
II
A
o\
r—I
0
H
I
CO 0 o  A cD O
S3
>d A HÎ p Pi •H 0 Pi
Ü ë'Wrd
P  0 O  
•H A  oo
p.
P  O  0 
M O P  
Pi t— MH • H m  cD 4h p tj
id o3 0 
•H !>
ïil i
0 Pit> O 1 
o  no
s
CM
0
II
O
0
p
0
0
1  
Î
4h
0
w1
A
'd
0p 0 
O H
PI Ü
nj 
0 0 
P  A  
u  A  
0 0 <P o 
PI •H
"d
0
P  0 
0 A
iW 0.g "
A  
0 0
0 0 
4-4 0.g
0
I
I
■ji
0
44
0
1
U
P
y
•HI
0
m
0
■â
CQ
•d
Pi
•H
id
g
0
0
CO
p
0
Pi
A
* Î
I
g
0
&I t
P  P
I
a A  . A  Q
C5 A 
>- >-
A
I I f§
0
&
P
d
p
d
Ip
O CÜs I
I
oÎ
C M O O ^ i t L r N V O t — C O O N
0  
0
1d
1
oCO
Pia
I
0
Pi
p
I
CM
w
d
*H
id
d
•H
P
0
•d0
Pi
44
O
000
Pi
bO0
rd
bfl
d
•H
CQ
d0
Pi0
d
•H
0
-Pcd0•H
rd
d
•H
+++
rd
I
+
+
„
+ rd0P0
bO 0
d P•H
rd P
d O
•H d
p
II
od
p
1 d
120
Concurrent binding of turkey and con A-red cells to the same virus- 
infected cell was observed in sample 5» Prior binding of turkey 
red cells had little effect on the later binding of con A-red cells 
(Sample 6) but con A-red cells partially masked some turkey 
erythrocyte binding sites (Sample 5)» Anti VACyG- completely blocked 
binding of turkey erythrocytes to infected monolayers but had no 
effect on the binding of con A-red cells which indeed was possibly 
enhanced (Samples 3 and 4)* There was no inter-red cell binding 
between turkey erythrocytes and con A-red cells by reaction with excess 
available con A sites on the human red cells (Sample 5)• Con A-red 
cells bound to either infected or uninfected monolayers were not 
eluted by anti-viral antibody (Samples 7 and 9) whereas turkey 
erythrocytes were eluted (Sample 8), Antibody however must have bound 
to sites not masked by the con A-red cells since further adherence of 
turkey erythrocytes was prevented (Samples 7 and 5)*
The above findings indicated that turkey red blood cells and 
con A have different receptor sites on vaccinia-infected cells.
D. THE SIALIC ACID CONTENT OF YAGCIhlA-INFECTED CELLS
Bubel and Latobert (I967) reported that increased quantities 
of acidic mucopolysaccharide were found in vaccinia-infected cells, 
compared to uninfected cells, and sialic acid synthesis was related 
temporally to virus synthesis. Later, Bubel and Blackman (1975) 
attempted to demonstrate a cell surface location for sialic acid by 
treatment of vaccinia-infected cells with neuraminidase. The unchanged 
electrophoretic mobility suggested that the increased amount of sialic
121
acid was located internally and not accessible to neuraminidase.
Here, the sialic acid content of cells was compared in the
absence of virus infection, 24 hours after virus infection and 24 hours
after infection but with ara-C included in the medium at 25 pg ml ^.
Three estimations of sialic acid content were each made from
7
4 X 10 monolayer HeLa cells. The results, presented in Table 20, 
suggested that no overall stimulation of sialic acid synthesis occurred 
in vaccinia-infected HeLa cells by 24 hours p.i. Indeed cells seemed 
to contain significantly less sialic acid than uninfected control 
cells. Cytosine arabinoside prevented the reduction in sialic acid 
content.
The sialic acid content of vaccinia-infected HeLa monolayers 
from zero to $2 h p.i. was measured. Haemadsorption and infectious 
virus titres were also monitored. The results (Figure lO) showed a 
rapid decline in sialic acid content following entry of virus into the 
host cell from 1,5 h p.i. to 14,0 h p.i,% During the parallel rise in 
virus titre and HAD from 10 h p.i. onwards, the total cell sialic acid 
content also increased, though only from around 15 h p.i. » By 24 h p.i. 
as indicated above, the sialic acid level was significantly lower than 
in control uninfected cultures.
E. HELA CELL PLASMA MmBRAHES : PREPARATION. PDHIFIGATIOH. ADD
CHARACTERISATION
(i) Preparation and purification
Increasing awareness of the importance of the cell surface
122
Table 20 The sialic acid content of HeLa cells 24 h 
after infection with vaccinia virus
(pg per mg protein)
Uninfected cells 4.90 4.41 4.17
Infected cells 2.98 2.75 1.83
Infected cells +
cytosine arabinoside 3.61 3.35 4.64
123
Figure 10 The sialic acid content of vaccinia-infected cells 
monitored during virus growth : comparison with the 
appearance of intracellular virus and cell surface 
haemagglutinin ^
Vaccinia-infected HeLa cell monolayers were examined at various 
stages during the virus growth cycle for the appearance of infectious 
virus and HAD, and these were compared with the sialic acid content 
of cells sampled at the same time. Whole cells were scraped from 
monolayers, washed and assayed for sialic acid content and also total 
protein, and the results expressed as pg sialic acid per mg protein.
Key:-
infectious virus (p,f.n.ml”^) 
haemadsorption (compared to HAD at 48 h p.i.* 
to vaccinia-infected cells) 
hWi sialic acid (pgmg ^ protein)
This experiment was carried out concurrently with that described in 
Figure 2 (section B(i)), but here, results of the 48 h samples for 
HAD, infectious virus and sialic acid are not included since no 
sample was available for sialic acid estimation.
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membrane as a dynamic structure (Singer and Eicholson, 1972) has 
stimulated studies of the "organelle" in a form free from other 
contaminating cellular membraneous material. The membrane may be 
harvested as an entire sheet or "ghost" (VJarren, Click and Nass, I966) 
or as vesicles produced by pressurised disruption of the cells 
(Steck and Wallach, 1970), In the former case, difficulties in 
detaching subcellular organelles and attached submembraneous systems 
may arise, while in the latter case the resulting "soup" of vesicular 
material may be partially resolved by use of Picoll gradients (Wallach 
and Lin, 1973)* In the case of HeLa cells, the isolation of intact 
ghosts has generally been the method of choice.
Several methods of isolation of plasma membranes were
attempted, however the combination of sudden pH change in low molarity
buffer with gentle mechanical shear regularly yielded intact ghosts
in high proportion, while causing minimal damage to other cell
organelles. Other methods attempted included the disruption of cells
2 -1-by osmotic lysis, and mechanical shear in the presence of Zn " ions which 
stabilises the membranes by hardening.
Osmotic lysis (Graham, J,, personal commun,). Cells were transferred 
from PBS to a solution of 5 mM Tris buffer pH 7*4 containing IM glycerol 
at 0^0. After $0 min the swollen cells were pelleted and resuspended 
in a solution containing 0.25M sucrose, 5 mM MgCl^, 1 raM OaOl^, 2 mM 
EDTA (pH 7*4) • However, the resultant cell rupture was too severe to 
preserve the plasma membrane in the intact state.
Homogenisation in the presence of Zn^^ ions (barren et 1966), Cells
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washed in PBS were allowed to swell in 10 volumes of 2 mM ZnCl^ for 
10 min at room temperature, then for a further 20 min at 0*^ 0 in fresh 
2 niM ZnClg solution. Homogenisation, using a Teflon plunger, was 
continued until >70 per cent of cells appeared ruptured. However, 
such breakage only occurred after excessive homogenisation (circa 200 
strokes) probably due to the hardening effect of the Zn^^ ions on the 
membranes. The procedure was not carried beyond this point,
2 I
An alternative method employing Zn ions, that of Brunette 
and Till (1971) was also attempted with little success. Again
2 i
hardening of the cell membrane with Zn made the cells less amenable 
to breakage by homogenisation. Brunette and Till modified the 
original Warren at al method to include separation of the plasma membrane 
fraction in a two-phase polymer system of polyethylene glycol 6000 
and Bextran T500, In this work the band obtained at the phase 
interface contained no intact ghosts or any identifiable organelles.
The eventual method of isolation provided a plasma membrane 
fraction identifiable as such by phase contrast microscopy and devoid 
of any gross contaminating material (Figure 11). Initial transfer of 
washed cells in 10 mM Tris-HCl pH 7*0 to the same buffer at pH 8.0 
resulted in an outward expansion of the cell membrane to three times 
the normal cell diameter leaving a distinct, centrally situated nucleus. 
Lengthy incubation in this buffer resulted in gradual cell rupture 
even at 0°C. Thus the initial weakening of the cell membrane was 
achieved by the pH change. Complete rupture was achieved by 
administering only one or two full strokes of the homogeniser. In 
this respect, the clearance between the plunger and barrel was critical
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Figure 11 : Purification of a plasma merobrane-rich fraction from
monolayer HeLa cells
0.02# Na~EDTA/PBS
XT
Cell suspension
2 X wash PBS
1 X wash 10 mM Tris pH 7*0
10 cells (4 X 120 cm flasks 
confluent growth)
Fraction designation
N/
cell suspension in 10 ml 10 mM Tris pH 7.0
1 X  wash 10 mM Tris pH 7*0
cell suspension in 5 ml 10 mM Tris pH 8.0
homogenisation
homogenate + 5 ml 10 mM Tris pH 7.0 containing 
2 mM calcium acetate
680 g/90 seconds (ix or 2x)
— pellet suspended in 3.0 ml 
10 mM Tris pH 7.0 
2 mM calcium acetate
supernatant
layered onto 30# w/w sucroseA5# w/w 
sucrose (4:1.5) gradients 
10000 g/20 min
upper band extracted
Lower band extracted^ diluted and recentrifuged 
in fresh gradient
upper band (if present) discarded 
lower band extracted, diluted and 
centrifuged into a pellet 
resuspended in 1.0 to 2.0 ml 10 mM Tris 
pH 7.0
"THIS"
"HOMOG"
"PELLET”
"TOP BAND"
"PMS"
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and a reproducible degree of homogenisation could be achieved using 
a plunger/barrel clearance of O.O5 mm. The liberated nuclei were 
stabilised by the addition of Ca^ ions which also strengthened the 
fragile ghosts in the homogenate. Failure to include this step 
resulted in nuclear lysis and release of DEA.
Centrifugation at 680 g for 90 seconds was sufficient to 
pellet most nuclei and unbroken cells. Some larger ghosts were also 
sedimented but the majority remained in the supernatant. Resuspension 
of the pellet to recover these ghosts tended to enhance nuclear 
breakage; the increased contamination by nuclear material of any 
ghosts further separated from the pellet was considered to be too 
great to justify re-processing.
High speed centrifugation (10,000 g) of the supernatant on 
sucrose density gradients resulted in the banding pattern illustrated 
in Figure 12. Bands were recovered either by piercing the gradient 
tube and collecting fractions or by extracting via the top of the 
gradient using a syringe. The upper zone consisted of cytoplasmic 
sap which failed to pass into the sucrose gradient. At the sucrose 
barrier, a sharper band was found, consisting of cellular organelles, 
possibly lysosomes and cytoplasmic membrane fractions. In a third 
diffuse area, towards the w/v sucrose barrier, was found
fragmented membraneous material. This area merged with a distinct 
band found at the interface. Here, with additional fragmented 
membraneous material, intact sheets of plasma membrane were found, as 
described by Atkinson (1973)• Occasionally some material passed 
through the gradient forming a pellet at the bottom of the tube.
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Figure 12 The distribution of cellular material on a
sucrose density gradient diiring purification 
of HeLa cell plasma membranes
Fractions obtained from sucrose density gradients were examined by 
phase contrast microscopy.
Sucrose
(percentage
17
20
25
ii
Dense cytoplasmic 
material
Fragmented plasma and 
other gross cytoplasmic 
membraneous material
Intact plasma membrane 
ghosts and fragments
Don-disrupted or aggregated 
cells and residual nuclei
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This mainly comprised nuclei and whole cells, present as contaminating 
material in the 680 g supernatant. The fragmented material found in 
the plasma membrane band could be removed by repeating the density 
gradient centrifugation.
Aliquots of fractions retained during the purification 
procedure were assayed for the presence of various marker enzymes.
(ii) Characterisation by assay of marker enzymes
(a) Assay of K~^-ATPase. The potassium-dependent, ouabain-
inhibited phosphatase is believed to be a composite part of the sodium- 
potassium-dependent adenosine triphosphatase (Na*", K’^-ATPase) (Dahl 
and Hokin, 1974)* This, in turn, has been reported to be active in 
the plasma membrane of all cells, functioning initially as a "pump" in 
the active transport of metabolites, as well as Ma'" and ions. The 
localisation in, and confinement of, the activity to the plasma 
membrane provides an excellent specific marker for determining the 
purity of plasma membrane fractions (Wallach and Lin, 1973)» Another 
activity, ^'-nucleotidase, has been regarded as a marker enzyme for 
HeLa cell plasma membranes (Bosmann, Hagopian and Eylar, 1968), 
however its specificity has been questioned (Johnsen et 1974)- 
Da**, k'^-ATPase activity has been detected in HeLa cell plasma membrane 
ghosts or fragments (Bosmann et al, I968; Boone ab I969).
However, despite attempting several assays designed to 
detect ATPase by measuring activity in the presence and absence of Ka"** 
and ions, or by inhibition with ouabain, no detectable levels of 
Ha**", K''-ATPase were found. Among the methods attempted were those
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of Quigley and Gotterer (1969), Wallach and Kamat (1966), Henmiinki 
(1973) and Izutsu, Siegel and Brisson (1974)* Failure to observe 
any activity by these methods was attributable possibly to very low 
inherent levels, to inactivation or inhibition by the original 
treatment of the monolayer cells with EDTA or to a combination of 
these factors.
(b) Assay of K~*~-dependent phosphatase. The K**'-dependent phospha­
tase activity was mainly associated with the fraction identified 
morphologically as that containing purified plasma membranes (Table 21). 
The low levels in the nuclei-rich (PELLET) fraction and 680 g 
supernatant fraction were taken as an indication of the amount of non­
plasma membrane protein present. With respect to the supernatant 
fraction the majority of the protein was of cytoplasmic origin and 
only a small fraction can be regarded as plasma membrane protein.
(c) Assay of phosphodiesterase. Phosphodiesterase activity has 
been widely used as a specific marker enzyme for purified plasma 
membrane fractions (Bosmann ^  I968; Rufeger, Tellhelm and Kfoker,
1974; Gavard, de Lamirande and Karasalci, 1974? Durham, Galanti and 
Revis, 1973).
In this work activity was detectable only in the presumed 
plasma membrane fraction and even then only at low levels (Table 22).
(d) Assay of NADH-diaphorase. NADH-diaphorase or oxidase is 
located specifically in the membranes of the endoplasmic reticulum 
(Wallach and Kamat, I966) and catalyses the oxidation of reduced DAD 
(DADH) by various acceptors. The activity has normally been assayed
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Table 21 Distribution of potassium-dependent p-nitrophenyl 
phosphatase activity in cell fractions during 
purification of HeLa cell plasma membranes
Enzyme activity, monitored by spectrophotometric measurement of
the release of p-nitrophenol from the substrate, p-nitrophenyl
phosphate (tris), is expressed as the difference in number of nmoles
of substrate hydrolysed in the presence or absence of ions in
the reaction mixture, per pg of cellular protein per $0 minutes of
incubation time. The conversion from A  E^^^^ - to nmoles410 nm
hydrolysed is shown in Figure 1$.
Fraction Average A  nmoles pDpp hydrolysed per
pg protein per 50 min when K*** ions 
were present in the reaction mixture
THIS
HOMOG
PELLET.'
sirpT
TOP DADD 
PMS
0.095
0.072
0.063
0.058
0.102
0.286
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13 Standard curve for determining hydrolysis of p-nitro-
•8 -
40 80 120 160 200
n m o l e s  p N I T R O P H E N O L  FORMED PER ASSAY
240
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Table 22 Distribution of phosphodiesterase activity in cell 
fractions during purification of HeLa cell plasma
membranes
The release of p-nitrophenol from calcium bis-p-nitro- 
phenyl phosphate was used as a measure of enzyme activity, by 
monitoring the of the reaction mixture. ^410 ïini 410 um
units was converted to jomoles p-nitrophenol formed per »mg: protein
per 30 min incubation by means of a standard curve (Figure I3).
Fraction Average nmoles p-nitrophenol formed
per mg protein per 30 min 
TRIS Undetectable ( < O.Ol)
HOMOG Undetectable
PELLET Undetectable
SUPT Undetectable
TOP BAJTO Undetectable
PMS 2.28
13k
when that of glucose-™6--phosphatase, also a specific endoplasmic 
reticnl'um marker, was too low to measure. NABH-diaphorase is 
therefore a negative marker with respect to plasma membranes, and a 
high parity of plasma membrane preparation is suggested by the absence 
of any appreciable NABH-diaphorase activity.
Figure I4 shows the curves of oxidation of KABH by each 
cell fraction during incubation with the reaction mixture. Potassium 
ferricyanide acted as the electron acceptor. The reaction rates 
were comparable in most fractions, however the fraction from the top 
of the sucrose density gradient, containing presumably the bulk of 
the intracellular membranes, had the fastest reaction rate. There 
was a complete absence of activity in the purified plasma membrane 
fraction,
(e) Assay of ^-glucuronidase. The enzyme |3-glucuronidase, 
present predominantly in the lysosomal fraction of cells (Allison and 
Sandelin, 1963)» has been used as a *negative' marker during the 
preparation of plasma membrane fractions (Marique and Hildebrand,
1973» Bin ab 1976). The enzyme catalyses the reaction, f3-B- 
glucuronidam# + water -^an alcohol + B-glucuronate. Enzyme activity 
was measured spectrophotometrically by the release of free phenol- 
phthalein from phenolphthalein-(3-glucuronide (Allison and Sandelin,
1963).
Most activity was again found in the "top" fraction (Table 
23), where the majority of the lysosomal material and other subcellular 
material would be expected to have concentrated. Moderate amounts
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Figure 14 The rate of oxidation of NABH by cell fractions obtained 
during the purification of a plasma membrane fraction 
from HeLa cells
Oxidation was monitored by following the gradual conversion of 
NADH to HAD by the cellular enzyme, HADH diaphorase, measureable 
spectrophotometrically by a decrease in E
Key;
cell fraction
Ow*0 "PELLET"
"TRIS"
A— 4 "HQMOG"
"SÜPT,"
"PMS"
A*m*A "TOP BAHD"
12:1
1-0
-o
-a
40032024016080
r e a c t i o n  t i m e  ( s e co nd s )
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Table 23 Distribution of g-fflucujonidase activity in cell 
fractions during purification of HeLa cell plasma
membranes
Enzyme activity was monitored by spectrophotoraetric 
measurement of the release of free phenolphthalein from phenol- 
phthalein-|3"glucuronide. The results are expressed as the ^  E^
545 ^
per mg protein during an incubation period of 50 min.
Fraction
TRIS
HOMOG
PELLET
SDPT
TOP BAED
PMS
^^545°^nm per mg protein per 50 min
0.22
0.30
0.08
0.25
0.38
Undetectable (  ^O.O4)
137
of activity were found, in other fractions but none was detected in 
the plasma membrane fraction.
(iii) Characterisation by specific uptake of ^H-L-fucose
In HeLa cells it has been reported that fucose is required 
as a constituent of cell glycoproteins (Trujillo and Can, 1971s 
Atkinson and Summers, 1971> Atkinson, 1973)* Much of the fucose 
can be accounted for in the plasma membrane (Shen and Gins burg, I968; 
Bosmann, Hagopian and Eylar, 19^9? Atkinson and Summers, 19711 
Howakowski, Atkinson and Summers, 1972) and this may also be true in 
other cell systems (Bennett and Leblond, 1970j Gahmberg, 1971)»
The relative specific activities of cell fractions may therefore 
indicate the purity of plasma membrane preparations (Atkinson, 1975)*
Exponentially growing HeLa cells (l x 10^) were incubated 
for 24 h with SEM containing 80 pCi H-L-fucose, and plasma membrane 
fractions prepared. After removing the cells from the glass and 
washing twice, 4*7 per cent of the original radioactivity added to 
the maintenance medium was associated with the cells. Earlier 
experiments indicated that approximately 25 per cent of the original 
H counts applied could be eluted from cells during treatment with 
EDTA (to strip the cells from the monolayer state) and during 
subsequent washes. Trypsin treatment is known to release up to 3I 
per cent of total cell fucose from monolayers of intact HeLa cells 
(Shen and Ginsburg, I968) and low frequency ultrasonication non- 
specifically released up to 26 per cent of total cell fucose during 
detachment from the monolayer state (Payne et al, 1973)*
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HeLa cell plasma membranes contained in the supernatant 
from a 680 g centrifugation of the cell homogenate were purified by- 
centrifugation on a 50 per cent/45 per cent w/v sucrose gradient.
The distribution of
a) total ^H“L“fucose label and
b) TCA"precipitable ^H-L-fucose label
in the sucrose gradient was compared with the microscopical 
distribution of purified plasma membranes (Table 24). The TOA- 
precipitable counts measured the protein-bound label while the total 
counts in addition accounted for any free L-fucose not incorporated 
into glycoprotein.
By phase contrast microscopy, intact plasma membrane ghosts
were consistently found at the 50 per cent/45 per cent w/v sucrose
interface. The major peaks of bo’bh TCA-precipitable and total
counts were coincident at this point in the gradient (Figure I5).
From Table 24? the TCA-precipitable co-unts per pg protein in the peak
fraction (Fraction 8) represented a 5«5^1oll purification from 'bhe
original cell suspension ("Tris") and 7*56 per cent of TCA-precipitable
H-L-fucose label present in the cell suspension prior to homogenisation
was recovered. This and the protein recovery of 3 per cent compared
favourably with the results of Atkinson (1973) who reported a total
protein recovery in terms of tritium label of 4 le 7 per cent in his
purified plasma membrane fraction. Thus by the criteria employed,
5phase contrast microscopy, enzyme assay and H-L-fucose uptake, the 
cell fraction banding at the 30 per cent/45 per cent interface in a 
sucrose density gradient, was considered an acceptably purified 
preparation of HeLa cell plasma membranes in the form of intact ghosts.
139
Table 24 Distribution of H-L-fucose label in cell fractions 
during purification of HeLa cell plasma membranes
Fraction
TRIS 
HOMOG 
SDPT 
PELLET 
TOP BAHD
(Gradient Fraction 3) 
PMS
(Gradient Fraction 8)
—1Counts min" ng protein” 
Total TCA Preci.pitable
150 70
128 67
138 72
90 57
116 64
288 249
The complete distribution of -^H-L-fucose label after centrifugation 
of the 680 g supernatant on a sucrose density gradient is shown in 
Figure 1^,
i4o
Figure 15 The distribution of ^E-L-fucose in sucrose density
gradients during a stage of purification of HeLa cell 
plasma membranes
Cells were prelabelled in the monolayer state with ^H-L-fucose 
before fractionation as described in the text. Density gradient 
centrifugation of the 680 g supernatant in sucrose was followed by 
fractionation of the gradient and estimation of the radioactive label 
distribution. The total counts, i.e. those incorporated into proteins 
plus "free" H-L-fucose were estimated directly on the fractions. An 
estimation was also made of the protein-bound label, as determined 
by precipitation with trichloroacetic acid ( TCA ) onto filter paper.
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(iv) Polyacrylamide gel electrophoresis of cell fractions 
obtained in the purification procedure
V/hen the fractions obtained by purification of HeLa cell 
plasma membranes were compared by SDS-PAGE considerable differences 
were observed (Plate 5) ■> Prom the complex banding pattern of the 
cell homogenate (  ^5O polypeptides) at least I4 polypeptides were 
identified in the PM fraction, two of which (molecular weights 39,000 
and 45,000 daltons respectively) were major constituents. Five low 
molecular weight and two high molecular weight polypeptides present 
in the crude homogenate were concentrated in the 680 g pellet. A 
number of polypeptides present in the 680 g supernatant but not in 
the PM fraction were presums,bly of cytoplasmic origin. One major 
band of 45,000 daltons was common to all the cell fractions tested,
P. COMPAHISOH OP PLASMA t'DMERAPES PROM TOÎIEPECTED APD VACGIPIA-
INPECPED HELA CELLS
(i) Polyacrylamide gel electrophoresis
The polypeptide banding patterns of plasma membranes of 
vaccinia-infected HeLa cells were outwardly very similar to those of 
plasma membrane fractions of uninfected cells or cells infected in 
the presence of ara-G except that three additional polypeptides (3^,000, 
56,000 and 88,000 daltons) were detected (Plate 6),
(ii) Investigation of the possible association of YEA with 
purified plasma membranes from uninfected HeLa cells
It was postulated by Blackman and Bubel (1972) that the
lU2
Sodium dodecyl sulphate polyacrylajnide gel electro­
phoresis of subcellular fractions isolated during 
purification of plasma membranes from HeLa
cells
Samples taken at each stage of plasma membrane 
purification were analysed by SDS-PAGE, The fractions correspond 
to those described in Figure 11.
Key;-
1. Cell homogenate
2. 680 g precipitate
5. 680 g supernate
4. Plasma membrane fraction
5. Blank
6* Molecular weight standards
The molecular weight standards used were lysozyme (14,500), ovalbumin 
(45,000) and human serum albumin (69,000) and the molecular weight 
scale was calculated from a calibration graph of log molecular 
weight against migration distance.
1 2 3 4 5 6
f
I
-  lOOOOO
- 8 0 0 0 0
6 0 0 0 0
40000
20000
4 1 4 0 0 0
Ih3
Plate 6 Sodium dodecyl sulphate polyacrylamide gel electro­
phoretic comparison of purified plasma membranes 
from uninfected and vaccinia-infected HeLa cells
SDS-PAGE was carried out on a purified plasma membrane 
fraction from uninfected HeLa cells and on similar fractions 
from vaccinia-infected HeLa cells (in the presence or absence 
of ara-C) harvested at 24 h p.i.
Key;.
1. HeLa cell homogenate
2. Plasma membrane fraction:- 24 h vaccinia-
infected cells (with ara.-C)
3* Plasma membrane fraction:- uninfected HeLa cells
4* Plasma membrane fraction:- 24 h vaccinia-
infected cells
5. Molecular weight standards (see Plate 5)-
1 2  3 4 5
   - ,f
#
lOOOOO  
8 0000 
6 0000
4 0 0 0 0
2 0000
1 4 0 0 0
origin of VHA was the plasma membrane of the virus-infected cell.
This was based largely on the finding that isolated plasma membrane 
ghosts from vaccinia-infected cells could haemadsorb susceptible fowl 
erythrocytes. It was of interest therefore to establish whether 
extracts of infected HeLa cells contained free YEA protein which
might under suitable conditions associate with plasma membrane ghosts
from uninfected cells resulting in formation of functional YEA.
Equal volumes of a preparation of purified plasma membranes 
(p m ), crude VHA and Tris buffer were mixed as below:
a) PM + VHA
b) PM 4 Tris
c) VHA 4 Tris.
Each mixture was incubated for ^0 rain at before
layering on to a two step gradient (30 per cent/45 per cent w/v, in 
10 mM Tris buffer, pH 7»0)« The distribution of HA and protein in 
the three gradients is shown in Figure 16. Interaction between an 
unbound VHA protein component and purified plasma membranes could 
lead to a peak of HA activity at the 50 per cent/45 per cent sucrose 
interface, the location of the plasma membrane band or to a depletion 
of the PM band. Ho shift in the HA peak or loss of HA activity was 
effected by isolated HeLa cell plasma membranes under these 
conditions and the HA peaks were coincident. Plasma membrane ghosts 
were found by microscopy in fractions 3 and 4*
(iii) Experiments with antisera to plasma membranes of uninfected 
and vaccinia-infected HeLa cells
1^5
Figure 16 Investigation of the possible association of VHA with 
purified plasma membranes from uninfected HeLa cells
Plasma membranes (from 8 x 10 cells) purified on sucrose density 
gradients as previously described, VHA (a crude extract of vaccinia- 
infected cells, HA titre I/256) and 10 mM Iris buffer, pH 7.0 were 
mixed together in dual combinations to determine whether the 
buoyant density of VHA or of plasma membranes in a $0 per cent/45 
per cent w/v sucrose gradient might be affected by possible inter­
action, After centrifugation (10,000 g for 20 min) 40 drop 
fractions were collected after piercing the bottom of the tube and 
assayed for HA, protein and sucrose concentration.
Key:-
0 -0  PM + VHA (1/HA^q titre)
PM H- VHA (protein, pg ml”^)
>=>— o PM 4- Tris (1/HA^q titre)
PM + Tris (protein, pg ml*"^ ) 
VHA 4 Tris (1/HA^q titre)
VHA 4- Tris (protein, pg ml*"^ )
sucrose (per cent w/v) (average).
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(a) Imm-unofluorescence: Fluorescence studies performed with
antiVACyG revealed the presence of specific YICSA (page 7*5 ).
Rahhit antiserum to HeLa cell plasma membranes from uninfected or 
vaccinia-infected cells were tested in an attempt to demonstrate 
specific cell surface fluorescence. The experimental conditions were 
as previously outlined using heat inactivated antisera or yG fractions.
Antisera to plasma membranes from uninfected cells (AUBI) 
reacted with uninfected cells giving distinct membrane fluorescence 
(plates 7a,b) and antiserum to plasma membranes from vaccinia-infected 
cells (AIPM) reacted to show weak cell membrane fluorescence. At 2 h 
p.i., AIPM showed strong membrane fluorescence but only with cells 
displaying virus-induced cell rounding (Plates 7o,d). Uninfected 
cells in the same field showed little or no reaction. The strong 
membrane fluorescence on vaccinia-infected cells was also observed 
24 h p.i. (plates le,f) or when ara-C was present in the medium (plates 
7g,h). Thus the antiserum to plasma membranes from 24 h vaccinia- 
infected cells, detected virus-induced cell surface changes as early 
as 2 h p.i., in the absence of viral HHA synthesis.
Since AIPM sera 34 and 35 were raised to plasma membranes 
of vaccinia-infected HeLa cell^antibodies to host components would be 
expected to be present. • To circumvent the reaction with host 
components AIPM sera 34 and 35 and antiVACyG were tested against 
vaccinia-infected RK I3 cells. Following addition of FITC-goat 
anti-rabbit y-globulin membrane fluorescence similar to that found 
with infected HeLa cells was evident at 2 h p.i. and 24 h p.i. with 
all sera. (Results not shovm).
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Plate 7 Iminimofluorescence studies using antisera to plasma 
membrane fractions from uninfected or vaccinia- 
infected HeLa cells
Monolayers of unfixed HeLa cells, uninfected or infected with 
vaccinia, were incubated with either ATJPM 27) or AIPM 
serum at various times after infection. After washing in PBS 
the monolayers were treated with PITC-labelled sheep anti-rabbit 
globulin and again washed. The presence and location of specific 
fluorescence was determined by comparing fields photographed at 
X4-00 magnification under phase contrast and W  light.
Plate 7a-: uninfected cells with AUPM 27) ; phase contrast
u yb: *' " " “ " Tjy
" 7c: vaccinia-infected cells (2 h p.i.) with AIHM (?^5)î
phase contrast
" 7d: " » " •» with AIPM (ÿ^5)j
W
" let '* " " (24 h p.i.) with AIPM (^35);
phase contrast
’• 71: " " ” ” with AIPM (/35);
W
” 7g: " " *' (24 h p.i. in the presence of
ara-C); with AIPM (ÿ^35)S
phase contrast 
(I Yh : ” ” " " " Uy
Plate magnification 1,8X.
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(b) Immune haemadsorption. Sera (AUPM and AIPM) were tested 
with both virus-infected and uninfected HeLa cells (Table 2$); AUPM 
serum bound similarly to uninfected and vaccinia-infected cells at
2 h p.i. although preferential binding of AIPM serum to virus- 
infected monolayers could be demonstrated at this time. By 24 h, 
after correction for the non-specific red cell binding increase, the 
AIPM serum still showed preferential and increased binding to virus- 
infected monolayers.
(c) Blocking of 'VHA-mediated haemadsorption. Undiluted antisera 
were tested for their ability to block HAD. The results (Table 26) 
showed that all antisera tested inhibited HAD. Anti-HeLa serum 
reduced HAD to ^0 per cent and still displayed some inhibition when 
diluted to 1/100; AIPM (rabbit 35) almost completely inhibited 
binding of turkey erythrocytes,
(d) Other properties of the antisera. The results of HAI, 
complement fixation and neutralisation titrations of the various 
antisera are shown in Table 27.
As expected, in all cases antiVACyG was the most potent 
antiserum tested, but this was magnified as the preparation was a 
concentrated y-globulin fraction. Antisera to HeLa plasma membranes 
and to whole cells had no HAI activity beyond a nonspecific inhibition 
of red cell pelleting.
Antisera 34 and 35 showed a considerable difference in ICV 
neutralising titres but similar ECV neutralising titres. On immuno­
diffusion, the two AIPM sera and antiVACyG showed identity reactions
Ik9
Detection of vaccinia-specific antigens on the 
surface of infected HeLa cells by immune haemad­
sorption using antiserum to plasma membranes 
from vaccinia-infected HeLa cells
Monolayers were assayed as described in Materials and 
Methods (p 59 ) as an integral part of that experiment.
Antiserum (rabbit) Average of lysate (corrected)
Uninfected cells Vaccinia-infected cells
2 h p.i. 24 h p.i. 2 h p.i. 2,4. h  &L
HyG 0.172 0.184 O.I6I 0.182
anti-He'La 1.050 1.070 n.t. n.t.
antiVACyG 0.165 0.184 0.285 0.600
(AUPM)
(rabbit No. 3I) 0.232 0.226 0.241 0.209
(AIPM)
(rabbit No. 35) 0.261 0.237 0.310 0.774
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Table 26 The inhibition of haemadsorption to vaccinia-infected
cells by antisera
Rabbit antiserum
A U m  (rabbit No. 3I) 
A I M  (rabbit No. 2?) 
Aim (rabbit No. 35) 
AEÎELA (rabbit No. 29) 
NORMAL RABBIT yG
Haemadsorption (%)*
Infected cells Uninfected cells
51, 56, 60
69, 80, 65
7, 6, 4
51, 47, 45
100, 100, 100
3, 3, 2 
2, 2, 1 
1, 0, 1
1, 2, 4
2, 0, 1
3E Compared to monolayers treated with NyG*
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against vaccinia soluble antigen preparations grown in HeLa cells 
(HVSA) and rabbit dermis (RVSA) although the AIBI sera showed fewer 
lines against the latter (plates 8a,b). Antisera 2? and $1 (AUPM) 
also reacted with HVSA (Plate 8c) and with a soluble antigen 
preparation from uninfected HeLa cells (ileSA) (Plate 8d), Sera 54 
and 55 showed no reaction with HeSA (Plate 8d) and no identity reactions 
with sera 29 and 51 (Plates 8c,d). This may have resulted from a 
form of antigenic competition between HeLa and vaccinia^specific 
antigens where the immunised rabbits may have reacted preferentially 
only to one immunogen (Taussig, 1973)»
On plate 8b, the reaction between serum 26 and serum 55 
was presumably due to allotypic differences between the animals.
In attemp'ta to identify the VHA-specif ic precipitin line 
HVSA was absorbed at 37*^ G for 1 hour with excess turkey red cells 
or with human cells. Nhen this antigen preparation, with no residual 
HA activity, was compared with control antigen (HA^q titre I/256) 
using antiVACyG and AIPM 55 serum, no loss of precipitinogens was 
detected (Plates 8e,f).
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Table 27 Complement fixing, neutralising and haemagglutination-
inhibition titres of antisera
Antiserum CPcn lltre^ 50 ..... ^ 5 0
titre^ HAlc-n titre 50
ECV ICV
NyG < 1/2 < 1/2 < 1/2 < 1/2
antiVACyG 1/64 - 1/128 1/16,000 1/22,000 1/16,000
A i m  (No, 34) n.t. 1/700 1/700 1/128
AIPM (No. 35) 1/16 1/500 1/10,000 1/512
A U m  (No. 27) n.t. n.t. n.t. 1/4
A U m  (No. 31) n.t. n.t. n.t. 1/4
antiHeLa 
(No, 26) n.t. n.t. n.t. 1/2
n.t.
1
: not tested 
complement fixation titre
'neutralising antibody titre.
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Plate 8 Immunodiffusion studies with antisera to plasma 
membranes from uninfected and vaccinia-infected 
HeLa cells
Key;-
A Aim (Ho.
B = AIPM (Ho. 55)
C = AUPM (Ho. 27)
D E ATJPM (Ho. 3l)
V = antiVACyG
E = anti-HeLa (Ho
F = anti-HeLa (Ho
Antigens 1 vaccinia/HeLa cell extracted 
soluble antigen (HVSA)
soluble antigen extract of 
vaccinia-infected rabbit 
dermis (RVSA)
soluble antigenic extract of 
HeLa cells. (HeSa)
HVSA pre'-absorbed with, human 
"0" erythrocytes
HVSA pre-absorbed with turkey 
erythrocytes
%
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DISCUSSION
l^k
The object of this work was to define the changes induced
at the surface of host cells by either a productive or non-productive
infection with vaccinia virus. In the case of many viruses, such 
u s
foreign, virall-y specified antigens in the host cell membrane 
constitute the initial in vivo contact with the host immune system.
Only recently has the importance of these antigens in eliciting the 
earliest of the immune responses to virus infection been realised 
(porter, 1971; Notkins, 1974)* However, for most viruses, the role 
of antibody to these antigens has still to be elucidated.
The strain of virus used in these experiments was originally 
derived from the Lister Institute strain (Westwood £t ad, 1966). Ito 
and Barron (1972b) and Koszinowski and Ertl (1976) examined similar 
Lister-derived strains and found minimal synthesis of early VICSA.
In the experiments described here the capacity for this 
derivative strain of Lister to induce early VICSA was unknown. In 
addition the antiserum used to detect surface antigens was, in most 
cases, rabbit hyperimmune serum to the same strain of virus. It was 
not known whether antibodies to VICSA were present in this antiserum.
However, since this work was carried out in the overall 
context of evaluating the nature of protection afforded by vaccination, 
the use of a derivative of the Lister Institute strain was justified as 
it has been shown to protect rabbits from challenge by rabbit pox virus 
(Boulter et al, I964) and is an effective human vaccine for protection 
against smallpox. Consequently, any antigen not induced, particularly 
in vivo, is unlikely to be of importance in eliciting protective 
antibodies.
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A. Early antigenic changes in the cell surface membrane of vaccinia- 
infeoted cells
Several methods were employed to detect new viral antigens 
appearing at the cell surface of unfixed monolayer cells and the 
results are briefly summarised in Table 28. Cell surface viral 
antigens were detected more efficiently using AIPM serum, which 
presumably contained a greater proportion of antibody directed against 
VICSA. The AIPM serum 55 showed consistently greater binding to 
virus-infected than to uninfected monolayers by immune haemadsorption, 
demonstrating that the specificity of the antiserum was directed mainly 
against virus-specific components of the plasma membrane. Antibodies 
to HeLa cell plasma membrane antigens were also present in AIPM serum 
55 as judged by the slightly elevated immune haemadsorption to 
uninfected cells (Table 25). Immunofluorescence provided the most 
sensitive comparison of the various antisera (Plates 5 and 7)*
AntiVACyG detected VICSA as early as 2 h p.i, even when viral DMA 
synthesis was prevented. The AIPM serum, although staining uninfected 
HeLa cells to a low, background level (similar to that shown by AHPM 
serum), reacted strongly with virus-infected cells, and membrane 
fluorescence was evident from as early as 2 h p.i. in both productive 
and non-productive infection (where ara-C was present). Prom the 
nature of the immunising antigen, AIPM serum might be expected to 
contain antibody to at least one late cell surface viral antigen, VHA, 
and this was confirmed by the recorded HAI and HADI titres. Early 
binding (2 h p.i.) cannot be attributed to the presence on the cells of 
surface VHA, since other experiments failed to detect VHA at the cell
Table 28 Detection of VICSA on vaccinia-infected HeLa cells
a) antiVACyG
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Technique early
(2 h p.i.)
Immuno flucrescenc e
Immune haem­
adsorption
Complement fixation
Complement-mediated
cytolysis
125
late
(24 h p.i.)
non-productive 
(no DNA 
replication)
I-antibody binding -
n.t.
n.t,
n.t.
n.t.
b) AIPM serum
Immunofluorescence
Immune haem­
adsorption
+
n.t.
n.t. - not tested
= surface antigen change detected 
= weak positive reaction 
= no reaction
4-
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surface before at least 8 h p.i. However this does not exclude the 
possibility that a VHA precursor is an early VICSA. It is probable 
that A I M  serum contained antibodies to an early virus antigen or 
virus-modified host antigen at the infected cell surface.
Although antiVACyG gave only weak immunofluorescence against 
early VICSA, when the same serum was used in the immune haemadsorption 
assay for VICSA, antibody was readily bound to virus-infected cells 
from as early as 2 h p.i. (Table 25). The A I M  serum, however, was 
again more efficient in recognising VICSA, particularly late in 
infection, as evidenced by the substantial increase in binding by immune 
haemadsorption between 2 and 24 h p.i. Red cells adhered preferen­
tially to vaccinia-infected cells both at 2 and 24 h p.i. suggesting 
that binding mediated by host plasma membrane components with their 
corresponding antibodies played only a minor role in this reaction.
The use of hyperimmune antiserum in VICSA assays by complement 
fixation and complement-mediated cytolysis, failed to reveal any 
major difference between 2 and 24 h p.i. In the case of fixation of 
complement, a depletion, presumably as a result of antigen-antibody 
reaction, was observed as early as 2 h p.i. but no significant increase 
was apparent by 24 h p.i. Cytolysis mediated by complement was more 
efficiently measured when antibody and complement were allowed 
simultaneously to interact with cell bound antigen. Using this 
technique only moderate differences were demonstrated at 2 and 5 h 
p.i* in complement-fixing VICSA using antiVACyG as compared to NyG, 
but the difference was significant by 24 h p.i. The relative 
insensitivity of the complement fixation assays may partially explain
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the inability to detect VICSA in appreciable quantities. However 
only low levels of complement fixing antibodies may have been present 
in the y-globulin concentrate or alternatively the anti-VICSA 
antibodies, if present, may not fix complement on interaction with 
VICSA. Although Ueda at ^  (1972) found that antiserum to early 
vaccinia soluble antigens was capable of fixing complement on reaction 
with extracts of infected cells, it was not established that complement 
was fixed when VICSA reacted with anti-VICSA.
There are several examples of antibodies which do not fix 
complement (reviewed by Mollison, I969). Within the human blood group 
system. Rhesus (Rh) antibodies, which are predominantly of subclasses 
IgG^ and IgG^ do not bring about lysis of Rh positive erythrocytes. 
However of the four IgG subclasses only IgG^ and IgG^ bind well to 
complement component C^q. It has been postulated that the paucity of 
Rh antigenic sites on the erythrocyte does not permit bridging of 
antibody molecules by C^q (see Mollison, I969). I ^  is approximately 
1000 times more effective than IgG in mediating erythrocyte lysis by 
complement (Humphrey and Dourmashkin, I965) and it is likely that 
antiVACyG contains predominantly IgG antibodies, since I ^  is 
associated mainly with the primary antibody response (Uhr and Pinkel- 
stein, 1967). Therefore the density of antigenic sites on the cell 
membrane and the class or subclass of antibody induced may affect the 
ability of cell-bound antigen-antibody complexes to fix complement.
The small changes both in depletion of complement and in dye 
uptake by cytolysis at 2 h p.i, may be due to residual virus or 
virion coat material (Chang and Metz, 1976) deposited on the cell
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surface rather than VICSA. However a significant increase in dye 
uptake was demonstrable by 24 h p.i. This may be attributed to the 
presence of either early non-virion antigens at the cell surface 
supplemented by the emergence of late antigens or the movement of 
mature virions to cell peripheral locations. Among the late antigens 
appearing at the cell surface, VHA may account for the increased 
susceptibility of virus-infected cells to cytolysis although it is 
not clear whether anti-VHA may fix complement because of the 
difficulty in obtaining highly purified VHA.
Thus the Liverpool strain of vaccinia induced formation of 
virus-specified antigens at the cell surface from an early stage in 
infection and throughout the infection cycle. The facility of 
detection of these antigens varied according to the antiserum employed. 
AntiVACyG was less efficient in detecting VICSA than the rabbit A I M  
antiserum despite the 128-fold greater HAI titre. Presumably there 
was a higher level of antibody to VICSA (both early and late) in the 
latter antiserum. An alternative explanation for the greater 
efficiency of AIPM serum in VICSA detection may lie in an "altered 
self" hypothesis originally postulated by Doherty and Zinkernagel (1975) 
and extended to vaccinia-infected mouse cells by Koszinowski and Ertl 
(19757)) where host cell surface anti^ns, particularly the trans­
plantation antigens, may be modified. Prom later work with poxvirus- 
infected cells (Ada at 1976; Jackson e^ 1976) it was suggested 
that newly specified virus antigens interacted with existing host 
membrane antigens to produce an alien antigen determinant at the cell 
surface recognised both by the cellular and humoral components of the 
immune system. Therefore AIPM serum may contain antibodies to
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altered components of the HeLa cell plasma membrane in addition to 
virus specified antigenic sites. Such antibodies directed against 
"altered HeLa” would be completely absent in antiVACyG raised against 
rabbit-passaged virus and would not be detected by AIPM sera 54 and 
55 on vaccinia-infected EKI5 cells.
Experiments designed to demonstrate the presence of viral 
antigen on the surface of vaccinia-infected cells by the double binding 
of rabbit antiVACyG and ^^^I-SARyG were unsuccessful.
It may be assumed that VICSA was present on the surface of 
infected cells since this was demonstrable by other techniques - 
immunofluorescence, complement-mediated cytolysis and immune haem­
adsorption - all of which depend on antibody-antigen interaction. The 
presence of late viral antigen, VHA, could be demonstrated on the cell
surface by the binding of turkey erythrocytes. The m.o.i, used in 
125the -"^ I-SAHyG experiments was sufficient to induce a high degree of
HAD. The fact that VICSA was demonstrable by other techniques using
125the same rabbit antiVACyG suggested that the I-SARyG, rather than
antiVACyG may have been defective. Tests showed that the antigen-
combining capacity of the SARyG was only moderately impaired by
iodination and the antibody was still viable. However the low
proportion of specific antibody in the labelled yG fraction compared to
125other protein may have resulted in a high background level of -^I in 
the tests. Under these conditions, this method was not sufficiently 
sensitive to detect antigenic changes at the cell surface.
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B, Late antigenic changes in the cell surface membrane of vaccinia-
infected cells - vaccinia haemagglutinln
The time of appearance of VHA at the cell surface in the 
experiments reported here concurred with previous reports (Blackman 
and Bubel, 1972; Bubel and Blackman, 1975)* The rise in infectious 
virus titre at 8 h p.i. preceded the rise in HAD titre by approximately 
2 h but the temporal correlation between HAD and VHA reported by
Blackman and Bubel (1972) was not found here. Whether this is 
significant in terms of the relationship between the two is doubtful 
as it probably reflects the varying sensitivities of the two assay 
techniques. The QHAD assay can detect small and smooth rises in titre 
whereas the HA test detects stepwise two-fold rises. The low m.o.i. 
employed here together with the small quantities of monolayer cells 
involved did not facilitate the detection of small rises in HA^q titre 
and it was only from 16 h p.i. that the large rise in HA^q titre could 
be measured. The sensitivity of the HAD assay is shown in experiments 
using varying m.o.i. where an m.o.i. as low as 0.01 still resulted in 
readily measurable HAD.
When changes in cellular or viral metabolism leading to the 
expression of VHA at the cell surface were investigated using various 
metabolic inhibitors, the reduction of viral DBA and protein synthesis 
resulted in a corresponding reduction in progeny virus yield, and the 
lack of HAD under these conditions confirmed the concept of VHA as a 
"late" antigen (Blaclonan and Bubel, 1972). Because of the low 
tolerance of HeLa cells to actinomycin D only reduced formation of VHA 
and mature virus occurred as demonstrated by Aasen and Haukenes (1972) 
using the same concentration of the drug.
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Rifampicin, while arresting mature virus production completely, has 
been shown to allow a reduced but significant amount of VHA formation 
(Aasen and Haukenes, 1972), suggesting that the antigen is produced 
relatively independently of virus. Here VHA formation was reduced 
by 85 per cent and a background non-specific HAD to uninfected cells 
was apparent. However examination of individual, rounded virus- 
infected cells by phase contrast microscopy revealed that HAD did 
indeed occur. The almost complete absence of progeny virus however 
limited the formation of secondary foci. Similar examination of 
test plates, with other inhibitors, failed to yield any evidence for 
HAD positive primary foci.
The second section of the study of the role of VHA as a cell 
surface antigen was concerned with the interaction between VHA and 
red cells to establish the conditions under which binding occurred.
Erythrocyte binding to infected cells was optimal close to 
physiological pH and significant binding occurred over the pH range 
5.75 - 8,70 (Table 10) in agreement with the findings of Chu (I948&) 
and Gurvin and Haukenes (1976) using haemagglutination titration.
The optimum incubation temperature, around 37^0, has also 
been reported by Nagler (1944) and McCarthy and Helbert (I960) by 
haemagglutination, and by Driessen and Greenham (1959) and Dekking and 
Van Dillen (1968) using haemadsorption. The substantial reduction in 
binding which occurred between 22.5^0 and 7°C (Figure 4) could have 
arisen from the breakdown of normal lipid flow patterns leading to 
decreased mobility in the respective membranes. Alternatively as VHA
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has been found to aggregate on storage at 4*^ 0 (chu, 1948a; Neff 
et al, 1965), aggregation or reorientation of VHA in the cell membrane 
may occur, thus reducing the capacity for red cell binding. Binding 
was stable at 58°0 for 30 min indicating that VHA is intrinsically 
heat stable, a finding previously reported (Chu, 1948a; Gillen et al, 
I95G; Gurvin and Haukenes, 1976). The heat stability of VHA in situ 
by HAD, has not however been previously reported.
Prom experiments on the relationship between HAD and the 
m.o.i. (Figure 5)» the input virus determined the extent of HAD. 
However when different cell lines were infected with vaccinia at a 
constant m.o.i, progeny virus titres bore little relationship to the 
HAD found (Table 12), For a given cell line, however, the progeny 
virus titre may be related to HAD. The most extreme example tested, 
L-.929 cells, with a similar virus output yielded 90 per cent less HAD 
than HeLa cells. No inherent inhibitor of VHA could be demonstrated 
in uninfected cell extracts. The formation of VHA may have been 
inhibited either at the transcription or translation stage of the 
protein moiety. Alternatively, a host component, possibly phospho­
lipid, required for incorporation into VHA, may be present only at 
very low levels in L-929 cells. This may be phosphatidyl choline or
phosphatidyl ethanolamine, both shown to participate with VHA-specific 
protein in reconstitution of viable VHA (ichihashi, 1977)» or, the 
selective removal of phospholipids for incorporation into VHA may 
result in a cell reaction to phospholipid deprivation leading to lipid 
rearrangement which may prevent expression of VHA at the cell surface. 
An analysis of cellular lipids and locations before and after vaccinia
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infection of L-929 cells may elucidate this. The differing degrees 
of HAD shown in other cell lines may also be related to phospholipid 
levels. Since VHA-specific glycoproteins have been detected by PAGE 
then their absence from vaccinia-infected L-929 cells might implicate 
an inhibition of protein synthesis or glycosylation. It would be of 
interest also to determine whether extracts of vaccinia-infected L-929 
cells react with anti-VHA antibodies.
One of the earliest observations on VHA was its specificity 
for agglutinating certain fowl red cells (Nagler, 1942). Of the 
eleven red cell species tested here, only turkey and mouse have been 
consistently shown to be agglutinable to any extent by VHA (Table 5). 
Neither cod nor African green monkey red cells have been previously 
tested while the agglutinability of cat and dog erythrocytes has also 
not been conclusively shown. All the red cell species displaying 
greater than 25 to 30 per cent HAD were found to be appreciably 
agglutinable (Table ll), and the results confirmed the non-adsorption 
of human, sheep and dog red cells (O'Connell et al, I964). Erythro­
cytes of 50 per cent of Rhode Island red chickens may be susceptible 
to HAD (Dekking and van Dillen, I968) but the red cells tested here 
seem to have originated from a negative bird. The results with turkey 
and mouse red cells confirm previous findings (Table 5)» however the 
susceptibility of rat and rabbit red cells is not clear. The QHAD 
test gave a more sensitive assessment of red cell susceptibility than 
the HA test, and showed clearly positive HAD with rabbit and mouse 
erythrocytes and a slight positive reaction with rat red cells.
No destruction of VHA by trypsin was evident here in contrast
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to previous findings (Blackman and Bubel, 1972; Gurvin and Haukenes, 
1976). Chu (1948a) reported that VHA susceptible fowl erythrocytes 
were agglutinated following exposure to trypsin, but if trypsin did 
inactivate VHA in this test system and residual trypsin was responsible 
for any HAD, it would be expected that virus-infected and uninfected 
cells would show comparable adsorption of red cells. The differential 
binding of red cells to virus-infected cells was still evident 
however, at levels below 10 |jLg ml  ^suggesting that minimal inactivation 
of VHA occurred, perhaps as a result of the inaccessibility of VHA to 
trypsin when situ in the membrane.
Cells incubated during infection with varying concentrations 
of trypsin also displayed enhanced HAD at 24 h p.i., possibly 
attributable in part to trypsin adsorption of red cells. Normal cells 
treated with trypsin are rendered agglutinable by concanavalin A 
(Burger, I969) and at certain stages of the cell cycle an increased 
agglutinability can also be observed (Pox, Sheppard and Burger, 1971)* 
The increased agglutinability was originally thought to be due to 
exposure of con A receptors by trypsin; however it now appears that 
receptors are induced to cluster on the cell surface, probably by 
glycoprotein cross-linking, resulting in enhanced susceptibility to 
con A agglutination (Nicholson, 1972).
This dramatic effect of trypsin treatment on the surface 
membrane of normal cells illustrates the extensive restructuring of 
the cell surface which may occur on exposure to a proteolytic enzyme, 
and indicates that disruption of protein and lipid mobility may alter 
the capacity of the lipoprotein VHA to bind turkey red blood cells.
l66
Trypsin may alter the cell surface in various ways; removal of 
mucopolysaccharides (Cook, Heard and Seaman, I96O), alterations of the 
distribution of receptor sites for both con A (see above) and anti- 
glycolipid antibodies (Hakomori, Teather and Andrews, I968) and 
reduction in electrophoretic mobility (Barnard, Weiss and Ratcliff, 
1969) have been reported. In addition it has been reported that 
after an initial lag phase (< 50 minutes) trypsin-dissociated cells 
regain the ability to aggregate (Steinberg, Armstrong and Granger, 
1975)* This latter observation may explain the haemagglutination 
reported by Chu (1948a).
Treatment of red cells with glutaraldehyde rapidly abolished 
their haemadsorptive qualities while prolonged exposure of infected 
HeLa cells to the fixative resulted in a progressive loss of the 
capacity to bind turkey red cells. Since glutaraldehyde is believed 
to cross-link protein molecules by reaction with free amino groups, 
producing cyclic and polymerised derivatives (Avrameas and Ternynck, 
1969) either the red cell receptor is a protein or mobility of proteins 
in the membrane is necessary for HAD to occur. Haemagglutination 
tests with other viruses may be carried out with glutaraldehyde-fixed 
erythrocytes (Wolff ^  1977) where the receptor is resistant to
modification. This may indicate that VHA is an atypical viral 
haemagglutinin, binding red cells by an alternative mechanism to other 
HA-bearing viruses.
By the flotation method of Gurvin and Haukenes (1975)» VHA 
could be appreciably purified from gross cell debris and the 
inhibitory effect of ara-C on the formation of VHA was confirmed by
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these experiments. Gurvin and Haulcenes (1975) claimed that this 
purification procedure produced material of high HA activity, which 
did not precipitate with antiviral serum in immunodiffusion tests and 
showed no evidence of polypeptide handing on PAGE. The complex 
handing pattern found here when "purified" VHA was subjected to PAGE 
casts doubt on the relative purity of VHA recovered by this simple 
purification procedure. Considering the low protein content of the 
purified VHA of Gurvin and Haukenes (lO pg ml"*^ ) it is perhaps not 
surprising that precipitin lines and polypeptide bands were undetect­
able. It might also be considered unlikely that such a simple 
procedure would result in substantial purification of one vaccinia 
antigen from what appears to be a highly complex mixture of viral 
antigens especially if associated with membrane fragments. In this 
study no immunodiffusion precipitin lines could be attributed to VHA. 
AntiVACyG, with an HAI^q titre of l/l6,000, detected no differences 
between antigen preparations before and after removal of VHA when 
these were compared by immunodiffusion. Therefore either the 
concentration of VHA in the antigen preparation was below the detect­
able limit or VHA was associated with material, possibly membrane 
fragments, unable to penetrate the immunodiffusion gel. If the latter 
explanation is correct then VHA/membrane fragments must be of 
considerable size as 3 per cent agar gels limit penetration of 
Caminella haemocyanin (molecular weight 6,6 x 10^) (Allison and 
Humphrey, I960) and in this study 0*75 per cent agar was used.
The ability of hyperimmune antivaccinia serum to inhibit 
HAD of turkey red cells to vaccinia-infected cells was in agreement
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with reported findings (Driessen and Greenham, 1959» Middelhoven, 
1962). Haemagglutination of turkey red cells was also inhibited, 
but to a higher titre reflecting a difference in the relative 
sensitivities of HAI and HADI tests. The reverse is true in the case 
of HA and HAD assays where HA is a relatively insensitive measure of 
the VHA content of vaccinia-infected cells.
It is clear from this study and from other work that VHA is 
intimately associated with the plasma membrane and that 'soluble* VHA 
possibly consists of membrane fragments containing vaccinia specified 
components. Treatment of virus-infected cells with anti-vaccinia 
serum blocked both haemadsorption and haemagglutination by cell 
extracts with only slightly reduced yields of virus and antigens 
(Table 15b). The reduction in the HA^q titre must have resulted from 
a direct effect of antiserum on the infected cell surface.
The reappearance of VHA on the cell surface after removal of 
antiserum overlays could be attributed to formation of new VHA at the 
membrane rather than elution of bound antibody. Firstly, haem­
adsorption in antiVACyG-treated cultures increased by a similar degree 
to cells treated with NyG over the 24 h period. It is of interest 
to note that in agreement with Oda (1963a), although virus yield 
was only 40 per cent of the control value, the HAD titre was more 
significantly reduced (25*5 per cent of control value) by 24 h after 
antiserum removal. Secondly, cycloheximide depressed the recovery in 
HAD titre noted in control cells after antiserum removal. This may 
not be related to direct interference with VHA formation but to the 
transport of VHA. If the surface is the origin of VHA (Blackman and
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Bubel, 1972) then the inhibitory effect may be upon synthesis or 
transport of a YIIA-precursor, possibly one or all of the glycoproteins 
described by Ichihashi (1977)» Weintraub and Bales (1974) and 
Ichihashi (1977) correlated the HA activity of plasma membrane 
fractions with the appearance of virus-specified glycoproteins. These 
observations do not preclude the possibility that VHA may be intimately 
associated with the cell plasma membrane without having been derived 
from it. Stokes (1976) showed that vaccinia release from the infected 
cell proceeded by transfer from cytoplasmic factories to the tips of 
cell microvilli possibly along a cytoplasmic microfilament network.
By electron microscopy, virus particles were found around the cell 
periphery enclosed in host cytoplasmic membranes. Although it has 
also been demonstrated, using ferritin-labelled antibody, that viral 
antigen becomes distributed over the entire cell surface except at the 
egress points of mature virus (ichihashi et I97I), other 
observations (Blackman and Bubel, 1972; Bubel and Blaclcman, 1975; 
this study) indicate that VHA becomes detectable at the cell surface 
at approximately the same time as mature virus suggesting a possible 
relationship between the appearance of cell surface VHA and emerging 
virus. The movement of virus particles outwards from the factories 
may further affect the already disrupted host cell metabolism and the 
formation of a lipoprotein such as VHA may simply be a by-product.
Ichihashi and Dales (1971) failed to demonstrate an 
association between VHA in a soluble antigen extract and a membrane 
fraction (including plasma and cytoplasmic membranes) from uninfected 
cells. In this study, no jn vitro association between VHA and 
purified plasma membranes from uninfected HeLa cells could be demonstrated.
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This is compatible with the concept of VHA as a viral glycoprotein 
already associated with membrane components. The plasma membrane 
from vaccinia-infected cells may be premodified in some way to allow 
insertion of VHA precursor and it would therefore be of interest to 
examine possible interactions between plasma membrane and VHA-specific 
glycoproteins. This might answer the question of whether VHA 
originates at the plasma membrane (vide supra). Also, antibody 
treatment of monolayers with adsorbed erythrocytes elicited 
progressive detachment of bound red cells. That the elution was not 
passive is shown by the lack of effect of NyG indicating that the VHA/ 
antibody binding affinity was much greater than the VHA/erythrocyte 
binding affinity.
Binding sites on the vaccinia-infected cell surface for 
susceptible fowl cells were distinct from those for con A. Some 
steric hindrance of turkey red cell binding was apparent but 
irrespective of this con A is bound to the cell surface at sites 
distinct from VHA and antiviral antibody has no effect on this union.
Antisera to host cell components inhibited HAD possibly 
because cell surface VHA may be partly composed of host material capable 
of reacting with such antisera or more likely because antibody/surface 
antigen interaction sterically hindered subsequent binding of turkey 
erythrocytes. It should be noted that antiserum raised to whole 
HeLa cells (AHeLa) and to a purified plasma membrane fraction (AUHM) 
were devoid of HAI activity suggesting that the above inhibition of 
HAD was a result of steric hindrance to red cell binding.
Antiserum raised to a plasma membrane fraction from vaccinia-
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infected cells (AIPM) had significantly higher HAI^^ and HADI^q 
titres than AUPM sera* However, in view of the possible steric 
hindrance of anti-host cell sera discussed above, the HADI activity 
of AIPM serum may be partially ascribed to steric hindrance by anti­
host components of the antiserum. Suitable cross absorption of
AIPM sera by HeLa cells might remove such anti-host antibodies but 
antibodies to "altered-self" antigens of the host cell would not be 
removed by this treatment.
C. Further changes in HeLa cells during infection by vaccinia virus
Vaccinia-infected HEL cells became agglutinable by con A 
by 2 h p.i.jprior to viral DNA replication, confirming the findings 
of Zarling and Tevethia (l97l)« In this virus-cell system it is not 
clear whether increased agglutinability of cells by con A reflects an 
increase in the number of lectin binding sites or a lectin-induced 
redistribution of existing sites into clusters. Cells transformed by 
oncogenic viruses show increased con A agglutinability apparently due 
to lectin-induced "capping”, a clustering of existing receptors since 
transformed and normal cells seem to possess similar numbers of 
receptors (Nicholson, 1974)*
Bubel and Blackman (1975) attempted to determine whether 
vaccinia infection did indeed induce an increase in lectin-binding 
sites in the cell surface. That this was the case, was suggested 
by the apparent increase in the number of mouse red cells bound to 
con A-treated vaccinia-infected cells and also by an increased binding 
of FITG-labelled con A.
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The modified method of Bubel and Blackman described here, 
detected marked differences in the binding of con A-coated human 
erythrocytes but only comparatively late in the infection cycle. 
Superimposed on the fluctuating binding to virus-infected cells 
(Figure ll) was a background binding to normal HeLa cells. The 
fluctuation may be attributed to a variation in the number of con A 
receptors present on the surface of HeLa cells, a continuous cell 
line, which is the case with other transformed cells during the cell 
cycle (Fox ^  al, 1971» Smets, 1975) and particularly at mitosis 
(Glick and Buck, 1975)» Some partial synchronisation of the cell 
culture may have occurred due to handling. Initial virus penetration 
provoked a sharp drop in con A-red cell binding followed by an equally 
sharp recovery. Differences in lectin binding between uninfected 
and vaccinia-infected HeLa cells can thus be observed from I4 h to 
24 h p.i. to be completely consistent and reproducible.
From these findings, and from those of Zarling and Tevethia
(1971) and Bubel and Blaclonan (1975), it can be concluded that 
vaccinia-infection produces a similar effect to transformation, by 
increasing the target cell agglutinability by con A, but differs from 
transformation by inducing an increase in the number of con A binding 
sites, demonstrable at certain times after infection.
Bubel and Blackman (1975) suggested that the binding sites 
for con A were distinct from VHA-red cell binding sites. As already 
discussed, phase contrast microscopy of vaccinia-infected HeLa cells 
treated with turkey cells and con A-human cells confirmed this. In 
contrast to the viral specificities exhibited by VHA, the lectin-binding
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site was not neutralised by potent anti-viral y8, and neither was the 
"union" between receptor and con A-red cell broken by antiserum, as 
was the case with VHA/turkey red cells.
Con A receptors are believed to be glycoproteins (Nicholson,
1974)• It might therefore be possible that the increased binding of 
con A shown by vaccinia-infected cells was mediated by the appearance 
of new viral glycoproteins at the cell surface. These indeed exist 
and include VEÎA components (Moss et al. 1971» Weintraub and Dales,
1974» Ichihashi, 1977). However, the lack of interaction of emerging 
receptors with anti-viral antibody suggests that these are of host 
origin and may represent a reaction of the host cell to virus infection. 
The state of the host cell metabolism may be a crucial factor in 
determining the allocation of lectin receptors at the cell surface as 
the results of the experiment with metabolic inhibitors suggest. It 
has been reported that the expression of con A receptors at the herpes 
virus-infected cell surface, measured by agglutination, requires viral 
protein synthesis (Tevethia £t 1972). Inhibition of cellular 
protein synthesis in control cultures did not affect con A agglutin­
ability but the authors also suggested that increased agglutinability 
was not a non-specific change caused by virus adsorption, penetration, 
or c.p.e. In contrast Zarling and Tevethia (1971) reported that 
increased cell agglutinability after vaccinia infection required early 
host protein synthesis, but not viral or host DNA synthesis. Poste
(1972) proposed that lysosomal enzyme release at the cell surface 
during paramyxovirus infection was responsible for increased cell 
agglutinability by con A, in combination with a virus-induced 
modification of cell surface oligosaccharides.
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The results obtained in this study suggest that with regard 
to con A-red cell binding the effects of metabolic inhibitors on the 
cell are greater than the effect of virus on the cell. The drastic 
effect of vaccinia infection on host metabolism, culminating in an 
eventual breakdown of host directed functions (Moss, I968), may mimic 
the effect produced by the cell antimetabolites, actinomycin D and 
cycloheximide. The complete shutdown of host functions was originally 
attributed to a component of the invading virion which inhibited 
cellular protein synthesis (Moss, I968). Recent studies (Bablanian,
1975) have suggested that early viral roRNA synthesis may be a 
prerequisite for this effect. Despite the relative inefficiency 
(c.f. oordgogpin) of actinomycin D in inhibiting vaccinia iriRNA synthesis 
(Metz and Esteban, 1972) there may be some correlation involving 
early viral raRNA synthesis, between the induction of c.p.e, and 
increased con A binding. The early viral iriRNA may have a direct 
inhibitory effect on host protein synthesis (Bablanian, 1975)- Thus 
the manifestation of new con A binding sites on the cell surface may 
represent a non-specific response of the cell to breakdown of protein 
and RNA synthesis.
The findings of Bubel and Lambert (I967) and Bubel and 
Blackman (1975) indicated that vaccinia-infected cells synthesised 
sialic acid in greater quantities than uninfected cells but the excess 
sialic acid probably had an intracytoplasmic location. In the 
experiments reported here vaccinia entry into the host cells initiated 
a sharp reduction in the sialic acid content of the cells. Only 
when mature virus appeared did the sialic acid content begin to rise.
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Gol-abev ^  al (1971) reported that in vaccinia-infected cells late in 
infection total glacose catabolism increased but the proportion of 
glucose oxidised by the pentose phosphate cycle decreased while the 
rate of glycolysis increased. Coincident with the appearance of 
c.p.e., an alteration of cell membrane permeability was apparent,
I
shown by leakage of glycolytic enzymes into the medium, Schumperli 
et al (1977) have also reported significant leakage of cytoplasmic 
enzymes from vaccinia-infected cells. One may speculate that the 
rate of sialic acid synthesis decreases partly because of such leakage 
of enzymes from cells. In addition, the late increase in glucose 
catabolism noted above may also be reflected in an overall increase 
in sialic acid synthesis, since this is intimately related to both 
glucose and phosphoenol pyruvate metabolism (Lehninger, 197D),
Leakage of the sialic acid pool from cells may also be important. 
Cytopathic effect, and thus leakage of cytoplasmic enzymes, is not 
prevented apparently by the presence of ara-C and the depressed levels 
may be prevented from rising by the lack of late virus activity.
The drop in sialic acid content of infected cells also 
suggests that the auto-agglutinability of vaccinia-infected cells seen 
from 2 h p.i, (in con A agglutination experiment) is probably not due 
to the deposition of extracellular sialic acid,
D. HeLa cell plasma membranes; isolation, purification and 
characterisation and properties of antisera
An obvious means to study vaccinia-induced antigenic 
modifications at the cell surface is to examine the changes effected 
in the protein profile of the plasma membrane.
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Purity of the plasma membrane fraction is essential for 
this approach. The plasma membrane fraction prepared here was 
devoid of "negative" enzymic markers for endoplasmic reticulum and 
lysosomal contamination and was enriched in "positive" enzymic markers. 
The specific uptake of ^H-fucose by the plasma membrane fraction also 
suggested that the fraction was of high purity.
Studies on plasma membranes from vaccinia-infected cells 
have generally lacked adequate characterisation of the purity of the 
preparations. Wallach and Lin (1973)» Oseroff, Robbins and Burger 
(1973) and Chang, Bennett and Cuatrecasas (1975) have all discussed 
at length the absolute necessity for using valid markers, where, for 
example, the presence of a certain enzyme in a cell is restricted to 
the plasma membrane. In HeLa cells, the Na"*", -dependent ATPase 
is believed to be such a marker (johnsen et 1974) and has been 
used as such during studies on the polypeptide profile of plasma 
membranes from vaccinia-infected cells (Weintraub and Bales, 1974)*
In other studies, plasma membrane fractions have been isolated and 
characterised with respect to 5'-#Mcleotidase (Blackman and Bubel,
1972; Jackson et al, 1976) although the specificity of this enzyme 
in terms of exclusive plasma membrane location has been questioned 
(Chang _et 1975)' It may vary in distribution according to the 
purification procedure adopted (Johnsen at al, 1974) and may fluctuate 
in activity during the cell cycle (Bosmann, 19?0). In other studies 
on isolated plasma membranes from vaccinia-infected cells character­
isation of the fraction obtained has been minimal (Bandlow et al,
1973; Ichihashi, 1977).
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Polyacrylamide gel electrophoresis confirmed that the H4 
fraction was considerably less complex than the cell homogenate and 
several polypeptides associated with the 680 g pellet but not 
detectable in the 680 g snpernate were probably associated with the 
nucleus (histones or non-histone chromatin protein). The fainter 
bands on polyacrylamide gels were not recorded satisfactorily by 
photography and substantial improvement in identification of membrane 
polypeptides might be obtained by autoradiography when using radio­
labelled polypeptides.
Plasma membranes from vaccinia-infected cells differed little 
from the plasma membranes of uninfected cells except that three additional 
polypeptides were detected. The smallest polypeptide (% 3^,000 daltons) 
was of a similar molecular weight to one of the three VHA-glycoproteins 
(12,000, 34,000 and 150,000) identified by Ichihashi (l9TT). A fourth 
polypeptide of a similar size to lysozyme, perhaps equivalent to the 
12,000 daltons polypeptide described by Ichihashi (1977), may also be 
present in the PM fraction of infected cells. However, unlike the other 
three polypeptides, this was not consistently demonstrated. The 88,000 
daltons polypeptide is unlikely to be one of the core associated virion 
polypeptides (Vp2a, 2b, 2c; Sarov and Joklik, 1972) but may be a non-virion 
polypeptide related to the early surface antigens.
The polypeptide of molecular weight approximately 56,000 
daltons may be equivalent to the structural surface tubule polypeptide 
(57»000 to 58,000 daltons) described by Dales et al (I976) and Stern 
and Dales (1976). The presence of this component in the PM fraction 
is compatible with the high levels of neutralising antibody to ICV 
induced on immunisation.
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The failure of Jackson et al (1976) to demonstrate 
consistent differences in polypeptide composition of plasma membranes 
from vaccinia-infected and normal HeLa cells is probably a reflection 
of the insensitivity of the direct gel staining technique compared to 
autoradiographical detection of newly synthesised polypeptides 
(Weintraub and Dales, 1974)*
As already discussed, isolated plasma membranes from vaccinia-
infected cells and also from uninfected HeLa cells, were used mainly
to raise antisera and the properties of these antisera compared with
hyperimmune anti-vaccinia serum and anti-HeLa cell serum. In terms
of potency, anti-HeLa serum reacted more strongly with uninfected HeLa
cells by immunofluorescence and immune haemadsorption, than did
antisera prepared to plasma membranes from either virus-infected or
uninfected HeLa cells. Anti-HeLa and ATTFK had significant and
comparable HADI titres, presumably, as previously discussed, by steric
inhibition of red cell binding, and zero HAI^q titres. AIPM 35
reacted strongly with virus-induced cell surface antigens, as measured
by immunofluorescence and immune haemadsorption, and in these tests
AIPM 55 exhibited greater activity against VICSA than antiVACyG.
Although the plasma membranes were prepared from 24 h-infected cells,
the positive immunofluorescent reaction seen on 2 h-infected cells is
further evidence for a virus-specific antigen on the host cell prior to 
dis)A
viral)\synthesis. Further antigens are present at 24 h p.i. One of 
these "late" antigens is VHA; AIPM 35 and to a lesser extent AIPM 34 
showed VHA-inhibitory activity to significant titres. This would 
confirm the likely presence of ’VHA as an integral part of the plasma 
membrane fraction of vaccinia-infected HeLa cells.
1T9
From the data on virus neutralisation, the most surprising 
finding was the marked difference in titres to ICV between
A I M  34 and 35* Although semi-purified, the plasma membrane fractions 
at 24 h p.i. would no doubt contain whole virus attached to membrane 
fragments but virus replication was prevented by pretreatment with W  
light. It is of interest that despite the considerable difference 
in ÎÎD^ q titre against ICV, only a minor difference in HAI^^ titre is 
apparent. This confirms that anti-VHA antibody is unrelated to 
neutralising antibody to ICV.
It is not clear whether there is a correlation between 
anti-VHA and neutralising antibodies to ECV; comparison of a wider 
range of antisera to plasma membrane fractions would be required to 
determine this. Alternatively absorption of anti VHA antibodies by 
VHA-coated erythrocytes could be investigated. In a recent study, 
however, Tagaya ejt ^  (1977) failed to demonstrate any correlation 
between HAI^q titres and ICV or ECV neutralising titres in the sera 
of rabbits immunised with membrane fractions from vaccinia-infected 
cells (HA"*" or HA ), heated virus or active virus. Preparations of 
early VICSA also failed to elicit neutralising or HAI antibody, but, 
as with the membrane fractions, skin resistance to live virus challenge 
was induced. These findings suggest that viral antigens other than 
VHA, present in cell membrane fractions from both HA*^  and HA** vaccinia- 
infected cells and also on ECV may be important both in inducing a 
neutralising response and in inducing skin resistance. The VHA/ 
membrane fractions, which were not apparently characterised, were 
heated at 100°C for 30 min during preparation and such antigens may 
well have been destroyed by this procedure. Anti-ECV neutralising
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antibody titres were very low (< 1/512) compared to the values 
obtained by Appleyard ^  ^  (I9?l) (1/6,000; anti-rabbitpox) and 
in this study (l/l6,000; anti-vaccinia)
E. Conclusions and general discussion
It is clear that poxviruses exert a profound effect on the 
host cell by virtue of complete metabolic reorganisation and, to a 
lesser extent, by modifications to the fine structure. Although the 
tubule polypeptide, VP4o, has been identified as the antigen 
responsible for elicitation of 10V-neutralising antibody (stern and 
Dales, 1976), the prospect that ICV-neutrailsing antibody itself is 
not sufficient to prevent spread of ECV allows further speculation on 
the "neutralisable" antigens of ECV* The apparent inclusion of a 
membrane bound antigen, VHA, in the "envelope" of ECV (Payne and 
Norrby, I976), with its implied derivation from the host cell plasma 
membrane, strengthens the assertion that virus-induced activity at 
the surface of vaccinia-infected cells may have some bearing on the 
immune response to poxvirus infection. This has been extensively 
demonstrated for the poxvirus altered H-2 cell surface antigens 
coexisting with new virus coded antigens in the mouse L-929 cell 
system where circulating T lymphocytes are activated to play an 
important role in early surveillance of virus-infected cells (Doherty
e t ^ ,  1976).
Of the cell surface modifications investigated here, those 
of an antigenic nature are clearly immunologically important. Prom 
as early as 2 h p.i. VICSA can be demonstrated. The emergence of
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this antigen(s) coincides with cell structural reorganisation, in the 
form of "rounding", a general decline in host metabolism, here 
typified by the drop in sialic acid content of the cell, increased 
con A agglutinability and slightly increased con A binding. The 
next major shift occurs as virions mature, when, simultaneously, more 
"late" antigens appear, the most easily measureable being VHA although 
others may exist.
In early reports on VHA, the antigen was considered to be 
"cytoplasmic" and "soluble" since high speed centrifugation failed to 
deposit appreciable quantities from cell sap (Chu, 1948a)• Clear 
evidence for the existence of a "soluble" VHA is lacking; the 
technique for preparation of cell extracts containing VHA is normally 
so severe that membranes containing VHA would be fragmented. It is 
likely that all cellular VHA is membrane-bound; the inherent nature 
of the molecule suggests a close relationship with lipid-rich 
organelles, modified by the inclusion of a virus-specified protein(s). 
Evidence suggests the plasma membrane as the likely site of VHA 
"assembly", i.e. the combination of phospholipid and specific virus 
protein(s). However considering the highly complex network of 
interlinked membrane systems, it is possible that VHA may be formed 
on an intracellular membrane and rapidly transported to the plasma 
membrane. Its association with isolated plasma membranes from 
infected cells has been shown by Blackman and Bubel (1972) and in this 
study when surface VHA was "blocked" by antibody soluble VHA could 
not be detected in disrupted cells (Table 15b). Also uninfected plasma 
membranes do not themselves show any association with VHA in vitro 
suggesting that VHA does not exist free from membrane. Although
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intracellular membranes represent a minor contaminant (by enzyme 
studies) of the plasma membrane fraction isolated here, VHA may be 
attached both to these and to the plasma membranes in this fraction. 
The mere presence of VHA in isolated plasma membrane fractions does 
not necessarily mean that the antigen originates here. Stokes (1976) 
has described the transport of virus via microfilaments to the cell 
periphery and it is possible that the host cytoplasmic membranes 
surrounding the emerging virion may be the site of origin of VHA, 
and the appearance of VHA at the cell surface may be related to the 
arrival there of mature virions.
Since neutralising antibody to ICV did not restrict spread 
of ECV (Boulter and Appleyard, 1975) and since VHA was detected on 
the envelope of ECV but not ICV, antibody to VHA might be of some 
importance in countering ECV spread. Vaccinia generally infects by 
cell-cell transfer (Smith and Sharp, I96O), only 10 per cent being 
released as ECV. Anti-VHA would be of little value in restricting 
virus spread in this fashion although the attachment of antibody to 
cell surface VHA may, from these experiments, depress overall virus 
production by restricting the formation of secondary foci. This may 
have some bearing in vivo. However some poxvirus strains may not 
produce HA (Cassel and Eater, 1958; Weintraub and Bales, 1974) and 
no strain of rabbitpox virus produces HA (Eenner, 1958)* Virulence 
in the latter case may not be affected by the loss of VHA. The 
partial agglutination of erythrocyte species such as rabbit by VHA 
also requires investigation in vivo. The fate of ECV (containing 
VHA) shed from infected tissue in vivo would then be questioned -
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is ECV more easily "neutralised" or recognised by phagocytic cells 
when adhering to an erythrocyte? On the other hand the dissemination 
of ECV may be facilitated by erythrocyte adherence.
The question of the "protective" poxvirus antigen exclusive 
to ECV is still unresolved, if there is indeed such an antigen, but 
it is clear that virus-induced modifications to the host cell membrane 
structure and biochemistry have important implications for the host 
immune system and further investigation of the relationship between 
the infected cell membrane and ECV is required.
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APPENDICES
APPENDICES
1. BTJPFERS AND DILUENTS
a) Tris(hydroxymethyl')amirxomethane"-HCl (Tris-HCl) buffers
Stock solutions (for final molarity of x/lO)
A. 0,2 X M Tris
B. 0.2 X  M ÏÏC1
50 ml of A + y ml of B diluted to 200 ml with H^O
1
5.0 9.0
8,1 8,8
12,2 8,6
16.5 8,4
21,9 8,2
26,8 8.0
52.5 7.8
58,4 7.6
41.4 7.4
44.2 7.2
Tris-HCl buffers were used at the following molarities and pH: 
O.OIM (10 mM) pH 7.0
O.OIM (10 mM) pH 8,0
0,1M pH 8.9
0.02M pH 7.4
b) Tris-glycine buffer pH 6,3
0,6 g Tris + 2,88 g glycine (ammonia-free) made up to 1000 ml 
with HgO.
o) Histidine monohydrochloride - Tris buffer pH 7*8 (Q.Q6m )
Stock solutions:
A. 0.12M Tris (14*52 gl“^)
B. 0,12M Histidine monohydrochloride (25.l6 gl
25 ml of A + 15*2 ml of B diluted to 50 ml.
d) Glyclne-NaOH buffer pH 8.6 (O.IM), pH 10.7 (0,4M)
Stock solutions:
A. 0.2M Glycine
B. 0.2M sodium hydroxide
25 ml of A + 2,0 ml of B diluted to 100 ml with H^O 
(0,1M, pH 8,6)
(0.4M, pH 10,7)
e) Veronal-buffered saline (VBS)
Sodium chloride 8,5 gl Barbitone 0,575 gl Sodium barbitone 
0,20 gl"^; Magnesium chloride 0.168 gl”^; Calcium chloride 0,028 gl
f) "Saijo buffer" pH 7,2 (Saijo, I975)
Tris 12.1 gl ^ ; Sodium chloride 2,922 gl ^; Magnesium chloride
0.102 gl ^ ; Calcium chloride 0.001 gl 
pH adjusted to 7*2 with HCl.
g) Sodium acetate buffer pH 5.0 (O.IM)
Stock solutions:
A. 0.2M sodium acetate (trihydrate)
B. 0.2M acetic acid
70 ml of A + 50 ml of B mixed.
h) Sodium phosphate buffers (Sorensen, 1909)
Stock solutions (for final molarity of x/lO)
A. 0.2 X M sodium di-hydrogen orthophosphate
B, 0.2 X M di-sodium hydrogen orthophosphate (dodecahydrate)
th HgOI ml of B diluted to 200 ml
Z Æ
92,0 8,0 5.8
87.7 12.3 6,0
81.5 18.5 6,2
73.5 26,5 6.4
62,5 57.5 6,6
51.0 49.0 6.8
39.0 61.0 7.0
28,0 72.0 7.2
19.0 81,0 7.4
13.0 87.0 7.6
3.5 91.5 7.8
5.3 84.7 8,0
i) Phosphate buffered saline pH 7.4 (Bulbecco and Vogt, 1954)
(Dulbecoo's PBS-A)
Calcium chloride (di-hydrate) 0.1325 gl*”^ » potassium chloride 0.2 gl""^ ; 
potassium dihydrogen orthophosphate 0.2 gl~^; magnesium chloride 0.1 gl~^: 
di-sodium hydrogen orthophosphate (anhydrous) 1.15 gl"^; sodium 
chloride 8,0 gl
This was prepared by dissolving one PBS-A tablet (Oxoid Ltd.) in 
100 ml of distilled water.
j) Citrate dextrose saline (CDS)
—1 ~1 
Dextrose 20.5 gl î tri-sodium citrate 8,0 gl ; sodium chloride
4.0 gl— 1
k) Chick erythrocyte diluent (CEP) pH 6,8
The composition of this diluent, marketed by Gibco-Biocult Ltd., is 
given below. The solution was however prepared with the modifications 
listed:
-1
Gibco-Biocult 
sodium chloride 8.766 gl 
disodium hydrogen ortho­
phosphate 11.795 gl""^  (7.H2O) 
sodium dihydrogen ortho­
phosphate 21.526 gl"^ (h^o)
calcium chloride 0,111 gl-1
Modifications
sodium chloride 8.766 gl”^
disodium hydrogen orthophosphate
(anhydrous) 6,246 gl*"^
sodium dihydrogen orthophosphate
—1
24.337 gl
calcium chloride 0,111 gl-1
1) Loeffler’s methylene blue
Saturated solution of methylene blue in alcohol 300 ml
Potassium hydroxide (O.Ol per cent in H^O) 1000 ml.
2. QUANTITATIVE SFEGTROPHQTOHETRIC ASSAY OF RED CELL BINDING TO 
MONOLAYER CELL CULTTOESs- DERIVATION OF THE EQUATION GIVING
ABSOLUTE READINGS
To be determined; E.^^ turkey red blood cells (t ) (or any given red
    blood cell species
Epp^ HeLa cells (H) (or any given cell
line)
Kliowi E^QH/EggpH = X ..........  (1);
w / w  = y (2)!
both determinable and are fixed 
values for any given erythrocyte 
or tissue culture cell
E410 total readable value (r)/E2qq total readable value (r);
measured directly by spectrophotometry of cell/erythrocyte 
lysates in saponin solution (0,005 per cent).
^410^ ” ^ 410^ ®410^ assuming additivity ................  (3)
®280® = B280K + 2280? ................................  (4)
Prom (1) = x.Ejqqjj
• • 1" (3)» ®4io? “ 2410® ~ **®280® ............... (5)
Prom (2) EgggT =
in (4), EgggH = BgagE -   (6)
From (5) - x.EgggH.
Substituting in (6) ^280^ ~ ^280^ " y= 2280  ^- ; (2410^) + f 2280%
•'• 2280% - #2280% = \ e O ^  ~ J  (2410%)
E230H (1 -f) = E^ aoR - # E410R
_ 1
"280"" ” -"280"' y
(1-f)
In (5) - X E^goH
= 2410% - ^ (2280% - 2410?/^ ) (6)
’ • 2410'^  “  ^*2410? / ^  -  2410®  "  ^  2280%
2410? (1 - #) = 2^ g R  _ X EgggR
" * 2410? ” 2440% - X EgggR
( 1 - f )
So from (7) and (8)
2 4 1 0 ?  ^  -  X  E g g p R  ^  g  - # )
2280% ”  ( ?  -#)
“ ^410^ " ^  ^280^
2280% -  7  2 4 1 ^ ^
The final value of E^^qT/E^qqW was computed using an Olivetti 
Programma 101 calculator.
(7)
(8)
5. STORAGE OF TURKEY ERYTHROCYTES
Since haemadsorption studies required regular supplies of turkey 
erythrocytes the optimum conditions for storage of turkey erythrocytes 
in liquid nitrogen were investigated. The procedure for storage of
red blood cells by rapid freezing in liquid was adapted from that of
Birkbeck, Chao and Arbuthnott (1974)* Optimum storage conditions 
were determined using combinations of either dimethyl sulphoxide (DHSO) 
or glycerol as cryoprotective agent with each of three physiological 
saline solutions:
a) Chick erythrocyte diluent (cED)
b) Dulbecco's A phosphate buffered saline (PBS)
o) Citrate-dextrose saline (CBS).
Solutions of DMSO or glycerol in each diluent were prepared at 
concentrations from 0 to 40 per cent v/v. Aliquots of whole citrated 
blood (0.9 ml) were mixed with 0,5 ml aliquots of the test solutions 
in triplicate. The contents, in plastic 5 % 0,5” test tubes, were 
snap frozen by immersion in liquid nitrogen. After rapid thawing in 
a bath of tepid water, the red cells were diluted with 0.5 ml volumes 
of cryoprotective agent in diluent, at a concentration half that of 
the original test solution (i.e. the same concentration as the frozen 
red cell suspension). Intact red cells were collected by centrifu­
gation and the supernatants removed, diluted and the E ^ ^ r e c o r d e d' 410 nm
against a distilled water blank.
A standard haemolysate (lOO per cent) was prepared by totally 
lysing an equivalent volume of blood with saponin and all readings
were expressed as percentages of standard lysis and presented in 
graph form (Figure I7).
Glycerol was found to he a more efficient preservative than 
DM80 for turkey red blood cells and with PBS or CDS best protection 
was afforded by glycerol concentrations of I5 to 30 per cent. The 
third diluent, CED, was less useful in combination with glycerol 
except at the highest concentrations. When cryoprotective agent was 
omitted, least lysis was found in the case of PBS. Glycerol at a 
concentration of I5 per cent in PBS was found to be the best protective 
combination.
4. ESTIMATION OF TOTAL PROTEIM
This was carried out according to the method of Lowry jet al
(1951).
5. ESTIMATION OF TOTAL SIALIC ACID
The method of Warren (1959) was used as described in 
"Experimental Immunochemistry" E.A. Kabat and M.M. Mayer. 2nd 
Edition (C.C. Thomas, Illinois, U.S.A.), pp. 554 to 536.
1. 0.2M sodium, metaperiodate in 9^ H^PO^.
2. 10 per cent sodium arsenite in O.5M sodium sulphate/ 
O.IN HgSO^.
5. 0.6 per cent thiobarbituric acid (fresh) in O.5M
sodium sulphate.
4. Cyclohexanone.
Figure 17. Determination of the optimum conditions for storage of 
turkey erythrocytes in liquid nitrogen
Employing three buffers and two recognised cryoprotective 
agents, and using differing concentrations of each agent in each 
buffer, the optimum concentration in the most efficient buffer for 
storage of turkey erythrocytes in nitrogen was determined. Red 
cells and cryoprotective agent/buffer were mixed and snap frozen 
in a liquid bath. The rate of thawing was standardised and the 
intact red cells centrifuged. Supernatants were harvested and the 
extent of haemolysis compared to a 100 per cent haemolysate of 
turkey erythrocytes in saponin solution.
Key:-
cryoprotective agent/buffer
o— o glycerol/pBS
A—A glycerol/CDS
0-0 glycerol/CED
e-e DMSO/PBS
A— A DMSO/CDS
DMSO/CED
20{
18^
20 .3010
P E R  C E N T  C R Y O P R O T E C T I V E  A G E N T ( v/ v )
Equal volumes of cell fractions { 1,0 ml) and 0.2E H^SO^
in ’•Pyrex” conical centrifuge tubes were heated at 80*^ C for 60 min and 
centrifuged at 1000 g for 15 min. The supernatants were decanted 
for assay of liberated sialic acid.
0.2 ml volumes of test supernatant were reacted in duplicate 
with 0,1 ml of reagent 1 by mixing and allowing to stand for 20 min.
1,0 ml of reagent 2 was then added and mixed until the yellow colour 
had disappeared. $.0 ml of reagent 5 was added and the tubes incubated 
in a boiling water bath for 15 rain, followed by immersion in cold 
water for 5 min. The pink-red colour was extracted with vigorous 
shaking by the addition of 4*5 ml of cyclohexanone. The tubes were 
centrifuged at 1000 g for 15 min and the upper layer removed for 
spectrophotometric determination. As recommended by Warren, a 
correction formula was used allowing for interference by 2-deoxyribose 
present in tissues, detectable by an absorption peak at 552 nm, in 
addition to the absorption peak of sialic acid at 549 nm.
Readings at 532 and 549 nm were taken (Pye Unicam SP500) 
and the molarity of the test sample with respect to sialic acid was 
determined, from the formula
fiM ÎÎ acetyl neuraminic acid
Standard assays containing 0, 5» 10, 15 dg (O - 0,05 pM) 
W-acetyl neuraminic acid were also carried out.
